StableX Technologies, Inc. (SBLX) — 10-K

Filed 2026-03-30 · Period ending 2025-12-31 · 74,695 words · SEC EDGAR

← SBLX Profile · SBLX JSON API

# StableX Technologies, Inc. (SBLX) — 10-K

**Filed:** 2026-03-30
**Period ending:** 2025-12-31
**Accession:** 0001493152-26-013650
**Source:** [SEC EDGAR](https://www.sec.gov/Archives/edgar/data/1086745/000149315226013650/)
**Origin leaf:** 123f2e5bf163c17bfc5a5446b3bb04ee19084c239b05c815f1a933ec59fa6293
**Words:** 74,695



---

**
UNITED
STATES**
**SECURITIES
AND EXCHANGE COMMISSION**
**Washington,
D.C. 20549**
**FORM
10-K**
**
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**
**For
the fiscal year ended: December 31, 2025**
**OR**
**
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**
**For
the transition period from ___ to ___**
**Commission
file number: 001-34643**
**STABLEX
TECHNOLOGIES, INC.**
(Exact
name of registrant as specified in its charter)
| 
Delaware | 
| 
98-0204758 | |
| 
(State
or other jurisdiction of
incorporation
or organization) | 
| 
(I.R.S.
Employer
Identification
No.) | |
| 
| 
| 
| |
| 
1185
Avenue of the Americas,
New
York, NY | 
| 
10036 | |
| 
(Address
of principal executive offices) | 
| 
(Zip
Code) | |
| 
(512)
994-4917 | |
| 
(Registrants
telephone number, including area code) | |
Securities
registered pursuant to Section 12(b) of the Exchange Act:
| 
Title
of each Class | 
| 
Trading
Symbol(s) | 
| 
Name
of each exchange on which registered | |
| 
Common
Stock, par value $0.0001 per share | 
| 
SBLX | 
| 
The
NASDAQ Stock Market LLC | |
Securities
registered pursuant to Section 12(g) of the Act: None
Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No 
Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes No 
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. Yes No 
Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files). Yes No 
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company or an emerging growth company. See the definitions of large accelerated filer, accelerated filer,
smaller reporting company and emerging growth company in Rule 12b-2 of the Exchange Act:
| 
Large
accelerated filer | 
| 
Accelerated
filer | 
| |
| 
| 
| 
| 
| |
| 
Non-accelerated
filer | 
| 
Smaller
reporting company | 
| |
| 
| 
| 
| 
| |
| 
| 
| 
Emerging
growth company | 
| |
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 
Indicate
by check mark whether the registrant has filed a report on and attestation to its managements assessment of the effectiveness
of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered
public accounting firm that prepared or issued its audit report. 
If
securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant
included in the filing reflect the correction of an error to previously issued financial statements. 
Indicate
by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation
received by any of the registrants executive officers during the relevant recovery period pursuant to 240.10D-1(b). 
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes No 
The
aggregate market value of voting stock held by nonaffiliates of the registrant as of June 30, 2025, the last business day of the registrants
most recently completed second quarter, was $3,893,040 based on a closing price of $7.37 on June 30, 2025. The registrant does not have
non-voting common stock outstanding.
As
of March 30, 2026, the registrant had 1,455,975 
shares of common stock, par value $0.0001
per share, outstanding.
**DOCUMENTS
INCORPORATED BY REFERENCE**
None.
| | | | |
**STABLEX
TECHNOLOGIES, INC.**
**TABLE
OF CONTENTS**
| 
| 
| 
PAGE | |
| 
| 
| 
| |
| 
Forward-Looking Statements; Risk Factor Summary | 
3 | |
| 
PART I | 
| |
| 
Item1. | 
Business | 
4 | |
| 
Item
1A. | 
Risk Factors | 
11 | |
| 
Item
1B. | 
Unresolved Staff Comments | 
29 | |
| 
Item
1C. | 
Cybersecurity | 
30 | |
| 
Item
2. | 
Properties | 
30 | |
| 
Item
3. | 
Legal Proceedings | 
30 | |
| 
Item
4. | 
Mine Safety Disclosures | 
30 | |
| 
| 
| 
| |
| 
PART II | 
| |
| 
Item
5. | 
Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities | 
31 | |
| 
Item
6. | 
[Reserved] | 
31 | |
| 
Item
7. | 
Managements Discussion and Analysis of Financial Condition and Results of Operations | 
32 | |
| 
Item
7A. | 
Quantitative and Qualitative Disclosures About Market Risk | 
43 | |
| 
Item
8. | 
Financial Statements and Supplementary Data | 
43 | |
| 
Item
9. | 
Changes in and Disagreements With Accountants on Accounting and Financial Disclosures | 
44 | |
| 
Item
9A. | 
Controls and Procedures | 
45 | |
| 
Item
9B. | 
Other Information | 
45 | |
| 
Item
9C. | 
Disclosure Regarding Foreign Jurisdictions That Prevent Inspections | 
45 | |
| 
| 
| 
| |
| 
PART III | 
| |
| 
Item
10. | 
Directors, Executive Officers and Corporate Governance | 
46 | |
| 
Item
11. | 
Executive Compensation | 
54 | |
| 
Item
12. | 
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters | 
56 | |
| 
Item
13. | 
Certain Relationships and Related Transactions, and Director Independence | 
60 | |
| 
Item
14. | 
Principal Accountant Fees and Services | 
60 | |
| 
| 
| 
| |
| 
PART IV | 
| |
| 
Item
15. | 
Exhibits and Financial Statement Schedules | 
61 | |
| 
Item
16. | 
Form 10-K Summary | 
61 | |
| 
| 
| 
| |
| 
Signatures | 
66 | |
| 2 | |
**FORWARD-LOOKING
STATEMENTS;**
**RISK
FACTOR SUMMARY**
This
Annual Report on Form 10-K contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of forward-looking terms such as anticipates,
assumes, believes, can, could, estimates, expects,
forecasts, guides, intends, is confident that, may, plans,
seeks, projects, targets, would, and will or the negative of such
terms or other variations on such terms or comparable terminology. Such forward-looking statements include, but are not limited to, future
financial and operating results, the companys plans, objectives, expectations and intentions, statements concerning its transition
to a Stable-coin focused cryptocurrency treasury model, the strategic review of our product development strategy, the re-engineering
and development of the Vanish (the Vanish) and other statements that are not historical facts. We have based these
forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe
may affect our business, financial condition, and results of operations. These forward-looking statements speak only as of the date of
this Annual Report on Form 10-K and are subject to a number of risks, uncertainties, and assumptions that could cause actual results
to differ materially from our historical experience and our present expectations, or projections described under the sections in this
Annual Report on Form 10-K and our other reports filed with the SEC titled Risk Factors and Managements Discussion
and Analysis of Financial Condition and Results of Operations.
A
summary of the principal risk factors that make investing in our securities risky and might cause our actual results to differ materially
from those projected in these forward-looking statements is set forth below. If any of the following risks occur, our business, financial
condition, results of operations, cash flows, cash available for distribution, and ability to service our debt obligations and prospects
could be materially and adversely affected:
| 
| 
| 
we
have a history of losses and have never been profitable, and we expect to incur additional losses in the future and may never be
profitable; | |
| 
| 
| 
our
failure to meet the continued listing requirements of the Nasdaq Capital Market (Nasdaq) could result in a delisting
of our common stock, par value $0.0001 per share (common stock); | |
| 
| 
| 
Our
historical operating results are not indicative of future performance due to our significant business model change from electric
vehicle manufacturing to digital asset treasury management; | |
| 
| 
| 
Digital
assets are subject to extreme price volatility and custody risks that could result in significant declines in value or permanent
loss of assets; | |
| 
| 
| 
Regulatory
uncertainty regarding digital assets, including proposed stablecoin legislation and potential classification as an investment company,
could adversely affect our business; | |
| 
| 
| 
we
may be required to raise additional capital to fund our operations, and such capital raising may be costly or difficult to obtain,
and could dilute our stockholders ownership interests; | |
| 
| 
| 
We
have identified a material weakness in our internal control over financial reporting, and if we are unable to remediate this weakness,
our business may be harmed; | |
| 
| 
| 
holders
of our Series H-7 Convertible Preferred Stock, with a stated value of $1,000 per share (Series H-7 Preferred Stock),
and our Series H-1 Convertible Preferred Stock, with a stated value of $1,000 per share (Series I Preferred Stock),
are entitled to certain payments that may be paid in cash or in shares of common stock depending on the circumstances, if we make
these payments in cash, we may be required to expend a substantial portion of our cash resources, and if we make these payments in
common stock, it may result in substantial dilution to the holders of our common stock; | |
| 
| 
| 
the
certificate of designations for the Series H-7 Preferred Stock (the Series H-7 Certificate of Designations), the
warrants issued concurrently therewith (Series H-7 Warrants), the certificate of designations for the Series I
Preferred Stock (the Series I Certificate of Designations and, together with the Series H-7 Certificate of
Designations, the Certificate of Designations) and the warrants issued concurrently therewith (the Series I
Warrants) contain anti-dilution provisions and other adjustment provisions that have resulted in the reduction of the
conversion price of the such preferred stock and the exercise price of such warrants and may do so again in the future. These
features may increase the number of shares of common stock issuable upon conversion of such preferred stock or upon the exercise of
the such warrants; | |
| 
| 
| 
under
the Series H-7 Purchase Agreement (as defined herein) and Series I Purchase Agreement (as defined herein) we are subject to certain
restrictive covenants that may make it difficult to procure additional financing; | |
| 
| 
| 
The
loss of key personnel or our failure to attract qualified employees could harm our business operations; | |
| 
| 
| 
Stablecoin
issuers may be unable to honor redemption obligations if they face mass redemptions, which could adversely affect the value of our
holdings; | |
| 
| 
| 
The
U.S. federal, state, local, and non-U.S. tax treatment of digital assets is unclear and could result in adverse tax consequences; | |
| 
| 
| 
failure
in our information technology and storage systems could significantly disrupt the operation of our business; | |
| 
| 
| 
We
may be named in legal proceedings or become subject to regulatory inquiries, which could be costly and result in unfavorable outcomes;
and | |
| 
| 
| 
Anti-takeover
provisions in our certificate of incorporation, bylaws, and Delaware law could discourage or prevent a change of control that stockholders
may consider favorable. | |
| 3 | |
For
a more detailed discussion of these and other factors that may affect our business and that could cause our actual results to differ
materially from those projected in these forward-looking statements, see the risk factors and uncertainties set forth in Part I, Item
1A of this Annual Report on Form 10-K. Any one or more of these uncertainties, risks and other influences could materially affect our
results of operations and whether forward-looking statements made by us ultimately prove to be accurate. We undertake no obligation to
publicly update or revise any forward-looking statements, whether from new information, future events or otherwise, except as required
by law.
****
**PART
I**
**ITEM
1. BUSINESS.**
*In
this Annual Report on Form 10-K, unless the context otherwise requires, references to we, us, our,
our company, StableX and Company refer to StableX Technologies, Inc. and its subsidiaries.*
**Overview**
We
have historically designed and manufactured compact, sustainable electric vehicles. In July 2025, we commenced a strategic transition
toward a new business model focused on digital asset initiatives, with a focus on targeting the acquisition of crypto tokens that are
directly capitalizing on the rapid growth of the stablecoin industry. We view the stablecoin ecosystem as a rapidly growing segment of
the global financial infrastructure and believe that the entry into this market can provide a complementary revenue stream and enhance
stockholder value. Our approach is intended to focus on acquiring and holding crypto assets within the stablecoin space and deploying
them in a manner designed to generate yield while managing associated risks. In connection with this strategic shift, we announced a
target goal of acquiring up to $100 million in crypto assets, subject to available capital, market conditions and regulatory considerations.
Our
investment strategy centers on acquiring digital assets (tokens) that provide essential infrastructure and enabling technologies for
the stablecoin sector, often referred to as the picks and shovels approach. Rather than directly investing in stablecoins
themselves (which function as the primary commodity in this analogy), we target tokens associated with protocols, networks,
and platforms that facilitate the issuance, transfer, custody, compliance, trading, lending, and scalability of stablecoins. We believe
this positions our portfolio to capture indirect but amplified exposure to the sectors anticipated expansion.
*Name Change*
On August 21, 2025, the Company filed a Certificate
of Amendment to the Companys Amended and Restated Certificate of Incorporation (as amended, the Certificate of Incorporation)
to change the name of the Company from AYRO, Inc. to StableX Technologies, Inc., effective as of August 22,
2025. In addition, effective before the open of market trading on August 25, 2025, the Companys common stock ceased trading under
the ticker symbol AYRO and began trading on Nasdaq under the ticker symbol SBLX.
*Business
Strategy*
Our
strategy is to generate revenue through capital appreciation driven by ecosystem growth. This mechanism is intended to provide diversified,
compounding returns aligned with the projected exponential expansion of stablecoins. By focusing on infrastructure providers, we capture
value accrual from increased transaction fees, network usage and adoption without direct exposure to stablecoin redemption risks.
In
implementing our business strategy, we hold our digital assets solely on a passive basis for treasury purposes and we do not have any
current plans to stake any portion of our crypto assets held in treasury for the foreseeable future.
We
have begun the purchase of certain tokens related to our strategy, including FLUID (a stablecoin swap exchange), LINK (an oracle for
blockchains) and INJ (a layer one token that has tools for issuing stablecoins and creating DeFi exchanges). We are dollar-cost averaging
to manage risk and intend to continue to spread out our purchases across several tokens. However, if we feel the tokens are no longer
correlated to the growth in stablecoins we will evaluate selling those tokens.
| 4 | |
**
*Core
Components of Our Strategy*
| 
| 
Target
Assets: We focus on tokens representing blockchain networks, layer-1/layer-2 solutions, oracle services, interoperability bridges,
exchanges, lending protocols, and compliance tools that underpin stablecoin operations. Examples include decentralized layer one
tokens for issuance, decentralized tokens that create stablecoin exchanges, decentralized lending protocols, among others. These
are selected based on their proven utility in supporting stablecoin flows, such as USD Coin (USDC), Tether (USDT), and emerging real-world
asset (RWA) backed variants. | |
| 
| 
| |
| 
| 
Market
Opportunity: Stablecoins have demonstrated robust growth, with total market capitalization surpassing $280 billion as of mid-2025
and daily transaction volumes exceeding $10 trillion annually.1 This surge is driven by increasing adoption in payments,
remittances, DeFi lending and tokenized real-world assets (RWAs). Infrastructure tokens benefit asymmetrically from
this growth: as stablecoin usage scales, demand for underlying blockspace, security, and interoperability intensifies, leading to
higher network fees, token burns, staking rewards, and governance value accrual. Historical data shows these tokens exhibiting 0.70.9
correlation coefficients with stablecoin market cap, often outperforming during expansion phases (such as during the 20232025
bull cycles).2 | |
| 
| 
| |
| 
| 
Portfolio
Construction and Risk Management: Our positions are expected to be across six to ten diversified tokens, with an emphasis on
those with established partnerships (such as integrations with Circle or Tether) and strong fundamentals like low inflation rates
and audited smart contracts. Our strategy assumes a three-to five-year horizon, projecting five to ten times returns tied to stablecoin
total value locked (TVL) reaching $1 trillion by 2030. We believe this approach leverages the stablecoin industrys
maturation as a foundational pillar of global digital finance, offering a balanced, growth-oriented exposure without the direct regulatory
and redemption risks of holding stablecoins. It aligns with broader trends in tokenized economies, where infrastructure providers
historically capture disproportionate value from ecosystem expansion. | |
*Tokens*
We
seek tokens that are generating revenues, are growing in step with the stablecoin industry, have good partnerships and development teams,
and have tokenomics linking token success with protocol success. The identification of suitable tokens for investment is conducted on
an ongoing basis by our investment team, which continuously monitors the digital asset ecosystem for emerging opportunities. This monitoring
includes: (i) reviewing market data and analytics from reputable third-party providers (e.g., on-chain metrics, trading volumes, and
protocol performance indicators); (ii) attending industry events, webinars, and conferences to assess project developments; (iii) engaging
directly with protocol teams through outreach and due diligence calls; and (iv) analyzing regulatory updates and macroeconomic trends
affecting the stablecoin sector. We do not have fixed timelines for purchases, as selections are opportunistic and depend on market conditions.
As of March 24, 2026, we have purchased $1,150,000 of FLUID, $1,450,000
of INJ, $1,250,000 of LINK, and $250,000 of AAVE. Tokens we have purchased, or are considering purchasing, include FLUID (Fluid Protocol),
INJ (Injective Protocol), LINK (Chainlink), AAVE (Aave Protocol), and USD (USD-Denominated Stablecoins).
1
Source: McKinsey & Company, The stable door opens: How tokenized cash enables next-gen payments, July 2025; AInvest,
Digital Asset Tokens as the New Corporate Standard: Institutional Adoption and Stablecoin-Driven Payment Ecosystems in 2025,
September 2025; Visual Capitalist, Visualized: Stablecoin Market Size Forecast into 2030, October 2025.
2
Source: Pintu News, Spike in stablecoin reserves on exchanges reaches $70 billion, a bullish signal?, September 2025.
| 5 | |
| 
| 
INJ
(Injective Protocol) - INJ is the native token of the Injective Protocol, a blockchain network designed to support decentralized
finance applications, including trading and derivatives. Within the Injective ecosystem, INJ is used to pay transaction fees and
for governance-related functions, and its supply and economic parameters are determined by protocol rules and governance decisions.
The Injective network operates through open-source software and smart contracts rather than a centralized operator, and activity
on the network is driven by developers and users building and interacting with decentralized applications. The market value of INJ
is generally influenced by activity, liquidity and adoption within the Injective ecosystem, as well as broader conditions affecting
digital asset markets. Changes to the protocol, competitive dynamics among blockchain networks or shifts in developer or user engagement
may affect the role and perceived utility of INJ over time. | |
| 
| 
| |
| 
| 
LINK
(Chainlink) - LINK is the native token of the Chainlink network, a decentralized oracle network that provides external data to
smart contracts operating across multiple blockchain platforms. LINK is used to compensate node operators that supply and validate
data for the network, and the Chainlink network is integrated with a broad range of blockchain protocols and decentralized applications.
The network is designed to enable smart contracts to reference off-chain data, such as price information and event outcomes, in a
decentralized manner. Demand for LINK is generally tied to usage of the Chainlink network, the scope and reliability of its data
services, and adoption across blockchain ecosystems. The economic characteristics of LINK may also be influenced by developments
in competing data solutions and changes in how decentralized applications source external information. | |
| 
| 
| |
| 
| 
AAVE
- AAVE is the governance and utility token of the Aave protocol, a decentralized lending and borrowing platform that operates through
smart contracts and is deployed across multiple blockchain networks. Holders of AAVE may participate in governance decisions relating
to protocol parameters and upgrades, although AAVE does not represent an ownership interest in the protocol or any affiliated entity.
The Aave protocol enables users to supply and borrow digital assets in a non-custodial manner, with terms governed by smart contracts.
The economic characteristics of AAVE are generally linked to activity, liquidity, and adoption of the Aave protocol. Changes in protocol
design, user participation, or broader conditions affecting decentralized finance may influence the perceived utility and value of
AAVE. | |
| 
| 
| |
| 
| 
USD-Denominated
Stablecoins - We are also considering holding U.S. dollar-denominated stablecoins, which are digital tokens designed to maintain
a value intended to track the U.S. dollar and are typically issued by centralized entities supported by reserves intended to facilitate
redemption. Within digital asset markets, stablecoins are commonly used as a medium of exchange, settlement asset, and liquidity
management tool, and they do not provide equity, governance, or profit participation rights. If acquired, our stablecoin holdings
would be used primarily for liquidity management, settlement and operational purposes within digital asset markets. | |
*Custodial
Account*
The
Company currently uses a third-party custodian, BitGo Trust Company, Inc. (BitGo) to store the Companys crypto assets,
pursuant to a custodian services agreement, dated as of August 12, 2025, by and between the Company and BitGo (the Custodian Agreement).
Pursuant to the Custodial Agreement, BitGo, through its custodial services enables the Company to create one or more custody accounts,
controlled and secured by BitGo to store certain supported digital currencies and digital tokens or certain fiat currencies such as U.S.
dollars. BitGo also provides the Company with the option to create non-custodial wallets that support certain digital assets via an API
and web interface. The Company may also elect to store fiat currency with BitGo. The Custodial Agreement has an initial term of one year.
After the initial term, it automatically renews for successive one-year periods, unless either party notifies the other of its intention
not to renew at least 60 days prior to the expiration of the then-current term. The Company and BitGo may terminate the Custodian Agreement
if the other party breaches a material term of the Custodian Agreement and fails to cure such breach within 30 calendar days following
written notice thereof.
Pursuant
to the Custodian Agreement, BitGo agreed to obtain or maintain insurance coverage in such types and amounts as are commercially reasonable
for the services provided pursuant to the Custodian Agreement, provided that, any such insurance related to theft of the Companys
digital assets shall only apply to custodial services (where all keys are held by BitGo) and not to any wallet services for non-custodial
accounts (where one or more keys are held by the Company). BitGo has private key procedures as well as the security and procedures in
place for securing assets and in withdrawing and transferring assets. Additionally, all the private keys in custodial wallets are generated
offline and held offline, and therefore, all of the Companys digital assets (100%) are held in cold wallets. All assets held by
BitGo are segregated from all other customers assets. However, BitGo does not use any external third-parties to verify the digital
assets it holds. Rather, BitGo verifies the digital assets the Company holds on a periodic basis.
| 6 | |
*Plan
of Operation*
Over
the next twelve months, our plan to fund operations is focused on the accumulation and management of tokens. Specifically, we plan to
diversify our holdings with six to ten types of tokens, representing different segments in the stablecoin infrastructure industry, including
issuance, exchanges, lending, payments and oracles, among others. We intend to allocate the cash proceeds received from the issuance
of our securities, whether through public offerings or private placements, to support ongoing operational expenses and the execution
of such purchases.
*Initial
Stage (Up to ~6 Months):* Until early to mid 2026, we plan to implement certain strategic initiatives to fund the purchases of additional
tokens, which may include conducting private placement offerings. We expect to leverage our existing relationships within the digital
asset and cryptocurrency sectors in connection with such offerings. However, such private placement transactions may be subject to certain
limitations, including applicable restrictions imposed by U. S. securities laws, including with respect to the types of investors that
may participate in such offerings, and standard negative and affirmative covenants imposed on the Company in these types of offerings.
In addition, we may issue registered securities pursuant to registration statements on Form S-3 and/or Form S-1. Our focus in such offerings
will be on institutional investors, supported by investor outreach efforts, which may include roadshows.
*Follow-On
Stage (6-12 Months)*: In the months following such offerings, we plan to expand our treasury operations and consider additional capital
raising activities, which may include the issuance of equity and equity-linked instruments, such as convertible debt. In mid to late
2026, we plan to continuously monitor the market for strategic capital raise opportunities. We expect that any net proceeds from our
capital-raising activities will be applied primarily toward additional token accumulation. Proceeds from any such offerings, whether
conducted publicly or privately, are expected to be reinvested to further expand our token holdings and compound treasury growth. However,
we may encounter challenges associated with this strategy, including market volatility, the timing of capital deployment, and potential
dilution of earnings per share resulting from future issuances of securities.
Throughout
the next twelve months, we also intend to form alliances with stablecoin issuers or co-investment funds, where partners contribute capital
in exchange for governance rights or revenue shares.
The
Company plans to continuously scan the landscape for opportunistic acquisition opportunities that are expected to either increase the
scale of its treasury operations or help in the generation of income. Anticipated potential challenges in the next twelve months primarily
include market volatility, regulatory delays in SEC approvals for potential future capital raises, and the emergence of competing digital
asset treasury companies. We will monitor market, regulatory, and counterparty risks on a continuous basis to optimize execution across
all phases of our plan of operations.
*Purchase
of FLUID Tokens*
We
recently purchased FLUID tokens as a core holding in our infrastructure-focused portfolio targeting the stablecoin ecosystem, viewing
it as a high-conviction picks and shovels play that we believe enables seamless cross-chain liquidity and lending. Fluid
Protocol (Fluid), developed by Instadapp, is a modular DeFi infrastructure layer launched in October 2023 that unifies liquidity across
blockchains and protocols. Rebranded from Instadapps original INST token to FLUID in December 2024, Fluid offers decentralized
lending, borrowing, and a Decentralized Exchange (DEX) for efficient asset swaps. We believe this positions FLUID tokens
to directly benefit from the increase in stablecoin usage, where protocols like Fluid facilitate borrowing against stablecoins and cross-chain
transfers, capturing value from trillions in annual transaction volumes. As of December 31, 2025, Fluid has achieved nearly $2 billion
in total market size (deposited collateral), with over $46 billion in DEX volume and deployments across Ethereum, Arbitrum, Base, Polygon,
and Solana. It positions itself as a foundational Liquidity Layer for building scalable DeFi applications,
enabling protocols to share liquidity without silos and supporting high Loan-to-Value (LTV) ratios up to 95% with liquidation penalties
as low as 0.1%.3
3
Source: Messari, Understanding Fluid: A Comprehensive Overview, June 2025.
| 7 | |
Fluids
core purpose is to create a unified liquidity ecosystem that transforms idle assets into productive ones, reducing fragmentation and
enabling seamless interactions between lending, borrowing, and trading. It draws from established protocols like Aave, Compound, Uniswap
V3, MakerDAO, and Curve to innovate on capital efficiency, with features that make Fluid suitable for retail users seeking sustainable
yields (35% borrow rates) and institutions optimizing large positions, with projections for $10 billion in liquidity and $30 million
in annualized revenue by mid-2026.4 Fluids use cases include pooling liquidity from multiple sources for low-slippage
trades and facilitating cross-chain lending for global remittances or arbitrage. Automated vaults layer strategies on top of lending
positions, enabling users to earn compounded yields while maintaining liquidity, integrated with platforms for syrup USDC deployments.
The FLUID token serves as the governance and utility token by holding and proposing votes, aligning incentives, earning rewards from
protocol fees, enabling participation in buybacks that enhance token scarcity, capturing upside through burns and distributions, and
using fees and revenue sharing to pay transaction fees (with a portion allocated to Decentralized Autonomous Organization (DAO) treasury
for growth initiatives like exchange listings, market making, and team expansion).
*FLUID
Tokenomics*
FLUIDs
total and maximum supply is capped at 100 million tokens, a fixed cap established at launch to promote scarcity and predictability. At
inception in 2021, the initial circulating supply was limited due to extensive vesting schedules, with only a portion allocated for immediate
liquidity and early ecosystem incentives. By March 2025, the circulating supply had reached approximately 39.4 million tokens, reflecting
gradual unlocks from pre-launch allocations. This growth accelerated through mid-2025, driven by vesting completions.5
As
of December 31, 2025, the circulating supply stands at approximately 78.5 million tokens, representing about 78.5% of the fully diluted
valuation (FDV). Overall allocations include roughly 37.1 million tokens to team members, investors, and advisors, of which all have
vested by the end of June 2025. This vesting-heavy structure has historically kept circulating supply below 80% of total, fostering controlled
distribution.
*Creation
of FLUID Tokens*
No
new FLUID tokens are minted post-launch; the supply is entirely pre-allocated within the 100 million token cap. New tokens
enter circulation solely through vesting unlocks from locked allocations, such as those for the team, investors, advisors, and ecosystem
funds. There is no ongoing emission schedule like staking rewards or inflationary minting and no additional tokens will enter circulation.
*Burn
Mechanisms*
Fluid
does not currently feature an active, automated token burn mechanism, such as transaction-based burns common in some DeFi tokens. However,
the protocol has outlined plans for deflationary buybacks to enhance scarcity: once annualized revenue reaches $10 million (from lending
fees, swaps, and DEX activity), up to 100% of earnings could be dynamically allocated to repurchase FLUID tokens from the open market.
These buybacks would potentially feed into the DAO treasury or be burned, though specifics on execution (e.g., via governance votes)
remain proposal-dependent. As of December 31, 2025, with Fluids TVL exceeding $1.75 billion and monthly fees around $3.01 million, this
threshold is approaching, positioning buybacks as a future value-accrual tool rather than a historical feature.7
*Inflationary
or Deflationary Mechanisms*
Fluids
tokenomics are fundamentally non-inflationary due to the cap of 100 million tokens and absence of perpetual minting or reward emissions.
Post-vesting (completed on June 2025), the supply stabilized at 100 million, eliminating dilution risks from new issuance. This fixed-supply
model contrasts with inflationary designs (e.g., those with ongoing staking rewards) and aligns with deflationary principles by design.
At the current date, FLUID is fully unlocked with no scheduled future unlocks.
4
Source: DailyCoin, FLUID Jumps 10% as DeFi Star Kicks Off Token Buyback, October 2025.
| 8 | |
Deflationary
pressures are emerging through planned revenue-driven buybacks, which could reduce effective circulating supply if repurchased tokens
are locked or burned. Historical transfers, like the 2024 DAO sales, have not involved burns but have recycled tokens into ecosystem
growth, indirectly supporting demand. Overall, as Fluid scales (e.g., via multi-chain expansions on Ethereum, Arbitrum, and Solana),
protocol fees could amplify deflation via buybacks, potentially increasing token value per unit amid stablecoin and DeFi growth. Governance
flexibility allows the DAO to introduce further deflationary levers, such as fee-based burns, if proposed and approved.
*Lifecycle*
The
lifecycle of FLUID tokens is summarized as follows:
| 
| 
Pre-Launch/Minting
(2021): 100 million FLUID tokens were created before launch. Only a small portion entered circulation initially due to four-year
vesting cliffs on for stakeholders on most tokens. | |
| 
| 
| |
| 
| 
Distribution
and Vesting (20212025): Tokens are gradually unlocked over time, either linearly or after specific cliffs. For example,
team and investor tokens vest over four years from the Token Generation Event (TGE). Community and ecosystem funds are released based
on governance decisions. | |
| 
| 
| |
| 
| 
Circulation
and Usage (Ongoing): As tokens become available, they can be used for staking and governance. Submitting a proposal requires
at least 1 million FLUID (around 1% of the supply), and a quorum of 4 million (4%) is needed for a vote. Voting lasts three days,
followed by a two-day timelock. Token holders can also earn indirect yields from the protocols revenue. | |
| 
| 
| |
| 
| 
Maturity
and Deflation (Post-2025): After vesting ends, the circulating supply may decrease through token buybacks and burns. These actions
help tie the tokens value to ecosystem activity. | |
| 
| 
| |
| 
| 
End-of-Life/Redemption:
FLUID does not have a redemption feature. Its value depends on governance decisions made by the DAO, and token burns may further
increase scarcity over time. | |
**Regulatory
Environment**
Our
digital asset activities are subject to evolving federal and state laws and regulations. Regulatory authorities, including the U.S. Securities
and Exchange Commission and the Commodity Futures Trading Commission, have asserted jurisdiction over certain digital asset activities.
Changes in regulatory interpretations or the adoption of new regulations could materially impact our ability to acquire, hold, stake,
or otherwise manage digital assets and could adversely affect our business, financial condition, and results of operations.
Our
legacy electric vehicle activities are also subject to applicable automotive, safety, environmental, and manufacturing regulations should
production resume.
**Intellectual
Property**
The Company may rely on a combination
of trademarks, trade secrets, know-how and contractual protections to protect its proprietary information.
**Patents**
As
of December 31, 2025, we held 11 granted United States patents, nine of which were granted in 2023. Of the 11 patents, four are design
patents, and seven are utility patents. In addition to these granted patents, as of December 31, 2025, we had two pending patent applications
on file with the United States Patent and Trademark Office (USPTO).
All
patent applications have been filed under accelerated consideration criteria due to the age (65) of the named inventor.
| 9 | |
**Trademarks**
Our
products are marketed under a variety of valuable trademarks.
As
of December 31, 2025, we own more than 30 trademark registrations and pending applications. Depending on the jurisdiction, trademarks
generally remain valid and can be renewed indefinitely as long as they are in use or their registrations are properly maintained.
**Segment
Information**
The
Company operates as a single operating and reportable segment. During the year ended December 31, 2025, the Companys principal
activities consisted of digital asset treasury management and the management of marketable securities and cash resources, and limited
EV re-engineering activities. The Company did not generate revenue during the year ended December 31, 2025.
The
Companys Chief Executive Officer, who serves as the Chief Operating Decision Maker (CODM), reviews consolidated
financial information, including total assets and overall financial performance, for purposes of assessing performance, allocating resources,
and making operating decisions. The Companys activities are managed centrally and are not organized or evaluated as separate business
units.
Accordingly,
the Company has determined that it has one operating and reportable segment in accordance with ASC 280, Segment Reporting.
**Employees**
As
of December 31, 2025, the Company did not have any direct, full-time employees. Instead, the Company engaged a network of independent
contractors, consultants, and other third-party service providers who perform various functions for our business, including sales, product
development, and administrative support.
**Geographic
Areas**
We
operate in the United States, and all our revenue was generated in the United States during the fiscal years ended December 31, 2025
and 2024.
**Corporate
Information**
Our
corporate headquarters is located at 1185 Avenue of the Americas, New York, NY 10036. Our phone number is 512-994-4917. Our website address
is www.stablextechnologies.com. The information on, or that can be accessed through, our website is not incorporated by reference into this
Annual Report on Form 10-K.
| 10 | |
**Available
Information**
We
are required to file Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q with the Securities and Exchange Commission (SEC)
on a regular basis, and are required to disclose certain material events in Current Reports on Form 8-K. The SEC maintains an Internet
website that contains reports, proxy and information statements and other information regarding issuers that file electronically with
the SEC. The SECs Internet website is located at http://www.sec.gov. We also make available, free of charge, our Annual Report
on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to these reports on our website at www.stablextechnologies.com
as soon as reasonably practicable after those reports and other information is electronically filed with, or furnished to, the SEC.
**ITEM
1A. RISK FACTORS.**
*Our
business, financial condition and operating results can be affected by a number of factors, whether currently known or unknown, including
but not limited to those described below, any one or more of which could, directly or indirectly, cause our actual financial condition
and operating results to vary materially from past, or from anticipated future, financial condition and operating results. Any of these
factors, in whole or in part, could materially and adversely affect our business, financial condition, operating results and stock price.
The following discussion of risk factors contains forward-looking statements. See Forward-Looking Statements; Risk Factor Summary.
These risk factors may be important to understanding other statements in this Annual Report on Form 10-K.*
**Risks
Related to Our Business**
**We
have a history of losses and have never been profitable. We expect to incur additional losses in the future and may never be profitable.**
We
have never been profitable or generated positive cash flow from our operations. We have incurred a net loss each year since our inception
in 2016 and have generated limited revenues since inception, principally as a result of our investments in building infrastructure in
support of our manufacturing and business operations and plans for growth. We incurred net loss of approximately $21.8 million and net
loss of $1.8 million for the years ended December 31, 2025 and 2024, respectively. As of December 31, 2025, we had an accumulated deficit
of approximately $139 million. We may incur significant additional losses as we continue to focus our resources on scaling up our operations
for growth and incur significant future expenditures for research and development, sales and marketing, and general and administrative
expenses, capital expenses and working capital fluctuations.
**We
did not generate revenue during 2025 and may not generate revenue in future periods.**
During
the year ended December 31, 2025, we did not generate revenue. Our current activities consist primarily of managing digital assets,
marketable securities and cash resources. We may not generate operating revenue in future periods. As a result, our ability to
increase stockholder value is currently dependent on the performance of our investment portfolio and our ability to manage liquidity
effectively and access to capital markets. If capital markets become unfavorable or inaccessible, we may be unable to raise additional
funds on acceptable terms, if at all. There can be no assurance that our strategy will result in increased stockholder value.
**Our
business model has changed, and our historical operating results may not be indicative of future performance.**
Historically,
we operated as a manufacturer and seller of electric vehicles. During 2025, we transitioned away from those activities and are now focused
on digital asset treasury management and management of marketable securities. As a result, our historical financial statements are not
indicative of our current operations or future performance. Investors may have difficulty evaluating our business due to the absence
of historical operating performance under our current strategy.
**We
continuously evaluate our business strategy and may modify our strategy as necessary to respond to developments in our business and other
factors, and any such modification, if not successful, could have a material adverse effect on our business, financial condition, and
results of operations.**
We
continuously evaluate our business strategy and modify our plans as necessary to achieve our objectives in response to changing circumstances.
As part of such a process, we may delay, modify or discontinue our business strategy in the digital asset sector and choose alternative
approaches if we believe such changes would be in our best interest. We have implemented such changes in our business strategy and may
continue to do so in the future. There can be no assurances that changes that we implement will be successful or that, after implementation
of any such changes, that we will not refocus our efforts on new or different objectives.
| 11 | |
**Our
financial results are highly dependent on the performance of digital assets and marketable securities.**
A
significant portion of our assets consists of digital assets and marketable securities. The value of these assets may fluctuate significantly
due to market volatility, changes in investor sentiment, macroeconomic conditions, regulatory developments, liquidity conditions, technological
developments, and other factors beyond our control.
Digital
assets in particular are highly volatile and may experience substantial price declines over short periods of time. If the value of our
digital assets or marketable securities declines materially, our financial condition and stockholders equity could be adversely
affected.
**Digital
assets are subject to extreme price volatility and may experience significant declines in value.**
Digital
asset markets have historically experienced extreme price volatility, including rapid and substantial decreases in value. Market prices
may fluctuate due to factors such as:
| 
| 
| 
regulatory
developments; | |
| 
| 
| 
technological
changes or perceived vulnerabilities; | |
| 
| 
| 
market
manipulation; | |
| 
| 
| 
macroeconomic
trends; | |
| 
| 
| 
security
breaches or failures of digital asset platforms; and | |
| 
| 
| 
changes
in market liquidity. | |
There
is no assurance that digital asset markets will continue to develop or that digital assets will retain long-term value. Any sustained
decline in the value of digital assets could materially and adversely affect our financial condition.
**Digital
asset custody and security risks could result in the loss of our assets.**
Digital
assets are susceptible to theft, loss, hacking, cyber intrusion, and other security breaches. If private keys are lost, compromised,
or destroyed, we may lose access to our digital assets permanently. While we utilize custody solutions and internal controls designed
to safeguard our holdings, no system is entirely immune from security risks. Any loss of digital assets could have a material adverse
effect on our financial condition.
**We
may be deemed an investment company under the Investment Company Act of 1940, as amended.**
Because
a substantial portion of our assets consists of digital assets and marketable securities, there is a risk that we could be deemed an
investment company under the Investment Company Act of 1940, as amended. If we were required to register as an investment
company, we would become subject to significant regulatory requirements and restrictions that could materially limit our ability to operate
our business as currently structured. We believe we are not currently required to register as an investment company; however, this determination
depends on complex legal standards and evolving interpretations.
| 12 | |
**We
may incur losses from impairment or fair value adjustments.**
Depending
on the accounting treatment of our digital assets and marketable securities, we may be required to record impairment losses or recognize
fair value fluctuations in earnings. These adjustments could result in significant volatility in our reported results of operations.
**We
depend on key personnel to operate our business, and the loss of one or more members of our management team, or our failure to attract,
integrate and retain other highly qualified personnel in the future, could harm our business.**
****
We
believe our future success will depend in large part upon our ability to attract and retain highly skilled managerial, technical, finance
and sales and marketing personnel. We are highly dependent upon the continued service of our key executive officers and other employees.
The loss of and failure to replace key management and personnel could have a serious adverse effect on strategic relationships and may
adversely impact the achievement of our objectives. Despite our efforts to retain valuable employees, members of our management may terminate
their employment with us at any time. Although we have written employment agreements with our executive officers, these employment agreements
do not bind these executives for any specific term and allow executive officers to leave at any time, for any reason, with or without
cause. We do not maintain any key-man insurance policies on any of the key employees nor do we intend to obtain such insurance.
Recruiting
and retaining qualified employees, consultants, and advisors for our business is crucial to continue to execute our growth strategy.
Because the pool of qualified personnel with digital asset experience is limited overall, recruitment and retention of senior management
is very competitive. Many of the companies with which we compete for experienced personnel have greater resources than us. We are also
at a disadvantage in recruiting and retaining key personnel, as our small size and limited resources may be viewed as providing a less
stable environment with fewer opportunities than would be offered at one of our larger competitors. As a result, we may not be successful
in either attracting or retaining such personnel and/or on acceptable terms given the competition and may be required to increase the
level of compensation paid to existing and new employees, which could materially increase our operating expenses. In addition, failure
to succeed in the expansion of our operations may make it more challenging to recruit and retain qualified personnel.
**Our
multi-token investment strategy targeting the stablecoin industry exposes us to significant risks, including market volatility, regulatory
uncertainty, and technological vulnerabilities, any of which could materially and adversely affect our business, financial condition
and results of operations.**
We
have begun a new business strategy focusing on a pureplay, multi-token investment strategy targeting the acquisition of digital assets
that directly benefit from the growth of the stablecoin industry. This strategy involves substantial risks that differ significantly
from those associated with our historical operations. Digital assets, including stablecoins and tokens tied to the stablecoin ecosystem,
are subject to extreme price volatility, liquidity constraints and rapid shifts in market sentiment. These factors could result in significant
fluctuations in the value of our holdings over short periods of time.
The
regulatory environment for digital assets, and stablecoins in particular, is rapidly evolving and subject to significant uncertainty
in the United States and abroad. Changes in laws, regulations, or government policy, such as restrictions on stablecoin issuance, trading,
or use, could adversely impact the viability and value of our investments. Regulatory actions could: restrict our ability to acquire or hold certain
digital assets; impose additional compliance burdens; limit liquidity in digital asset markets; require asset divestitures; or result
in penalties or enforcement actions. Additionally, stablecoins are dependent on the continued maintenance
of their pegged value to a reference currency. Loss of such a peg, operational failures of issuers, or adverse market perceptions could
impair the value of related investments.
| 13 | |
Our
strategy also involves risks related to custody, cybersecurity and technology. Digital asset holdings are subject to the risk of theft,
hacking, or loss of access due to private key mismanagement or third-party service provider failures. Unlike bank deposits or many traditional
investments, digital assets are generally not insured, and we may have no recourse if our holdings are lost or compromised.
There
can be no assurance that our multi-token investment strategy will generate positive returns or preserve our capital. If we are unable
to effectively manage the risks associated with digital assets, our business, financial condition, and results of operations could be
materially harmed.
**There
are volatility risks related to stablecoin.**
There
are volatility risks related to stablecoins, which are designed to have a relatively stable price relative to an underlying physical
asset, most commonly a fiat currency, such as U.S. dollars, or an exchange-traded commodity. The stability of a stablecoin results from
the underlying assets backing the stablecoin that are held by the stablecoins issuer in reserve accounts, among other factors
such as the ability of a holder to redeem the stablecoin from its issuer at par. The issuers of certain stablecoins currently retain
broad discretion to determine the composition and amounts of assets held in the issuers accounts backing those stablecoins, and
to substitute assets other than the fiat currency that is initially deposited. The composition of backing assets varies considerably
across popular stablecoins, with some stablecoins backed entirely by off-chain assets including cash or short-term, highly liquid assets,
and others backed by assets significantly less liquid than cash or cash equivalents. A lack of applicable law and regulation has afforded
discretion to certain stablecoin issuers to determine the composition and amounts of assets backing those stablecoins. There is a risk
that an issuer may be unable to liquidate enough backing assets if it were to face mass redemptions of its stablecoin, which could cause
the price of the stablecoin to deviate from the price of the underlying fiat currency or other asset with which the stablecoin is designed
to align in price. In extreme cases, such as a request to immediately redeem all or substantially all of a particular stablecoin in circulation,
even stablecoins backed by reserves comprised primarily of cash and cash equivalents may be subject to instability or an inability of
the stablecoin issuer to meet all redemption requests, as the market for short-dated U.S. government obligations might not be sufficiently
price stable. Market participants have increasingly shown concern about the actual underlying liquidity and reserves for dollar stablecoins
such as USDT and USDC. If a stablecoin issuer were to fail to honor its redemption obligations, this could undermine public confidence
in stablecoins and in digital assets more broadly, which could have a widespread impact on the cryptoeconomy, causing the prices of other
stablecoins and digital assets to become more volatile.
**Our
digital assets (tokens) holdings are and will be less liquid than cash and cash equivalents and may not be able to serve as a source
of liquidity for us to the same extent as cash and cash equivalents.**
****
We
intend to adopt digital assets (tokens) as our primary treasury reserve asset. Historically, the digital assets market has been characterized
by significant volatility in price, limited liquidity and trading volumes compared to sovereign currencies markets, relative anonymity,
a developing regulatory landscape, potential susceptibility to market abuse and manipulation, compliance and internal control failures
at exchanges, and various other risks inherent in its entirely electronic, virtual form and decentralized network. During times of market
instability, we may not be able to sell our bitcoin at favorable prices or at all. As a result, our holdings may not be able to serve
as a source of liquidity for us to the same extent as cash and cash equivalents. Further, digital assets we hold with our custodian does
not enjoy the same protections as are available to cash or securities deposited with or transacted by institutions subject to regulation
by the Federal Deposit Insurance Corporation or the Securities Investor Protection Corporation. Additionally, we may be unable to enter
into term loans or other capital raising transactions collateralized by our unencumbered digital assets or otherwise generate funds using
our bitcoin holdings, including in particular during times of market instability or when the price of bitcoin has declined significantly.
If we are unable to sell our digital assets, enter into additional capital raising transactions using bitcoin as collateral, or otherwise
generate funds using our digital assets holdings, or if we are forced to sell our digital assets at a significant loss, in order to meet
our working capital requirements, our business and financial condition could be negatively impacted.
**Our
digital assets treasury strategy could subject us to enhanced regulatory oversight.**
****
There
has been increasing focus on the extent to which digital assets can be used to launder the proceeds of illegal activities, fund criminal
or terrorist activities, or circumvent sanctions regimes, including those sanctions imposed in response to the ongoing conflict between
Russia and Ukraine. We are committed to acquiring digital assets exclusively through entities that are subject to, and compliant with,
know your customer and anti-money laundering regulations and related compliance rules in the United States. If we are found to have purchased
any of our digital assets from bad actors that have used bitcoin to launder money or persons subject to sanctions, we may be subject
to regulatory proceedings and any further transactions or dealings in bitcoin by us may be restricted or prohibited.
We
may incur indebtedness or enter into financial instruments in the future that may be collateralized by our digital assets holdings. We
may also consider pursuing strategies to create income streams or otherwise generate funds using our digital assets holdings. These types
of digital assets-related transactions are the subject of enhanced regulatory oversight. These and any other digital assets-related transactions
we may enter into, beyond simply acquiring and holding digital assets, may subject us to additional regulatory compliance requirements
and scrutiny, including under federal and state money services regulations, money transmitter licensing requirements and various commodity
and securities laws and regulations.
The
laws and regulations applicable to digital assets are evolving and subject to interpretation and change. See Risks Related to
Regulatory Matters - Regulatory and compliance uncertainty in the U.S. and abroad could limit or delay our ability to execute our digital
asset strategy. In addition, private actors that are wary of bitcoin or the regulatory concerns associated with bitcoin may in
the future take further actions that may have an adverse effect on our business or the market price of our Common Stock.
| 14 | |
**We
plan to purchase additional digital assets using primarily proceeds from equity and debt financings, but we may be unable to obtain such
financings on favorable terms.**
****
Our
ability to achieve the objectives of our digital asset acquisition strategy depends in significant part on our ability to obtain equity
and debt financing. The terms of debt or equity securities that we issue may require us to make periodic payments to the holders of those
securities. If we are unable to obtain equity or debt financing on favorable terms or at all, we may not be able to successfully execute
on our digital asset acquisition strategy.
Our
ability to obtain equity or debt financing may in turn depend on, among other factors, the value of our digital asset holdings, investor
sentiment and the public perception of digital assets, our strategy and our value proposition. Accordingly, a significant decline in
the market value of our digital asset holdings, our inability to monetize our digital assets, decentralized finance or other yield-generating
activities, or a negative shift in these other factors may create liquidity and credit risks, as such a decline or such shifts may adversely
impact our ability to secure sufficient equity or debt financing.
Digital
assets constitute the vast bulk of assets on our balance sheet. If we are unable to secure equity or debt financing in a timely manner,
on favorable terms, or at all, we may be required to sell our digital assets to satisfy our financial obligations, and we may be required
to make such sales at prices below our cost basis or that are otherwise unfavorable. Any such sale of digital assets may have a material
adverse effect on our operating results and financial condition and could impair our ability to secure additional equity or debt financing
in the future. Our inability to secure additional equity or debt financing in a timely manner, on favorable terms or at all, or to sell
our digital assets in amounts and at prices sufficient to satisfy our financial obligations, including any debt service and cash dividend
obligations, could cause us to default under such obligations. Any default on our future indebtedness or any newly issued preferred stock
could have a material adverse effect on our financial condition. Such actions could cause significant variation in our operating results.
There
are also volatility risks related to stablecoins, which are designed to have a relatively stable price relative to an underlying physical
asset, most commonly a fiat currency, such as U.S. dollars, or an exchange-traded commodity. The stability of a stablecoin results from
the underlying assets backing the stablecoin that are held by the stablecoins issuer in reserve accounts, among other factors
such as the ability of a holder to redeem the stablecoin from its issuer at par. The issuers of certain stablecoins currently retain
broad discretion to determine the composition and amounts of assets held in the issuers accounts backing those stablecoins, and
to substitute assets other than the fiat currency that is initially deposited. The composition of backing assets varies considerably
across popular stablecoins, with some stablecoins backed entirely by off-chain assets including cash or short-term, highly liquid assets,
and others backed by assets significantly less liquid than cash or cash equivalents.
A
lack of applicable law and regulation has afforded discretion to certain stablecoin issuers to determine the composition and amounts
of assets backing those stablecoins. There is a risk that an issuer may be unable to liquidate enough backing assets if it were to face
mass redemptions of its stablecoin, which could cause the price of the stablecoin to deviate from the price of the underlying fiat currency
or other asset with which the stablecoin is designed to align in price. In extreme cases, such as a request to immediately redeem all
or substantially all of a particular stablecoin in circulation, even stablecoins backed by reserves comprised primarily of cash and cash
equivalents may be subject to instability or an inability of the stablecoin issuer to meet all redemption requests, as the market for
short-dated U.S. government obligations might not be sufficiently price stable. Market participants have increasingly shown concern about
the actual underlying liquidity and reserves for dollar stablecoins. If a stablecoin issuer were to fail to honor its redemption obligations,
this could undermine public confidence in stablecoins and in digital assets more broadly, which could have a widespread impact on the
crypto economy, causing the prices of other stablecoins and digital assets to become more volatile.
Volatility
in stablecoins, operational issues with stablecoins (for example, technical issues that prevent settlement), concerns about the sufficiency
of any reserves that support stablecoins, or regulatory concerns about stablecoin issuers or intermediaries, such as crypto asset spot
markets, that support stablecoins, could have a significant impact on the global digital asset market and may adversely affect our business.
Because
stablecoins purport to be backed by underlying reserve assets, a fundamental issue in the event of the bankruptcy or insolvency of the
issuer of a given stablecoin is which party possesses beneficial ownership of the underlying reserve assets: the holder of the stablecoin,
or the issuer. If a particular stablecoin were structured in a manner that entitles its holder only to a contractual right to payment
from the issuer (even if such payments are to be derived from the underlying assets), then the assets underlying the stablecoins may
be considered to be the property of the issuers bankruptcy estate, such that all of the issuers creditors would be entitled
to their pro rata share of such assets, with the stablecoin holder being treated as an unsecured creditor of the issuer. In such an event,
if the issuer were to have insufficient funds or assets to satisfy the claims of its creditors, then the holder of a stablecoin would
likely receive only a partial recovery, and not the full purported value of its stablecoin holdings. Conversely, if a particular stablecoin
were structured in a manner that entitles its holder to absolute beneficial ownership of the underlying reserve assets, whereby the issuer
holds bare legal title to the underlying assets but has no beneficial interest or property rights in such assets, then the holders would
likely have a stronger claim on the underlying assets in the event of a bankruptcy or insolvency of the issuer. However, due to the novelty
of stablecoins, courts have not yet considered the treatment of underlying reserve assets in the context of a bankruptcy or insolvency
of a stablecoin issuer, and there can be no certainty as to a courts determination in such circumstances.
**Risks
Related to Our Legacy Electric Vehicle Operations**
****
**We
have paused manufacturing activities and are re-engineering the Vanish and if we later continue our manufacturing activities; we may not be successful.**
We
have paused manufacturing activities primarily due to a pause in manufacturing of the Vanish as we focus on re-engineering the vehicle
to optimize its design and improve manufacturing efficiencies. The re-engineering process may take longer than expected, may not achieve
targeted cost reductions or performance objectives, and may require additional engineering, supplier, regulatory, or manufacturing validation
work. We may ultimately determine not to resume manufacturing or commercialization of the Vanish or other electric vehicles. Any inability
to successfully re-engineer and commercialize the Vanish could adversely affect our business, results of operations and financial condition,
including through further impairment of inventory, equipment, tooling, or other legacy assets.
**Even
if we complete re-engineering efforts, the Vanish may not achieve market acceptance or be commercially viable.**
If
we resume commercialization efforts, our ability to generate future revenue from electric vehicle operations would depend on achieving
a product offering that meets customer requirements at a competitive price and performance profile. Market acceptance for electric vehicles,
particularly specialized fleet or low-speed vehicles, may be lower than we anticipate due to competition, evolving customer preferences,
regulatory and safety requirements, charging or service infrastructure constraints, and macroeconomic conditions. In addition, competitors
may introduce products with better features, lower pricing, greater brand recognition, or stronger distribution and service capabilities.
If the Vanish or any future vehicle offering is not accepted by customers or channel partners, our prospects, results of operations and
financial condition could be materially adversely affected.
| 15 | |
****
**Resuming
electric vehicle manufacturing would require significant capital and operating resources, and we may be unable to obtain them on acceptable
terms, if at all.**
The
design, validation, manufacturing, and commercialization of vehicles is capital intensive. If we decide to resume manufacturing or commercialization
of the Vanish, we would likely need to invest in engineering, tooling, component sourcing, assembly capacity, quality systems, sales
and service infrastructure, and working capital. Because we did not generate revenue during 2025 and may not generate revenue in future
periods, any resumption of electric vehicle operations would likely depend on our ability to access capital markets and raise additional
funds. Such funding may not be available on acceptable terms, may be highly dilutive to stockholders, and may be subject to restrictive
covenants. If we are unable to obtain sufficient capital, we may be unable to resume manufacturing or commercialization, or may be required
to delay, reduce, or discontinue those efforts.
**Our
legacy electric vehicle assets may be subject to further impairment, disposal losses, or ongoing carrying costs.**
We
maintain certain legacy assets associated with our prior electric vehicle operations, which may include equipment, tooling, inventory,
intellectual property, lease obligations, and other long-lived assets. The value of these assets depends in part on our ability to successfully
re-engineer and commercialize the Vanish or otherwise monetize legacy assets through sales, dispositions, or other strategic alternatives.
If we are unable to resume commercialization or realize value from these assets, we may be required to record additional impairment charges,
incur losses on disposal, or continue to incur costs to maintain, store, insure, or otherwise support these assets and related obligations.
Any such charges or costs could materially and adversely affect our financial condition and results of operations.
**Any
future resumption of electric vehicle activities could expose us to product quality, safety, warranty, and product liability risks.**
If
we resume manufacturing or commercialization of the Vanish or other vehicles, we would again be exposed to risks associated with product
quality, safety performance, recalls, warranty claims, and product liability litigation. Electric vehicles and lithium-ion battery systems
present particular risks, including the potential for battery malfunctions, thermal events, or other safety incidents. Any actual or
perceived defect, failure to meet safety or regulatory requirements, or significant warranty or product liability claim could result
in substantial costs, reputational harm, lost sales, and diversion of management attention, any of which could materially adversely affect
our business, results of operations and financial condition.
**Risks
Relating to Our Financial Position and Need for Additional Capital**
**We
have incurred recurring losses and may continue to incur losses**.
Although
our going concern uncertainty was alleviated during 2025 due to financing activities, we have historically incurred net losses and may
continue to incur losses in future periods, particularly if the value of our investment portfolio declines or if operating expenses exceed
investment returns. . If our cash on hand and our sales revenue are not sufficient to cover our cash requirements, we will need to raise
additional capital, whether through the sale of equity or debt securities, the entry into strategic business collaborations, the establishment
of other funding facilities, licensing arrangements, or asset sales or other means, in order to support our business plan. In addition,
we may need to raise additional capital for strategic acquisitions or transactions. Such additional capital may not be available on reasonable
terms or at all.
Our
ability to obtain the necessary financing to carry out our business plan is subject to a number of factors. These factors may make the
timing, amount, terms and conditions of such financing unattractive or unavailable to us. If we are unable to obtain additional financing
on a timely basis, we may have to curtail, delay or liquidate our portfolio and growth plans, and/or be forced to sell some or all digital
assets, perhaps on unfavorable terms, which would have a material adverse effect on our business, financial condition and results of
operations, and ultimately we could be forced to discontinue our operations and liquidate, in which event it is unlikely that stockholders
would receive any distribution on their shares. Further, we may not be able to continue operating if we do not generate sufficient revenues
from operations to stay in business.
| 16 | |
We
have raised capital in the past primarily through public offerings, as well as debt and private placements of our convertible preferred
stock. We may in the future pursue the sale of additional equity and/or debt securities, or the establishment of other funding facilities
including asset-based borrowings. There can be no assurances, however, that we will be able to raise additional capital through such
an offering on acceptable terms, or at all. Issuances of additional debt or equity securities could impact the rights of the holders
of our common stock and may dilute their ownership percentage. The terms of any securities issued by us in future capital transactions
may be more favorable to new investors, and may include preferences, superior voting rights and the issuance of warrants or other derivative
securities, which may have a further dilutive effect on the holders of any of our securities then outstanding.
The
terms of debt securities we may have to issue or future borrowings we may have to incur to fund our operations could impose significant
restrictions on our operations. The incurrence of indebtedness or the issuance of certain equity securities could result in increased
fixed payment obligations and could also result in restrictive covenants, such as limitations on our ability to incur additional debt
or issue additional equity, limitations on our ability to acquire or license intellectual property rights, and other operating restrictions
that could adversely affect our ability to conduct our business.
If
we raise additional funds through collaboration and licensing arrangements with third parties, it may be necessary to relinquish some
rights to our technologies to grant licenses on terms that are not favorable to us, or to issue equity instruments that may be dilutive
to our stockholders.
In
addition, we may incur substantial costs in pursuing future capital financing, including investment banking fees, legal fees, accounting
fees, securities law compliance fees, printing and distribution expenses and other costs. We may also be required to recognize non-cash
expenses in connection with certain securities we issue, such as convertible notes and warrants, which may adversely impact our financial
condition.
**We
may invest in or acquire other businesses, and our business may suffer if we are unable to successfully integrate acquired businesses
into our company or otherwise manage the growth associated with multiple acquisitions.**
As
part of our business strategy, we may make acquisitions as opportunities arise to add new or complementary businesses or technologies.
In some cases, the costs of such acquisitions may be substantial, including as a result of professional fees and due diligence efforts.
There is no assurance that the time and resources expended on pursuing a particular acquisition will result in a completed transaction,
or that any completed transaction will ultimately be successful. In addition, we may be unable to identify suitable acquisition or strategic
investment opportunities or may be unable to obtain any required financing or regulatory approvals, and therefore may be unable to complete
such acquisitions or strategic investments on favorable terms, if at all. We may decide to pursue acquisitions with which our investors
may not agree, and we cannot assure investors that any acquisition or investment will be successful or otherwise provide a favorable
return on investment. In addition, acquisitions and the integration thereof require significant time and resources and place significant
demands on our management, as well as on our operational and financial infrastructure. In addition, if we fail to successfully close
transactions or integrate new teams, or integrate the products and technologies associated with these acquisitions into our company,
our business could be seriously harmed. Acquisitions may expose us to operational challenges and risks, including:
| 
| 
| 
the
ability to profitably manage acquired businesses or successfully integrate the acquired businesses operations, personnel,
financial reporting, accounting and internal controls, technologies and products into our business; | |
| 
| 
| 
| |
| 
| 
| 
increased
indebtedness and the expense of integrating acquired businesses, including significant administrative, operational, economic, geographic
or cultural challenges in managing and integrating the expanded or combined operations; | |
| 
| 
| 
| |
| 
| 
| 
entry
into jurisdictions or acquisition of products or technologies with which we have limited or no prior experience, and the potential
of increased competition with new or existing competitors as a result of such acquisitions; | |
| 17 | |
| 
| 
| 
diversion
of managements attention and the over-extension of our operating infrastructure and our management systems, information technology
systems, and internal controls and procedures, which may be inadequate to support growth; | |
| 
| 
| 
| |
| 
| 
| 
the
ability to fund our capital needs and any cash flow shortages that may occur if anticipated revenue is not realized or is delayed,
whether by general economic or market conditions, or unforeseen internal difficulties; and | |
| 
| 
| 
| |
| 
| 
| 
the
ability to retain or hire qualified personnel required for expanded operations. | |
Our
acquisition strategy may not succeed if we are unable to remain attractive to target companies or expeditiously close transactions. Issuing
shares of our common stock to fund an acquisition would cause economic dilution to existing stockholders. If we develop a reputation
for being a difficult acquirer or having an unfavorable work environment, or target companies view our common stock unfavorably, we may
be unable to consummate key acquisition transactions essential to our corporate strategy and our business may be seriously harmed.
****
**We
have issued preferred stock and other equity-linked securities that may result in dilution.**
We
have outstanding preferred stock and warrants that may convert into shares of common stock. The issuance of additional shares upon conversion
or exercise could result in significant dilution to existing stockholders. Anti-dilution provisions in certain securities may increase
the number of shares issuable in the future.
**We
may need to raise additional capital, which may be dilutive or restrictive.**
Future
capital raises could involve the issuance of equity or equity-linked securities at prices below the current market price, resulting in
dilution. Debt financings may impose restrictive covenants that limit our operational flexibility.
**Risks
Related to Internal Controls**
**We
have identified a material weakness in our internal control over financial reporting, and if we are unable to remediate the material
weakness, or if we experience additional material weaknesses in the future, our business may be harmed.**
****
Our
management is responsible for establishing and maintaining adequate internal control over financial reporting and for evaluating and
reporting on the effectiveness of our system of internal control. Our internal control over financial reporting is a process designed
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
reporting purposes in accordance with Generally Accepted Accounting Principles in the United States (GAAP). As a public
company, we are required to comply with the Sarbanes-Oxley Act and other rules that govern public companies. In particular, we are required
to certify our compliance with Section 404 of the Sarbanes-Oxley Act, which requires us to furnish annually a report by management on
the effectiveness of our internal control over financial reporting.
Our
management performed an assessment of the effectiveness of our internal control over financial reporting as of December 31, 2025 and
concluded our internal control over financial reporting was not effective as of December 31, 2025, due to the fact that: (i) we were
unable to document, formalize, implement and revise where necessary controls, policies and procedure documentation to evidence a system
of controls, inclusive of IT controls, including testing of such controls that is consistent with our current personnel and available
resources; (ii) we failed to document, maintain and test effective control activities over our control environment, risk assessment,
information technology and monitoring components; and (iii) we had insufficient segregation of duties, oversight of work performed and
lack of compensating controls in our finance and accounting functions, including, without limitation, the processing, review and authorization
of all routine and non-routine transactions, due to limited personnel and resources.
Remediation
efforts place a significant burden on management and add increased pressure to our financial resources and processes. If we are unable
to successfully remediate our existing material weakness or any additional material weaknesses in our internal control over financial
reporting that may be identified in the future in a timely manner, the accuracy and timing of our financial reporting may be adversely
affected; our liquidity, our access to capital markets, the perceptions of our creditworthiness may be adversely affected; we may be
unable to maintain or regain compliance with applicable securities laws, the listing requirements of the Nasdaq Stock Market; we may
be subject to regulatory investigations and penalties; investors may lose confidence in our financial reporting; our reputation may be
harmed; and our stock price may decline.
| 18 | |
****
**Risks
Related to Regulatory Matters**
****
**Political
or economic crises may motivate large-scale sales of digital assets, which would result in a reduction in values and materially and adversely
affect us.**
Cryptocurrencies,
as an alternative to fiat currencies that are backed by central governments, are subject to supply and demand forces based upon the desirability
of an alternative, decentralized means of buying and selling goods and services, and it is unclear how such supply and demand will be
impacted by geopolitical events. For example, political or economic crises could motivate large-scale acquisitions or sales of digital
assets either globally, regionally or locally. Large-scale sales of certain digital assets would result in a reduction in their value
and could materially and adversely affect our investment and trading strategies, the value of our assets and our value.
**The
U.S. federal income tax treatment of transactions in digital assets is unclear.**
Due
to the new and evolving nature of digital assets and the absence of comprehensive guidance with respect to digital assets, many significant
aspects of the U.S. federal income tax treatment of digital assets are uncertain. Our operations and dealings, in or in connection with
digital assets, as well as transactions in digital assets generally, could be subject to adverse tax consequences in the United States,
including as a result of development of the legal regimes surrounding digital assets, and our operating results, as well as the price
of digital assets, could be adversely affected thereby.
Many
significant aspects of the U.S. federal income tax treatment of digital assets (including with respect to the amount, timing and character
of income recognition) are uncertain. In 2014, the U.S. Internal Revenue Service (the IRS) released a notice (the Notice)
discussing certain aspects of digital assets for U.S. federal income tax purposes and, in particular, stating that such digital assets
(1) are property, (2) are not currency for purposes of the rules relating to foreign currency gain or loss
and (3) may be held as a capital asset. In 2019, the IRS released a revenue ruling and a set of Frequently Asked Questions
(the Ruling & FAQs) that provide some additional guidance, including guidance to the effect that, under certain circumstances,
hard forks of digital assets are taxable events giving rise to ordinary income and guidance with respect to the determination of the
tax basis of digital assets. The Notice and the Ruling & FAQs, however, do not address other significant aspects of the U.S. federal
income tax treatment of digital assets. We do not intend to request a ruling from the IRS on these issues, and we will take positions
on these and other U.S. federal income tax issues relating to digital assets that we believe to be reasonable. There can be no assurance
that the IRS will agree with the positions we take, and it is possible that the IRS will successfully challenge our positions.
There
can be no assurance that the IRS will not alter its position with respect to digital assets in the future or that a court would uphold
the treatment set forth in the Notice and the Ruling & FAQs. It is also unclear what additional guidance on the treatment of digital
assets for U.S. federal income tax purposes may be issued in the future. Any such alteration of the current IRS positions or additional
guidance could result in adverse tax consequences for us and could have an adverse effect on the value of digital assets. Because of
the evolving nature of digital assets, it is not possible to predict potential future developments that may arise with respect to digital
assets. Such developments may increase the uncertainty with respect to the treatment of digital assets for U.S. federal income tax purposes.
For example, the Notice addresses only digital assets that are convertible virtual currency, and it is conceivable that
we will hold certain types of digital assets that are not within the scope of the Notice.
On
November 15, 2021, former President Biden signed into law the Infrastructure Investment and Jobs Act (the IIJA). The IIJA
implements a set of comprehensive tax information reporting rules that will apply to persons, including digital asset trading platforms
and custodians, that regularly effect transfers of digital assets on behalf of other persons. In particular, these rules will require
digital asset trading platforms and custodians to report certain digital asset transactions (including sales, exchanges and other transfers)
effected on behalf of other persons on an annual return, in a manner similar to the current reporting rules for brokers that effect stock
and other securities transactions on behalf of customers. In addition, the IIJA extends the reporting requirements for businesses that
receive more than $10,000 in cash in a transaction (or related transactions) to transactions involving the receipt of digital assets
with a fair market value of more than $10,000.
In
July 2024, the IRS and the U.S. Department of the Treasury released final regulations to implement certain of these reporting rules (the
July final regulations). The July final regulations definition of the term broker is broad and, in
a number of respects, is unclear in scope, but generally requires custodial brokers and brokers acting as principals to perform information
reporting and backup withholding functions. Under the July final regulations and a notice released contemporaneously by the IRS and the
U.S. Department of the Treasury, such reporting of cost basis information and backup withholding generally will apply in respect of transactions
occurring on or after January 1, 2025, but certain transitional relief may be available for transactions occurring prior to January 1,
2026. The July final regulations do not address all aspects of the IIJA information reporting regime and their application is uncertain
in a number of respects, including with respect to the collection and reporting of cost basis information for digital assets and the
scope of transactions subject to reporting. In December 2024, the IRS and the U.S. Department of the Treasury issued separate final regulations
describing information reporting rules for non-custodial industry participants (the December final regulations), including
the requirement to file information returns and furnish payee statements reporting gross proceeds on dispositions of digital assets effected
for customers in certain sale or exchange transactions. The December final regulations were repealed on April 10, 2025, under the Congressional
Review Act. Regulations repealed under the Congressional Review Act generally may not be reissued in substantially the same form, and
a new rule that is substantially the same as such a rule may not be issued, unless the reissued or new rule is specifically authorized
by a law subsequently enacted. The impact on the IIJA information reporting regime of the repeal of the December final regulations is
unclear and there can be no assurance that the same or similar regulations will not be authorized by future law.
| 19 | |
The
effects of the IIJA reporting regime and its application to us may depend in significant part on future Congressional action and further
regulatory or other guidance from the IRS and could create significant compliance burdens and uncertainties for us and our customers,
and could affect the price of digital assets, which could have an adverse effect on our business.
**The
recently enacted Guiding and Establishing National Innovation for U.S. Stablecoins Act of 2025 (the GENIUS Act) creates
a new federal regulatory framework for stablecoins in the United States, and its implementation could materially impact our stablecoin-related
business, operations, and compliance obligations.**
****
In
July2025, the United States enacted the GENIUS Act, which establishes the first comprehensive federal framework governing the
issuance, custody, and use of payment stablecoins. The GENIUS Act addresses, among other things, the state and federal licensing of stablecoin
issuers, reserve composition and management, redemption rights, disclosure obligations, and ongoing regulatory supervision. Although
the GENIUS Act has been signed into law, it will not become effective until the earlier of January 18, 2027 or 120 days after the primary
federal payment stablecoin regulators issue final implementing regulations (the GENIUS Act Effective Date).
Among
its many provisions, the GENIUS Act defines the term payment stablecoin, generally prohibits the issuance of payment stablecoins
in the United States by any person other than a permitted payment stablecoin issuer (PPSI), establishes a comprehensive
regulatory framework applicable to PPSIs, generally prohibits PPSIs from paying interest on issued payment stablecoins, excludes payment
stablecoins issued by a PPSI from the definition of a security under the U.S. federal securities laws and restricts the
type of reserve assets that may be held in support of payment stablecoins. Because the GENIUS Act will require significant rulemaking
by U.S. regulators, its ultimate impact will depend in part on how those regulations are adopted and implemented. While the establishment
of a consistent federal framework could, over time, increase institutional and consumer confidence in payment stablecoins, the scope,
timing, and substance of the implementing regulations and supervisory practices remain uncertain. Compliance with the GENIUS Act and
related regulations may require us to make significant changes to our strategy. These changes could increase our legal, compliance, operational,
and technology costs.
**The
state, local and non-U.S. tax treatment of digital assets is unclear.**
The
taxing authorities of certain states (i) have announced that they will follow the Notice with respect to the treatment of digital assets
for state income tax purposes and/or (ii) have issued guidance exempting the purchase and/or sale of digital assets for fiat currency
from state sales tax. It is unclear what further guidance on the treatment of digital assets for state tax purposes may be issued in
the future. Any future guidance on the treatment of digital assets for state or local tax purposes could result in adverse tax consequences
to us and could adversely affect the price of digital assets.
The
treatment of digital assets for tax purposes by non-U.S. jurisdictions may differ from the treatment of digital currency for U.S. federal,
state or local tax purposes. It is possible, for example, that a non-U.S. jurisdiction would impose sales tax or value-added tax on purchases
and sales of digital assets for fiat assets.
**Exposure
to market volatility and token-specific risks could adversely affect the value of our digital asset holdings.**
Our
business strategy involves acquiring and holding certain tokens, including, FLUID, INJ, LINK, AAVE, SYRUP, QNT, and ETHFI tokens as part
of our effort to capture growth in the stablecoin infrastructure sector. While this strategy offers potential long-term upside, it also
exposes us to the extreme price volatility and speculative nature of digital assets.
The
market for digital assets is highly unpredictable and has historically experienced significant and sudden declines in value. Stablecoin-related
infrastructure tokens, such as those we intend to hold, may not move in parallel with the broader stablecoin market and can suffer material
losses during economic downturns.
Each
token also presents its own set of risks. For example, FLUID may face downward pressure as previously restricted tokens become freely
tradable, ETHFI may be sensitive to Ethereum network activity or operational costs and SYRUPs link to real-world-asset collateral
may make it more responsive to changes in broader financial conditions. These factors could materially reduce the value of our digital
asset portfolio, limit liquidity, and adversely affect our financial results.
| 20 | |
****
**Regulatory
and compliance uncertainty in the U.S. and abroad could limit or delay our ability to execute our digital asset strategy.**
Because
we are a public company investing in digital assets, our activities may attract heightened regulatory, accounting, and investor scrutiny.
The legal framework governing stablecoins, decentralized finance, and tokenized instruments continues to evolve, and new legislation
or rulemaking could impose additional compliance, registration or disclosure requirements on us or on the protocols in which we participate.
In
the United States, proposed stablecoin legislation and related guidance may alter the way certain tokens are classified or traded, which
could affect our ability to hold or dispose of them. Outside the U.S., emerging frameworks, such as the MiCA and various regional restrictions
on non-compliant stablecoins, could similarly affect liquidity and access to markets. If these or other regulatory developments restrict
the issuance, trading, or use of tokens such as FLUID, INJ, LINK, AAVE, SYRUP, QNT, or ETHFI, we may be required to modify, delay, or
curtail our investment activities. Any resulting limitations could materially and adversely impact our business strategy, reputation,
or financial condition.
**Risks
Related to Our Series Preferred Stock**
**Holders
of our Series H-7 Preferred Stock are entitled to certain payments under the Certificate of Designations that may be paid in cash or
in shares of common stock depending on the circumstances. If we make these payments in cash, we may be required to expend a substantial
portion of our cash resources. If we make these payments in common stock, it may result in substantial dilution to the holders of our
common stock.**
****
Under
the Certificate of Designations (the Certificate of Designations) of our Series H-7 Preferred Stock we are required to
redeem the shares of Series H-7 Preferred Stock in monthly installments. Holders of Series H-7 Preferred Stock are also entitled to receive
dividends, payable in arrears monthly, and dividends payable on installment dates shall be paid as part of the applicable installment
amount. Installment amounts are payable, at the companys election, in shares of common stock or, subject to certain limitations,
in cash. Installment amounts paid in cash must be paid in the amount of 105% of the applicable payment amount due. For installment amounts
paid in shares of common stock, the number of shares of common stock shall be calculated by dividing the applicable payment amount due
by the installment conversion price. The installment conversion price shall be equal to the lower of (i) the Conversion
Price (as defined in the Certificate of Designations) in effect as of the applicable payment date and (ii) the greater of (A) 80% of
the average of the three lowest closing prices of our common stock during the thirty trading day period immediately prior to the date
the payment is due or (B) $11.904 (subject to adjustment for stock splits, stock dividends, stock combinations, recapitalizations or other
similar events) or, in any case, such lower amount as permitted, from time to time, by the Nasdaq Stock Market (the Floor Price).
Our
ability to make payments due to the holders of Series H-7 Preferred Stock using shares of common stock is subject to certain
limitations set forth in the Certificate of Designations. If we are unable to make installment payments in shares of common stock,
we may be forced to make such payments in cash. If we do not have sufficient cash resources to make these payments, we may need to
raise additional equity or debt capital, and we cannot provide any assurance that we will be successful in doing so. If we are
unable to raise sufficient capital to meet our payment obligations, we may need to delay, reduce or eliminate certain research and
development programs or other operations, sell some or all of our assets or merge with another entity.
Our
ability to make payments due to the holders of Series H-7 Preferred Stock using cash is also limited by the amount of cash we have on
hand at the time such payments are due, as well as certain provisions of the Delaware General Corporation Law. Further, we intend to
make the installment payments due to holders of Series H-7 Preferred Stock in the form of common stock to the extent allowed under the
Certificate of Designations and applicable law in order to preserve our cash resources. The issuance of shares of common stock to the
holders of our Series H-7 Preferred Stock will increase the number of shares of common stock outstanding and could result in substantial
dilution to the existing holders of our common stock.
| 21 | |
****
**The
Certificate of Designations for the Series H-7 Preferred Stock and the Series H-7 Warrants issued concurrently therewith contain anti-dilution
provisions that may result in the reduction of the conversion price of the Series H-7 Preferred Stock or the exercise price of such Series
H-7 Warrants in the future. These features may increase the number of shares of common stock being issuable upon conversion of the Series
H-7 Preferred Stock or upon the exercise of the Series H-7 Warrants.**
****
The
Certificate of Designations the Series H-7 Warrants contain anti-dilution provisions, which provisions require the lowering of the applicable
conversion price or exercise, as then in effect, to the purchase price of equity or equity-linked securities issued in any subsequent
offerings. If in the future, while any shares of Series H-7 Preferred Stock or Series H-7 Warrants are outstanding, we issue securities
for a consideration per share of common stock (the New Issuance Price) that is less than the Conversion Price of the Series
H-7 Preferred Stock or the exercise price of the Series H-7 Warrants, as then in effect, we will be required, subject to certain limitations
and adjustments as provided in the Certificate of Designations or the Series H-7 Warrants, to reduce the Conversion Price or the exercise
price to be equal to the New Issuance Price, which will result in a greater number of shares of common stock being issuable upon conversion
of the Series H-7 Preferred Stock and the exercise of the Series H-7 Warrants, which in turn will increase the dilutive effect of such
conversions or exercises on existing holders of our common stock. It is possible that we will not have a sufficient number of shares
available to satisfy the conversion of the Series H-7 Preferred Stock or the exercise of the Series H-7 Warrants if we enter into a future
transaction that reduces the applicable Conversion Price or exercise price. If we do not have a sufficient number of available shares
for any Series H-7 Preferred Stock conversions or Series H-7 Warrant exercises, we may need to seek stockholder approval to increase
the number of authorized shares of our common stock, which may not be possible and will be time consuming and expensive. The potential
for such additional issuances may depress the price of our common stock regardless of our business performance and may make it difficult
for us to raise additional equity capital while any of the Series H-7 Preferred Stock or Series H-7 Warrants are outstanding.
**Under
the Purchase Agreement we are subject to certain restrictive covenants that may make it difficult to procure additional financing.**
****
The
Securities Purchase Agreement, dated as of August 7, 2023, by and among the Company and the investors signatory thereto (Purchase
Agreement), in which we issued the Series H-7 Preferred Stock and Series H-7 Warrants, contains the following restrictive covenants:
(i) until no shares of Series H-7 Preferred Stock are outstanding, we agreed not to enter into any variable rate transactions; (ii) for
approximately six months after the date on which the shares of common stock issuable upon conversion of the Series H-7 Preferred Stock
and upon exercise of the Series H-7 Warrants are eligible for sale by the Investors under a registration statement declared effective
by the SEC or pursuant to Rule 144 under the Securities Act, we agreed not to issue or sell any equity security or convertible security,
subject to certain exceptions; and (iii) until the later of no shares of Series H-7 Preferred Stock being outstanding and the maturity
date of the Series H-7 Preferred Stock, we agreed to offer to the investors party to the Purchase Agreement the opportunity to participate
in any subsequent securities offerings by us. If we require additional funding while these restrictive covenants remain in effect, we
may be unable to effect a financing transaction while remaining in compliance with the terms of the Purchase Agreement, or we may be
forced to seek a waiver from the investors party to the Purchase Agreement.
**Holders
of our shares of Series I Preferred Stock are entitled to certain payments under the Series I Certificate of Designations that may
be paid in cash, or in certain circumstances, in share of Common Stock, which may require the expenditure of a substantial portion
of our cash resources.**
Under
the Series I Certificate of Designations, we are required to redeem the shares of Series I Preferred Stock in equal quarterly installments,
commencing on November 30, 2025. The Installment Amount (as defined in the Series I Certificate of Designations) due upon such redemption
are payable, at the Companys election, in cash at 107% of the applicable Installment Redemption Price (as defined in the Series
I Certificate of Designations). Notwithstanding the foregoing, at any time from the date of the applicable Installment Notice Date (as
defined in the Series I Certificate of Designations) through the applicable Installment Date, and subject to certain beneficial ownership
limitations, a holder of Series I Preferred Stock may require the Company to convert all or any part of the Installment Amount at a price
to be mutually determined by the Company and such holder, which shall not be less than the Floor Price (as defined in the Series I Certificate
of Designations).
| 22 | |
Holders
of our Series I Preferred Stock are also entitled to receive dividends of 7% per annum, compounded each calendar quarter, which are payable
in arrears (i) quarterly on each Installment Date (as defined in the Series I Certificate of Designations), in cash out of funds legally
available therefor, (ii) prior to the first Installment Date, payable by way of inclusion of the dividends in the Conversion Amount (as
defined in the Series I Certificate of Designations) on each conversion date occurring prior to the first Installment Date, and (iii)
upon any redemption or any required payment upon any Triggering Event (as defined in the Series I Certificate of Designations. Upon the
occurrence and during the continuance of a Triggering Event (as defined in the Series I Certificate of Designations), the Series I Preferred
Stock accrue dividends at the rate of 15% per annum. In connection with a Triggering Event, each holder of Series I Preferred Stock will
be able to require us to redeem in cash any or all of the holders Series I Preferred Stock at a premium set forth in the Series
I Certificate of Designations. If such Triggering Event occurs, our financial condition and results of operations could be materially
affected.
If
we do not have sufficient cash resources to make these payments, we may need to raise additional equity or debt capital, and we cannot
provide any assurance that we will be successful in doing so. If are unable to raise sufficient capital to meet our payment obligations,
we may need to delay, reduce or eliminate certain research and development programs or other operations, sell some or all of our assets
or merge with another entity. Our ability to make payments due to the holders of our Series I Preferred Stock using cash is also limited
by the amount of cash we have on hand at the time such payments are due as well as certain provisions of the Delaware General Corporation
Law.
**The
Series I Preferred Stock and the Private Placement Warrants contain certain anti-dilution provisions, which may dilute the interests
of our stockholders, depress the price of our common stock, and make it difficult for us to raise additional capital.**
Certain
events, for example, a Stock Combination Event (as defined in the Series I Certificate of Designations) may reduce the conversion price
of the Series I Preferred Stock, which in turn may lead to further dilution to the holders of our Common Stock. The Private Placement
Warrants additionally contain anti-dilution provisions applicable to the exercise price. If in the future, while any of the Private Placement
Warrants are outstanding, we may be required upon the occurrence of certain events, to adjust the exercise price of the Private Placement
Warrants, and simultaneously with any adjustment to the exercise price, the number of shares of Common Stock that may be purchased upon
exercise of the Private Placement Warrants shall be increased or decreased proportionately, so that after such adjustment the aggregate
exercise price payable thereunder for the adjusted number of shares of Common Stock issuable upon exercise of the Private Placement Warrants
shall be the same as the aggregate exercise price in effect immediately prior to such adjustment. Such adjustments can dilute the book
value per share of Common Stock and reduce any proceeds we may receive from the exercise of the Private Placement Warrants. In addition,
the perceived risk of dilution may cause our shareholders to be more inclined to sell their Common Stock, which may in turn depress the
price of common shares regardless of our business performance. We may also find it more difficult to raise additional equity capital
while any of the Private Placement Warrants and the Series I Preferred Stock remain outstanding.
**The
Series I Certificate of Designations contains restrictive covenants and terms that may make it difficult to procure additional financing
and that may affect our financial condition and results of operations.**
The
Series I Certificate of Designations contains certain restrictive covenants including but not limited to, maintaining a Cash Minimum
(as defined in the Series I Certificate of Designations), restrictions on incurring any indebtedness until the date on which no Series
I Preferred Stock are outstanding, subject to certain exceptions, restrictions on directly or indirectly, redeeming, repurchasing or
declaring or paying any cash dividend or distribution on any of our capital stock (other than as required by the Series I Certificate
of Designations), and restrictions on directly or indirectly, permitting any of our indebtedness to mature or accelerate prior to the
Maturity Date (as defined in the Series I Certificate of Designations). Additionally, the Series I Preferred Stock also contains certain
purchase rights (the Purchase Rights) permitting the holders of the Series I Preferred Stock to acquire upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which such holder could have acquired if such holder had held the number
of shares of Common Stock acquirable upon complete conversion of all of its Series I Preferred Stock. These restrictive covenants may limit our flexibility in raising capital or incurring any indebtedness, which may have an adverse effect on our financial condition.
| 23 | |
****
**Under
the Series I Purchase Agreement, we are subject to certain restrictive covenants that may make it difficult to procure additional financing.**
The
Series I Purchase Agreement contains, among others, the following restrictive covenants: (A) until ninety (90) days following the earlier
of (x) the date on which the Registration Statement is declared effective or (y) the date on which the holders of the Series I Preferred
Stock or Series I Warrants may sell their shares of common stock issuable upon conversion of the Series I Preferred Stock or Series I
Warrants without restriction pursuant to Rule 144 under the Securities Act, we may not issue, offer, sell, grant any option or right
to purchase, or otherwise dispose of (or announce any issuance, offer, sale, grant of any option or right to purchase or other disposition
of) any equity security or any equity-linked or related security, (B) until all of the Series I Warrants are no longer outstanding, we
shall be prohibited from effecting or entering into an agreement to effect any subsequent placement involving a variable rate transaction,
and (C) until the later of (i) the Maturity Date (as defined in the Series I Certificate of Designations), and (ii) the date in which
no Series I Preferred Stock remain outstanding, the Company must provide the holders of the Series I Preferred Stock the opportunity
to participate in any subsequent securities offerings by us.
If
we require additional funding while these restrictive covenants remain in effect, we may be unable to effect a financing transaction
on terms acceptable to us, or at all, while also remaining in compliance with the terms of the Series I Purchase Agreement, or we may
be forced to seek a waiver from the investors party to the Purchase Agreement, which such investors are not obligated to grant to us.
****
**Risks
Related to Our Intellectual Property**
**If
we are unable to adequately protect our proprietary designs and intellectual property rights, our competitive position could be harmed.**
Our
ability to compete effectively is dependent in part upon our ability to obtain patent protection for our designs, products, methods,
processes and other technologies, to preserve our trade secrets, to prevent third parties from infringing on our proprietary rights and
to operate without infringing the proprietary rights of third parties. We rely on design patents, trademarks, trade secret laws, confidentiality
procedures and licensing arrangements to protect our intellectual property rights. There can be no assurance these protections will be
available in all cases or will be adequate to prevent our competitors from copying, reverse engineering or otherwise obtaining and using
our designs, technology, proprietary rights or products. For example, the laws of certain countries in which our products, components
and sub-assemblies are manufactured or licensed do not protect our proprietary rights to the same extent as the laws of the United States.
To
prevent substantial unauthorized use of our intellectual property rights, it may be necessary to prosecute actions for infringement and/or
misappropriation of our trade secrets and/or proprietary rights against third parties. Any such action could result in significant costs
and diversion of our resources and managements attention, and there can be no assurance we will be successful in such action.
Furthermore, our current and potential competitors may have the ability to dedicate substantially greater resources to enforce their
intellectual property rights than we do. Accordingly, despite our efforts, we may not be able to prevent third parties from infringing
upon or misappropriating our trade secrets and/or intellectual property.
In
addition, third parties may seek to challenge, invalidate or circumvent our patents, trademarks, copyrights and trade secrets, or applications
for any of the foregoing. There can be no assurance that our competitors or customers will not independently develop technologies that
are substantially equivalent or superior to our technology or design around our proprietary rights. In each case, our ability to compete
could be significantly impaired.
**We
may need to license intellectual property from third parties in the future. If we fail to obtain licenses we need or fail to comply with
our obligations in agreements under which we license intellectual property and other rights from third parties, we could lose our ability
to manufacture our vehicles.**
We
may need to license intellectual property from third parties in the future for new vehicle models. No assurance can be given that we
will be able to obtain such license or meet our obligations to maintain the licenses we may have to obtain from third parties in the
future. If we were to lose or otherwise be unable to maintain these licenses for any reason, it would halt our ability to manufacture
and sell our vehicles or may prohibit development of our future models, which could result in a material adverse effect on our business
or results of operations.
| 24 | |
In
addition, if we do not own the patents or patent applications that we license, as was the case with the AYRO 411xs patents, we
may need to rely upon our licensors to properly prosecute and maintain those patent applications and prevent infringement of those patents.
If our licensors are unable to adequately protect their proprietary intellectual property we license from legal challenges, or if we
are unable to enforce such licensed intellectual property against infringement or alternative technologies, we will not be able to compete
effectively in the electric vehicle markets we are targeting.
**Many
of our proprietary designs are in digital form, and a breach of our computer systems could result in these designs being stolen.**
If
our security measures are breached or unauthorized access to private or proprietary data is otherwise obtained, our proprietary designs
could be stolen. Because we hold many of these designs in digital form on our servers, there exists an inherent risk that an unauthorized
third party could conduct a security breach resulting in the theft of our proprietary information. While we have taken steps to protect
our proprietary information, because techniques used to obtain unauthorized access or sabotage systems change frequently and generally
are not identified until they are launched against a target, we may be unable to anticipate these techniques or to implement adequate
preventative measures. Any or all of these issues could negatively impact our competitive advantage and our ability to obtain new customers,
thereby adversely affecting our financial results.
**Our
proprietary designs are susceptible to reverse engineering by our competitors.**
Much
of the value of our proprietary rights is derived from our vast library of design specifications. While we consider our design specifications
to be protected by various proprietary, trade secret and intellectual property laws, such information is susceptible to reverse engineering
by our competitors. We may not be able to prevent our competitors from developing competing design specifications, and the cost of enforcing
these rights may be significant. If we are unable to adequately protect our proprietary designs, our financial condition and operating
results could suffer.
**If
we are unable to protect the confidentiality of our trade secrets or know-how, such proprietary information may be used by others to
compete against us.**
We
consider trade secrets, including confidential and unpatented know-how and designs important to the maintenance of our competitive position.
We protect trade secrets and confidential and unpatented know-how, in part, by customarily entering into non-disclosure and confidentiality
agreements with parties who have access to such knowledge, such as our employees, outside technical and commercial collaborators, consultants,
advisors and other third parties. We also enter into confidentiality and invention or patent assignment agreements with our employees
and consultants that obligate them to maintain confidentiality and assign their inventions to us. Despite these efforts, any of these
parties may breach the agreements and disclose our proprietary information, including our trade secrets, and we may not be able to obtain
adequate remedies for such breaches.
**Legal
proceedings or third-party claims of intellectual property infringement and other challenges may require us to spend substantial time
and money and could harm our business.**
The
vehicle design and manufacturing industry is characterized by vigorous protection and pursuit of intellectual property rights, which
has resulted in protracted and expensive litigation for many companies. We may become subject to lawsuits alleging that we have infringed
the intellectual property rights of others. The nature of claims contained in unpublished patent filings around the world is unknown
to us, and it is not possible to know which countries patent holders may choose for the extension of their filings under the Patent Cooperation
Treaty, or other mechanisms. To the extent that we have previously incorporated third-party technology and/or know-how into certain products
for which we do not have sufficient license rights, we could incur substantial litigation costs, be forced to pay substantial damages
or royalties, or even be forced to cease sales in the event any owner of such technology or know-how were to challenge our subsequent
sale of such products (and any progeny thereof). In addition, to the extent that we discover or have discovered third-party patents that
may be applicable to products or processes in development, we may need to take steps to avoid claims of possible infringement, including
obtaining non-infringement or invalidity opinions and, when necessary, re-designing or re-engineering products. However, we cannot assure
you that these precautions will allow us to successfully avoid infringement claims. We may also be subject to claims based on the actions
of employees and consultants with respect to the usage or disclosure of intellectual property learned from other employers. Third parties
may in the future assert claims of infringement of intellectual property rights against us or against our customers or channel partners
for which we may be liable.
| 25 | |
Our
involvement in intellectual property litigation could result in significant expense to us, adversely affect the development of sales
of the challenged product or intellectual property and divert the efforts of our technical and management personnel, whether or not such
litigation is resolved in our favor. Uncertainties resulting from the initiation and continuation or defense of intellectual property
litigation or other proceedings could have a material adverse effect on our ability to compete in the marketplace. In the event of an
adverse outcome in any such litigation, we may, among other things, be required to:
| 
| 
pay
substantial damages; | |
| 
| 
| |
| 
| 
cease
the development, manufacture, use, sale or importation of products that infringe upon other patented intellectual property; | |
| 
| 
| |
| 
| 
expend
significant resources to develop or acquire non-infringing intellectual property; | |
| 
| 
| |
| 
| 
discontinue
processes incorporating infringing technology; or | |
| 
| 
| |
| 
| 
obtain
licenses to the infringing intellectual property, which licenses may not be available on acceptable terms, or at all. | |
**We
are generally obligated to indemnify our sales channel partners, customers, suppliers and contractors for certain expenses and liabilities
resulting from intellectual property infringement claims regarding our products, which could force us to incur substantial costs.**
We
have agreed, and expect to continue to agree, to indemnify our sales channel partners and customers for certain intellectual property
infringement claims regarding our products. As a result, in the case of infringement claims against these sales channel partners and
end-customers, we could be required to indemnify them for losses resulting from such claims or to refund amounts they have paid to us.
Our sales channel partners and other end-customers in the future may seek indemnification from us in connection with infringement claims
brought.
**General
Risk Factors**
**Our
stock price may be volatile.**
The
market price of our common stock is likely to be highly volatile and could fluctuate widely in price in response to various factors,
many of which are beyond our control, including the following:
| 
| 
results
of our operations and product development efforts; | |
| 
| 
| |
| 
| 
our
ability to obtain working capital financing; | |
| 
| 
| |
| 
| 
additions
or departures of key personnel; | |
| 
| 
| |
| 
| 
limited
public float in the hands of a small number of persons whose sales or lack of sales could result in positive or negative
pricing pressure on the market price for our common stock; | |
| 
| 
| |
| 
| 
our
ability to execute our business plan; | |
| 
| 
| |
| 
| 
sales
of our common stock and decline in demand for our common stock; | |
| 
| 
| |
| 
| 
regulatory
developments; | |
| 
| 
| |
| 
| 
economic
and other external factors; | |
| 
| 
| |
| 
| 
investor
perception of our industry or our prospects; and | |
| 
| 
| |
| 
| 
period-to-period
fluctuations in our financial results. | |
| 26 | |
In
addition, the securities markets have from time-to-time experienced significant price and volume fluctuations that are unrelated to the
operating performance of particular companies.
**Our
failure to meet the continued listing requirements of the Nasdaq Capital Market (Nasdaq) could result in a delisting of
our common stock.**
Our
common stock is currently listed for trading on The Nasdaq Capital Market. We must satisfy Nasdaqs continued listing requirements,
including, among other things, a minimum closing bid price of $1.00 per share or risk delisting, which would have a material adverse
effect on our business. A delisting of our common stock from The Nasdaq Capital Market could materially reduce the liquidity of our common
stock and result in a corresponding material reduction in the price of our common stock. In addition, delisting could harm our ability
to raise capital through alternative financing sources on terms acceptable to us, or at all, and may result in the potential loss of
confidence by investors, suppliers, customers and employees and fewer business development opportunities.
****
There
is no assurance that we will maintain compliance with such minimum listing requirements. If our common stock were delisted from Nasdaq,
trading of our common stock would most likely take place on an over-the-counter market established for unlisted securities, such as the
OTCQB or the Pink Market maintained by OTC Markets Group Inc. An investor would likely find it less convenient to sell, or to obtain
accurate quotations in seeking to buy, our common stock on an over-the-counter market, and many investors would likely not buy or sell
our common stock due to difficulty in accessing over-the-counter markets, policies preventing them from trading in securities not listed
on a national exchange or other reasons. In addition, as a delisted security, our common stock would be subject to SEC rules as a penny
stock, which impose additional disclosure requirements on broker-dealers. The regulations relating to penny stocks, coupled with
the typically higher cost per trade to the investor of penny stocks due to factors such as broker commissions generally representing
a higher percentage of the price of a penny stock than of a higher-priced stock, would further limit the ability of investors to trade
in our common stock. In addition, delisting could harm our ability to raise capital through alternative financing sources on terms acceptable
to us, or at all, and may result in the potential loss of confidence by investors, suppliers, customers and employees and fewer business
development opportunities. For these reasons and others, delisting would adversely affect the liquidity, trading volume and price of
our common stock, causing the value of an investment in us to decrease and having an adverse effect on our business, financial condition
and results of operations, including our ability to attract and retain qualified employees and to raise capital.
**We
may in the future be named in legal proceedings, become involved in regulatory inquiries or be subject to litigation, all of which are
costly, distracting to our core business and could result in an unfavorable outcome or a material adverse effect on our business, financial
condition, results of operations or the market price for our common stock**
We
may in the future be involved in legal proceedings and/or receive inquiries from government and regulatory agencies from time to time.
Additionally, we have in the past and may in the future be subject to claims, litigation and other proceedings. Defending these lawsuits
and becoming involved in these investigations or other proceedings may divert managements attention and may cause us to incur
significant expenses. In addition, we may be required to pay damage awards, penalties or settlements, or become subject to injunctions
or other equitable remedies, which could have a materially adverse effect on our business, financial condition, results of operations
and cash flows.
In
the event that we are involved in significant disputes or are the subject of a formal action by a regulatory agency, we could be exposed
to costly and time-consuming proceedings that could result in any number of outcomes. Any future claims or regulatory actions initiated
by or against us, whether successful or not, could result in significant costs, costly damage awards or settlement amounts, injunctive
relief, increased costs of business, fines or orders to change certain business practices, significant dedication of management time,
diversion of significant operational resources, or otherwise harm our business, financial condition and results of operations. If we
are not successful in any such legal proceedings and litigation, we may be required to pay significant monetary damages, which could
hurt our results of operations. Lawsuits are time-consuming and expensive to resolve and divert managements time and attention.
We also cannot predict how the courts will rule in any potential lawsuit against us. Decisions in favor of parties that bring lawsuits
against us could subject us to significant liability for damages, adversely affect our results of operations and harm our reputation.
| 27 | |
**An
active trading market for our Common Stock may not be sustained.**
The
listing of our Common Stock on The Nasdaq Capital Market does not assure that a meaningful, consistent and liquid trading market exists.
An active trading market for shares of our Common Stock may not be sustained. If an active market for our Common Stock is not sustained,
it may be difficult for investors to sell their shares either without depressing the market price for the shares or at all.
**We
incur increased costs and demands on management as a result of compliance with laws and regulations applicable to public companies, which
could harm our operating results.**
As
a public company, we incur significant legal, accounting and other expenses that we did not incur as a private company, including costs
associated with public company reporting requirements. In addition, the Sarbanes-Oxley Act and the Dodd-Frank Act, as well as rules implemented
by the SEC and Nasdaq, impose a number of requirements on public companies, including with respect to corporate governance practices.
Our management and other personnel need to devote a substantial amount of time to these compliance and disclosure obligations. Moreover,
compliance with these rules and regulations has increased our legal, accounting and financial compliance costs and has made some activities
more time-consuming and costly. It is also more expensive for us to obtain director and officer liability insurance.
**We
do not anticipate paying cash dividends on our Common Stock and, accordingly, stockholders must rely on stock appreciation for any return
on their investment.**
We
have never declared or paid cash dividends on our Common Stock and do not expect to do so in the foreseeable future. So long as any shares
of Series H-7 Preferred Stock are outstanding, as they are at this time, we are not able to declare or pay any cash dividend or distribution
on any of our capital stock (other than as required by the Certificate of Designation) without the prior written consent of the Required
Holders (as defined in the Certificate of Designation). The declaration of dividends is further subject to the discretion of our board
of directors and limitations under applicable law, and will depend on various factors, including our operating results, financial condition,
future prospects and any other factors deemed relevant our board of directors. You should not rely on an investment in us if you require
dividend income from your investment in us. The success of your investment will likely depend entirely upon any future appreciation of
the market price of our Common Stock, which is uncertain and unpredictable. There is no guarantee that our Common Stock will appreciate
in value.
**A
failure in or breach of our operational or security systems or infrastructure, or those of third parties with which we do business,
including as a result of cyberattacks, could disrupt our businesses, result in the disclosure or misuse of confidential or proprietary
information, damage our reputation, increase our costs and cause losses.**
Information
security risks in our industry have significantly increased in recent years in part because of the proliferation of new technologies,
the use of the Internet and telecommunications technologies to conduct operations, and the increased sophistication and activities of
organized crime, hackers, terrorists and other external parties, including foreign state actors. Our technologies, systems, networks,
may have been subject to, and are likely to continue to be the target of, cyberattacks, computer viruses, malicious code, phishing attacks
or information security breaches that could result in the unauthorized release, gathering, monitoring, misuse, loss or destruction of
our confidential, proprietary and other information, or otherwise disrupt third parties business operations.
We
may suffer material losses relating to cyberattacks or other information security breaches. Our risk and exposure to these matters remain
heightened because of, among other things, the evolving nature of these threats, the continued uncertain global economic environment,
threats of cyberterrorism, and system and customer account conversions. As a result, cybersecurity and the continued development and
enhancement of our controls, processes and practices designed to protect our systems, computers, software, data and networks from attack,
damage or unauthorized access remain a priority for us. As cyber threats continue to evolve, we may be required to expend significant
additional financial, technical and operational resources to continue to modify or enhance our protective measures or to investigate
and remediate any information security vulnerabilities.
| 28 | |
In
addition, we also face the risk of operational failure, termination or capacity constraints of any of the third parties with which we
do business or that facilitate our and our subsidiaries business activities. Any such failure, termination or constraint could
adversely affect our and our subsidiaries ability to provide our services and products, service the customers, manage the exposure
to risk or expand our businesses and could have an adverse impact on our liquidity, financial condition and results of operations.
Disruptions
or failures in the physical infrastructure or operating systems that support our business, or cyberattacks or security breaches of the
networks, systems or devices that products use could result in the loss of customers and business opportunities, significant disruptions
to our operations and business, misappropriation of our confidential information and/or that of our customers, or damage to our computers
or systems and those of our customers and/or counterparties, and could result in violations of applicable privacy laws and other laws,
litigation exposure, regulatory fines, penalties or intervention, loss of confidence in our security measures, reputational damage, reimbursement
or other compensatory costs, and additional compliance costs.
**Anti-takeover
provisions of our certificate of incorporation, our bylaws and Delaware law could make an acquisition of us, which may be beneficial
to our stockholders, more difficult and may prevent attempts by our stockholders to replace or remove the current members of our board
and management.**
Certain
provisions of our certificate of incorporation and bylaws could discourage, delay or prevent a merger, acquisition or other change of
control that stockholders may consider favorable, including transactions in which you might otherwise receive a premium for your shares.
Furthermore, these provisions could prevent or frustrate attempts by our stockholders to replace or remove members of our board of directors.
These provisions also could limit the price that investors might be willing to pay in the future for our securities, thereby depressing
the market price of our securities. Stockholders who wish to participate in these transactions may not have the opportunity to do so.
These provisions, among other things:
| 
| 
allow
the authorized number of directors to be changed only by resolution of our board of directors; | |
| 
| 
| |
| 
| 
authorize
our board of directors to issue, without stockholder approval, preferred stock, the rights of which will be determined at the discretion
of the board of directors and that, if issued, could operate as a poison pill to dilute the stock ownership of a potential
hostile acquirer to prevent an acquisition that our board of directors does not approve; | |
| 
| 
| |
| 
| 
establish
advance notice requirements for stockholder nominations to our board of directors or for stockholder proposals that can be acted
on at stockholder meetings; and | |
| 
| 
| |
| 
| 
limit
who may call a stockholder meeting. | |
In
addition, we are governed by the provisions of Section 203 of the Delaware General Corporation Law that may, unless certain criteria
are met, prohibit large stockholders, in particular those owning 15% or more of the voting rights on our common stock, from merging or
combining with us for a prescribed period of time.
**ITEM
1B. UNRESOLVED STAFF COMMENTS.**
None.
| 29 | |
**ITEM
1C. CYBERSECURITY.**
We
operate in the electric vehicle manufacturing sector and recently pivoted our business towards a digital asset. Treasury management strategy,
which is subject to various cybersecurity risks that could adversely affect our business, financial condition, and results of operations,
including intellectual property theft; fraud; extortion; harm to employees or customers; violation of privacy laws and other litigation
and legal risk; and reputational risk. We recognize the importance of assessing, identifying, and managing material risks associated
with cybersecurity threats. Both our executive management team and our board of directors are involved in the assessment, identification,
and management of such risks, including prevention, mitigation, detection, and remediation of cybersecurity incidents.
Our
executive management team is responsible for day-to-day assessment, identification and management of material risks from cybersecurity
threats, including the prevention, mitigation, detection, and remediation of cybersecurity incidents. The individual currently serving
in this role is our Executive Chairman. The executive management team monitors current events in order to remain aware of current cybersecurity
threats and is informed of cybersecurity incidents as they arise by our frontline personnel.
We
engage a third-party consultant to review our cybersecurity defense measures, inform our executive management team of emerging cybersecurity
threats, and assist our executive management team in responding to any potential cybersecurity incidents. The executive management team
is also responsible for overseeing and identifying risks from cybersecurity threats associated with our use of any third-party service
providers.
Our
board of directors is responsible for oversight of risks from cybersecurity threats in conjunction with our executive management team.
Our board of directors receives updates from our management team with respect to risks from cybersecurity threats and are notified of
any new significant cybersecurity threats or incidents as they arise. Additionally, our board of directors considers risks from cybersecurity
threats as part of its overall assessment of risk management, including its general oversight of the Companys business strategy,
risk management policies, and financials.
To
date, no cybersecurity incident (or aggregation of incidents) or cybersecurity threat has materially affected our business strategy,
results of operations or financial condition, and we are not aware of any cybersecurity incidents that are reasonably likely to materially
affect the Company, including our business strategy, results of operations, or financial condition. For further information regarding
the risks associated with cybersecurity incidents, see Risk Factors - Failure in our information technology and storage systems
could significantly disrupt the operation of our business in Item 1A of this Annual Report on Form 10-K.
**ITEM
2. PROPERTIES.**
Our
corporate headquarters is located at 1185 Avenue of the Americas, New York, NY 10036. We currently lease approximately 23,927 square
feet of office space in Round Rock, Texas under a lease that expires in February 2027. The Round Rock Lease provides for a base monthly
rent, and we are also responsible for real estate taxes, maintenance and other operating expenses applicable to the leased premises.
On
March 11, 2025, the Company entered into the Sublease Agreement of the Round Rock Lease with a third-party, commencing on April 1, 2025,
and expiring on February 28, 2027, with substantially the same terms as the Round Rock Lease. The Company remains bound to the Landlord
of the Round Rock Lease for all liabilities and obligations under the Round Rock Lease.
We
believe that this facility is adequate for our present operations.
**ITEM
3. LEGAL PROCEEDINGS.**
We
are subject to various legal proceedings and claims, either asserted or unasserted, which arise in the ordinary course of business, that
we believe are incidental to the operation of our business. While the outcome of these claims cannot be predicted with certainty, management
does not believe that the outcome of any of these legal matters will have a material adverse effect on our results of operations, financial
positions or cash flows.
**ITEM
4. MINE SAFETY DISCLOSURES.**
Not
applicable.
| 30 | |
**PART
II**
**ITEM
5. MARKET FOR REGISTRANTS COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.**
**Market
Information**
Our
common stock trades on the Nasdaq Capital Market under the symbol SBLX.
**Stockholders**
As
of March 30, 2026, there were approximately 91 stockholders of record of our common stock.
**Dividends**
We
have not paid any cash dividends to our common stockholders since inception and do not plan to pay cash dividends in the foreseeable
future. So long as any shares of Series H-7 Preferred Stock and Series I Preferred Stock are outstanding, as they are at this time,
we are not able to declare or pay any cash dividend or distribution on any of our capital stock (other than as required by the
Certificate of Designations) without the prior written consent of the Required Holders (as defined in the Certificate of
Designations). Any future declaration of dividends will depend on our earnings, capital requirements, financial condition, prospects
and any other factors that our board of directors deems relevant, as well as compliance with the requirements of state law. In
general, as a Delaware corporation, we may pay dividends out of surplus capital or, if there is no surplus capital, out of net
profits for the fiscal year in which a dividend is declared and/or the preceding fiscal year. We currently intend to retain
earnings, if any, for reinvestment in our business.
**Recent
Sales of Unregistered Securities**
All
sales of unregistered securities during the year ended December 31, 2025 were previously disclosed in a Quarterly Report on Form 10-Q
or a Current Report on Form 8-K.
**Issuer
Purchases of Equity Securities**
****
We
did not re-purchase any of our equity securities during the fourth quarter of the fiscal year ended December 31, 2025.
**ITEM
6. [RESERVED].**
| 31 | |
**ITEM
7. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.**
*The
following managements discussion and analysis should be read in conjunction with our historical financial statements and the related
notes thereto. This managements discussion and analysis contains forward-looking statements, such as statements of our plans,
objectives, expectations and intentions. Any statements that are not statements of historical fact are forward-looking statements. When
used, the words believe, plan, intend, anticipate, target, estimate,
expect and the like, and/or future tense or conditional constructions (will, may, could,
should, etc.), or similar expressions, identify certain of these forward-looking statements. These forward-looking statements
are subject to risks and uncertainties, including those under Risk Factors in our filings with the Securities and Exchange
Commission (SEC) that could cause actual results or events to differ materially from those expressed or implied by the
forward-looking statements. Our actual results and the timing of events could differ materially from those anticipated in these forward-looking
statements as a result of several factors. See Forward-Looking Statements; Risk Factor Summary.*
*References
in this managements discussion and analysis to we, us, our, the Company,
our Company or StableX refer to StableX Technologies, Inc. and its subsidiaries.*
**Overview**
**Business**
We
have historically designed and manufactured compact, sustainable electric vehicles. In July 2025, we commenced a strategic transition
toward a new business model focused on digital asset initiatives, with a focus on targeting the acquisition of crypto tokens that are
directly capitalizing on the rapid growth of the stablecoin industry. We view the stablecoin ecosystem as a rapidly growing segment of
the global financial infrastructure and believe that the entry into this market can provide a complementary revenue stream and enhance
stockholder value. Our approach is intended to focus on acquiring and holding crypto assets within the stablecoin space and deploying
them in a manner designed to generate yield while managing associated risks. In connection with this strategic shift, we announced a
target goal of acquiring up to $100 million in crypto assets, subject to available capital, market conditions and regulatory considerations.
Our
investment strategy centers on acquiring digital assets (tokens) that provide essential infrastructure and enabling technologies for
the stablecoin sector, often referred to as the picks and shovels approach. Rather than directly investing in stablecoins
themselves (which function as the primary commodity in this analogy), we target tokens associated with protocols, networks,
and platforms that facilitate the issuance, transfer, custody, compliance, trading, lending, and scalability of stablecoins. We believe
this positions our portfolio to capture indirect but amplified exposure to the sectors anticipated expansion.
The
Company did not generate revenue during the year ended December 31, 2025. Operating activities during the year primarily consisted of
(i) evaluating and implementing the Companys digital asset treasury strategy, (ii) completing financing transactions to support
liquidity and capital deployment, and (iii) managing corporate overhead and compliance costs as a public company.
As
of December 31, 2025, the Companys primary assets consisted of cash, digital assets and marketable securities. The Companys
results of operations for the year were primarily affected by operating expenses, preferred stock dividends and accretion, changes in
the fair value of derivative liabilities, and fluctuations in the fair value of digital assets. The Companys financial results
may continue to experience volatility due to market conditions affecting digital asset valuations and the accounting treatment of certain
financial instruments.
| 32 | |
**Reverse
Stock Split**
****
The
Company effected a 1-for-16 reverse stock split (Reverse Stock Split) of the Companys common stock on June 25, 2025,
which began trading on a split-adjusted basis on June 26, 2025, pursuant to which every 16 shares of the Companys issued and outstanding
common stock were reclassified as one share of common stock. The Reverse Stock Split had no impact on the par value of the Companys
common stock or the authorized number of shares of common stock. Unless otherwise indicated, all share and per share information prior
to the Reverse Stock Split are retroactively adjusted to reflect the Reverse Stock Split, prior to the rounding of any fractional shares.
Any fractional shares resulting from the Reverse Stock Split were rounded up to the next whole number of shares, upon which 124 shares
of common stock were issued in June 2025.
**Factors
Affecting Results of Operations**
****
The
Company did not generate revenue during the year ended December 31, 2025. As a result, the Companys results of operations for
the year were primarily driven by operating expenses, preferred stock dividends and accretion, changes in the fair value of financial
instruments, and fluctuations in the fair value of digital assets and marketable securities. The following factors materially affected
the Companys financial condition and results of operations during the year ended December 31, 2025 and are expected to continue
to affect future periods.
**Strategic
Transition to Digital Asset Treasury Activities**
****
In
July 2025, the Company initiated a strategic transition toward digital asset treasury management and capital allocation activities. As
part of this transition, the Company deployed capital into digital assets and marketable securities. Because the Companys strategy
involves holding and managing assets that are subject to market price volatility, future results of operations may fluctuate significantly
based on changes in fair value of these holdings. Gains and losses associated with digital assets and certain financial instruments may
materially impact net income (loss) from period to period.
**Fair
Value of Digital Assets and Financial Instruments**
****
The
Company accounts for certain digital assets and derivative financial instruments at fair value. Changes in the fair value of these assets
and liabilities are recognized in the Companys consolidated statements of operations. As a result, the Companys reported
net loss may vary significantly from period to period due to market-driven price changes rather than changes in underlying operating
activity. The valuation of embedded derivatives and other financial instruments requires management judgment and the use of estimates,
including volatility assumptions and other inputs, which may materially affect reported results.
**Preferred
Stock Dividends and Accretion**
****
The
Companys outstanding Series I Preferred Stock and Series H-7 Preferred Stock contain dividend and redemption features that impact
reported results. The Company records preferred stock dividends and, where applicable, accretion of discounts to redemption value as
deemed dividends or interest expense in accordance with applicable accounting guidance. These non-cash charges reduce net income available
to common stockholders and may materially impact loss per share.
**Market
Conditions and Volatility**
****
The
Companys financial performance is directly influenced by conditions in the digital asset markets and broader capital markets.
Digital asset prices have historically experienced significant volatility. Market fluctuations, regulatory developments, counterparty
risk and macroeconomic conditions may materially affect the value and liquidity of the Companys holdings. Such volatility may
result in substantial fluctuations in reported earnings or losses in future periods.
| 33 | |
**Components
of Results of Operations**
**Revenue**
The
Company did not generate revenue during the year ended December 31, 2025.
**Cost
of Goods Sold**
Cost
of goods sold primarily consists of adjustments to inventory related to the adjustments to inventory stock counts resulting from impairment
write downs.
**Operating
Expenses**
Operating
expenses consist primarily of general and administrative expenses, including compensation and related costs, professional fees, consulting
expenses, public company compliance costs and stock-based compensation.
**Stock-Based
Compensation**
We
account for stock-based compensation expense in accordance with Accounting Standards Codification (ASC) 718, *Compensation
- Stock Compensation,* which requires the measurement and recognition of compensation expense for share-based awards based on the
estimated fair value on the date of grant.
The
fair value of each stock option granted to employees is estimated on the date of the grant using the Black-Scholes option-pricing model,
and the related stock-based compensation expense is recognized over the vesting period during which an employee is required to provide
service in exchange for the award. The fair value of the options granted to non-employees is measured and expensed as the options vest.
Restricted
stock grants are stock awards that entitle the holder to receive shares of our common stock as the award vests over time. The fair value
of each restricted stock grant is based on the fair market value price of common stock on the date of grant, and it is measured and expensed
as the restricted stock vests.
**Research
and Development Expense**
Research
and development expense consists primarily of employee compensation and related expenses, prototype expenses, depreciation associated
with assets acquired for research and development, amortization of product development costs, product strategic advisory fees, third-party
engineering and contractor support costs and allocated overhead. We expect our research and development expenses to increase in absolute
dollars as we continue to invest in new and existing products.
**Sales
and Marketing Expense**
Sales
and marketing expenses consist primarily of employee compensation and related expenses, sales commissions, marketing programs, travel
and entertainment expenses and allocated overhead. Marketing programs consist of advertising, trade shows, events, corporate communications,
and brand-building activities. We expect sales and marketing expenses to increase in absolute dollars as we expand our sales force, expand
our product lines, increase marketing resources, and further develop potential sales channels.
**General
and Administrative Expense**
General
and administrative expenses consist primarily of employee compensation and related expenses for administrative functions including finance,
legal, human resources, and fees for third-party professional services, and allocated overhead. We expect our general and administrative
expense to increase in absolute dollars as we continue to invest in growing our business.
**Other
(Expense) Income**
Other
(expense) income consists of income received or expenses incurred for activities outside of our core business. Other (expense) income
consists primarily of interest expense, unrealized gain/loss on marketable securities, the changes in fair value of the warrant and the
derivative liability, vendor and legal settlements, and write-off of prepaid inventory as a result of vendor bankruptcy.
| 34 | |
**Provision
for Income Taxes**
Provision
for income taxes consists of estimated income taxes due to the United States government and to the state tax authorities in jurisdictions
in which we conduct business. In the case of a tax deferred asset, we reserve the entire value for future periods.
**Results
of Operations**
**Year
Ended December 31, 2025 Compared with Year Ended December 31, 2024**
The
following table sets forth our results of operations for each of the years set forth below:
| 
| | 
2025 | | | 
2024 | | | 
Change | | |
| 
Revenue | | 
$ | - | | | 
$ | 63,777 | | | 
$ | (63,777 | ) | |
| 
Cost of goods sold | | 
| 956,160 | | | 
| 6,650,979 | | | 
| (5,694,819 | ) | |
| 
Gross loss | | 
| (956,160 | ) | | 
| (6,587,202 | ) | | 
| 5,631,042 | | |
| 
Operating expenses: | | 
| | | | 
| | | | 
| | | |
| 
Research and development | | 
| 1,394,905 | | | 
| 1,493,202 | | | 
| (98,297 | ) | |
| 
Sales and marketing | | 
| - | | | 
| 990,471 | | | 
| (990,471 | ) | |
| 
General and administrative | | 
| 8,104,834 | | | 
| 8,646,301 | | | 
| (541,467 | ) | |
| 
Loss on impairment of long-lived assets | | 
| - | | | 
| 1,659,835 | | | 
| (1,659,835 | ) | |
| 
Total operating expenses | | 
| 10,199,739 | | | 
| 12,789,809 | | | 
| (2,590,070 | ) | |
| 
Loss from operations | | 
| (10,455,899 | ) | | 
| (19,377,011 | ) | | 
| 8,921,112 | | |
| 
Other income (expense): | | 
| | | | 
| | | | 
| | | |
| 
Interest income | | 
| 126,620 | | | 
| 484,325 | | | 
| (357,705 | ) | |
| 
Change in fair value - warrant liability | | 
| (11,627,100 | ) | | 
| 10,956,900 | | | 
| (22,584,000 | ) | |
| 
Change in fair value - derivative liability | | 
| 2,854,000 | | | 
| 6,739,000 | | | 
| (3,885,000 | ) | |
| 
Unrealized gain (loss) on marketable securities | | 
| (91,936 | ) | | 
| (98,315 | ) | | 
| 6,379 | | |
| 
Unrealized loss on digital assets | | 
| (2,151,001 | ) | | 
| - | | | 
| (2,151,001 | ) | |
| 
Realized gain on marketable securities | | 
| 409,818 | | | 
| 1,322,971 | | | 
| (913,153 | ) | |
| 
Legal settlement | | 
| - | | | 
| (1,096,222 | ) | | 
| 1,096,222 | | |
| 
Vendor settlement | | 
| - | | | 
| (647,833 | ) | | 
| 647,833 | | |
| 
Consent and waiver fee Series H-7 | | 
| (350,000 | ) | | 
| - | | | 
| (350,000 | ) | |
| 
Other income (expense), net | | 
| 196,353 | | | 
| (39,294 | ) | | 
| 235,647 | | |
| 
Net loss | | 
$ | (21,089,145 | ) | | 
$ | (1,755,479 | ) | | 
$ | (19,333,666 | ) | |
**Revenue**
Revenue
was $0 for the year ended December 31, 2025, as compared to $63,777 for the year ended December 31, 2024, a decrease of 100%, or $63,777.
The decrease in revenue was primarily due to a reduction of $43,200 in product sales and a $20,577 decrease in service revenue, mainly
due to the pause in manufacturing of the Vanish as the Company focuses on re-engineering the vehicle to optimize its design and improve
manufacturing efficiencies.
**Cost
of goods sold and gross loss**
Cost
of goods increased by $5,694,819, or 85.6% for the year ended December 31, 2025, as compared to the year ended December 31, 2024. The
decrease in cost of goods sold was mainly due to the decrease of $1,001,065 related to overhead allocation, a decrease of $4,209,794
related to adjustments to inventory stock counts and impairment that as the result of the Companys pause on manufacturing of the
Vanish.
| 35 | |
**Research
and development expenses**
Research
and development (R&D) expense was $1,394,905 for the year ended December 31, 2025, as compared to $1,493,202 for the
year ended December 31, 2024, a decrease of $98,297, or 6.6%. The Company had a decrease of $312,376 in salaries and related personnel
costs that was offset by assembly costs related to redesign work during the early portion of the year ended December 31, 2025. The overall
decrease was primarily due to the Company being substantially complete with the R&D on the Vanish at the end of 2024, offset by the
increase in re-engineering work and design changes in the current year associated with the Companys objective of lowering the
bill of material and overall manufacturing expenses of the Vanish.
**Sales
and marketing expense**
Sales
and marketing expense was $0 for the year ended December 31, 2025, as compared to $990,471 for the year ended December 31, 2024, a decrease
of $990,471, or 100%. Due to the Companys decision towards the end of 2024 to pause the manufacturing of the Vanish the Company
did not engage in advertising or marketing activities during the year ended December 31, 2025.
**General
and administrative expenses**
The
majority of our operating losses from continuing operations resulted from general and administrative expenses. General and administrative
expenses consist primarily of costs associated with our overall operations and with being a public company. These costs include personnel,
legal and financial professional services, insurance, investor relations, and compliance related fees.
General
and administrative expense was $8,104,834 for the year ended December 31, 2025, compared to $8,646,301 for the year ended December 31,
2024, a decrease of $541,467, or 6.3%. Personnel expenses decreased by $283,214 for the year ended December 31, 2025, compared to the
year ended December 31, 2024, due to the increase in stock-based compensation $521,674 which was offset by a decrease in headcount
associated with the internal restructuring. Consultants and professional services decreased by $437,335 for the year ended December 31,
2025 compared to the year ended December 31, 2024 primarily due to fewer engagements that required external professional services; this
was offset by an increase in consulting expense related to warrants of $1,019,114 for the year ended December 31, 2025 as compared to
the year ended December 31, 2024. Cost and associated expenses related to the issuance of Series Preferred Stock increased by $773,677
for the year ended December 31, 2025 compared to the year ended December 31, 2024. Depreciation expense decreased by $1,142,352 for the
year ended December 31, 2025, compared to the year ended December 31, 2024, due to the Companys property and equipment being fully
impaired during the year ended December 31, 2024.
**Impairment
of long-lived assets**
The
Company did not record an impairment of long-lived assets during the year ended December 31, 2025.
For
the year ended December 31, 2024, the Company recorded an increase of $1,659,835 related to loss on impairment of long-lived assets,
consisted of a $1,615,660 loss due to write down of idle fixed assets that were intended to be used in the production of the Vanish,
and $44,175 increase in impairment of right-of-use asset due to a remeasurement of the assets carrying value.
**Other
income and expense**
For
the year ended December 31, 2025, the Company recorded a $28,254,778 decrease of net other income. For the years ended December 31, 2025
and 2024, the Company recognized a loss of $11,627,100 and a gain of $10,956,900, respectively, for the change in fair value - warrant
liability, a decrease of $22,584,000 primarily due to the decrease in the trading price of the Companys common stock and the increase
in the exercise price. For the years ended December 31, 2025 and 2024, the Company recognized a gain of $2,854,000 and $6,739,000, respectively,
for the change in fair value derivative liability, a decrease of $3,885,000 primarily due to the decrease in the trading price
of the Companys common stock and the decrease in carrying amount of derivative liability from redemptions of Series H-7 Preferred
Stock.
| 36 | |
**Liquidity
and Capital Resources**
As
of December 31, 2025, we had $4,981,798 in cash and cash equivalents, $110,264 in restricted cash, $3,168,362 in marketable securities
and working capital of $7,567,805. As of December 31, 2024, we had $16,035,475 in cash and cash equivalents, and $164,682 in restricted
cash, and working capital of $17,100,605. The decrease in cash and cash equivalents and working capital was primarily a result of the
payment of Series H-7 preferred stock redemptions and purchases of digital assets. Our sources of cash since inception have been predominately
from the sale of equity and debt, including the issuance of the Series H-7 and Series I Preferred Stock.
Our
future liquidity requirements or future capital needs will depend on, among other things, capital required to manufacture our products
and the operational staffing and support requirements, as well as the timing and amount of future revenue and product costs. Our business
is capital-intensive, and future capital requirements will depend on many factors, including our growth rate, the timing and extent of
spending to support development efforts, the results of our strategic review, the timing of new product introductions and the continuing
market acceptance of our products and services. We are working to control expenses and deploy our capital in the most efficient manner.
We
are evaluating other options for the strategic deployment of capital beyond our ongoing strategic initiatives. We anticipate being opportunistic
with our capital, and we intend to explore potential partnerships and acquisitions that could be synergistic with our competitive stance
in the market.
We
also implemented a multi-token investment strategy, pursuant to which we intend to use capital in excess of working capital requirements
to invest in one or more alternative investments or assets, which may include digital assets linked to stablecoin. We intend to target
$100 million in crypto tokens that capitalize on the stablecoin industry, and we will continue to monitor market conditions in determining
whether to engage in additional financings to purchase such crypto tokens. This overall strategy also contemplates that we may (i) periodically
sell the crypto tokens we purchase for general corporate purposes, including to generate cash for treasury management (which may include
debt repayment), or in connection with strategies that generate tax benefits in accordance with applicable law, (ii) enter into additional
capital raising transactions that are collateralized by our potential digital asset holdings, and (iii) consider pursuing additional
strategies to create income streams or otherwise generate funds using potential digital asset holdings.
We
are subject to a number of risks similar to those of earlier stage commercial companies, including dependence on key individuals and
products, the difficulties inherent in the development of a commercial market, the potential need to obtain additional capital, and
competition from larger companies, other technology companies and other technologies. Based on the foregoing, management believes
that the existing cash and cash equivalents and marketable securities at December 31, 2025 will not be sufficient to fund operations
for at least the next twelve months following the date of this report.
*Series
H-7 Preferred Stock*
On August 7, 2023, the Company entered into the Securities Purchase Agreement
with certain accredited investors (the Investors), pursuant to which it agreed to sell to the Investors (i) an aggregate
of 22,000 Series H-7 Preferred Stock with a stated value of $1,000 per share, initially convertible into up to 171,875 shares of the Companys
common stock at an initial conversion price of $128.00 per share, and (ii) warrants (Warrants) initially exercisable for
up to an aggregate of 171,875 shares of common stock.
The shares of Series H-7 Preferred Stock are convertible into common stock
(the Conversion Shares) at the election of the holder at any time at an initial conversion price of $128.00 (the Conversion
Price), which, following the Companys one-for-eight reverse stock split effected on September 15, 2023 (the Reverse
Stock Split) and pursuant to the stock combination event adjustment provisions in the Certificate of Designations, was subsequently
reduced to $32.00. The Conversion Price is subject to adjustments for stock dividends, stock splits, reclassifications and the like, and
subject to price-based adjustment in the event of any issuances of common stock, or securities convertible, exercisable or exchangeable
for common stock, at a price below the then-applicable Conversion Price (subject to certain exceptions). The Company is required to redeem
the Series H-7 Preferred Stock in 12 equal monthly installments from, and including, the applicable Installment Date (as defined in the
Certificate of Designations). On February 9, 2024, the Company filed with the Secretary of State of the State of Delaware a Certificate
of Amendment of Certificate of Designations of Series H-7 Preferred Stock, which became effective upon filing, which amended the commencement
of the monthly installment dates, to be between May 7, 2024, and August 7, 2025. The first such installment date was May 7, 2024 and August
7, 2024, as elected by the applicable investor.
| 37 | |
The
amortization payments due upon redemption of the Series H-7 Preferred Stock are payable, at the Companys election, in cash at
105% of the Installment Redemption Amount (as defined in the Certificate of Designations), or subject to certain limitations, in shares
of common stock valued at the lower of (i) the Conversion Price then in effect and (ii) the greater of (A) 80% of the average of the
three lowest closing prices of the Companys common stock during the thirty consecutive trading day period immediately prior to
the date the amortization payment is due and (B) $11.904 (as adjusted for the Companys Reverse Stock Split and subject to adjustment
for stock splits, stock dividends, stock combinations, recapitalizations or other similar events) or, in any case, such lower amount
as permitted, from time to time, by the Nasdaq Stock Market. The holders of the Series H-7 Preferred Stock have the option to defer amortization
payments or, subject to certain limitations as specified in the Certificate of Designations, can elect to accelerate installment conversion
amounts.
The
holders of the Series H-7 Preferred Stock are entitled to dividends of 8.0% per annum, compounded monthly, which are payable in cash
or shares of common stock at the Companys option, in accordance with the terms of the Certificate of Designations. Upon the occurrence
and during the continuance of a Triggering Event (as defined in the Certificate of Designations), the Series H-7 Preferred Stock will
accrue dividends at the rate of 15% per annum. Upon conversion or redemption, the holders of the Series H-7 Preferred Stock are also
entitled to receive a dividend make-whole payment.
The
Certificate of Designations provides that, except as required by applicable law, the holders of the Series H-7 Preferred Stock will be
entitled to vote with holders of the common stock on an as converted basis, with the number of votes to which each holder of Series H-7
Preferred Stock is entitled to be determined by dividing the Stated Value by a conversion price equal to $92.16 per share (as adjusted
for the Reverse Stock Split), which was the Minimum Price (as defined in Nasdaq Listing Rule 5635(d)) applicable immediately
before the execution and delivery of the Purchase Agreement, subject to certain beneficial ownership limitations and adjustments for
any stock splits, stock dividends, stock combinations, recapitalizations or other similar transactions, as set forth in the Certificate
of Designations.
Notwithstanding
the foregoing, the Companys ability to settle conversions and make amortization and dividend make-whole payments using shares
of common stock is subject to certain limitations set forth in the Certificate of Designations. Further, the Certificate of Designations
contains a certain beneficial ownership limitation after giving effect to the issuance of shares of common stock issuable upon conversion
of, or as part of any amortization payment or dividend make-whole payment under, the Certificate of Designations or Warrants.
The
Certificate of Designations includes certain triggering events including, among other things, the suspension from trading or the failure
of the common stock to be trading or listed (as applicable) on an eligible market for a period of five (5) consecutive trading days,
the Companys failure to pay any amounts due to the holders of the Series H-7 Preferred Stock when due. In connection with a triggering
event, each holder of Series H-7 Preferred Stock will be able to require the Company to redeem in cash any or all of the holders
Series H-7 Preferred Stock at a premium set forth in the Certificate of Designations.
On
December 2, 2024, the Company entered into a Waiver and Amendment Agreement (the Amendment) with the Required Holders (as
defined in the Certificate of Designations). Pursuant to the Amendment, the Company and the Required Holders agreed (i) to amend (a)
the Certificate of Designations, by filing a Certificate of Amendment to the Certificate of Designations with the Secretary of the State
of the State of Delaware (the Certificate of Amendment), and (b) the Purchase Agreement, such that, in each case, certain
grants made to the Companys directors on December 2, 2024, in the form of RSUs and fully vested restricted shares of common stock
(the Director Equity Grants) under the StableX Technologies, Inc. Long-Term Incentive Plan (as amended, the Plan),
are deemed to constitute Excluded Securities under the Transaction Documents (as such term is defined in the Purchase Agreement),
and (ii) that the Required Holders waive the applicability of certain other provisions of the Transaction Documents with respect to such
Director Equity Grants.
| 38 | |
On
March 30, 2025, the Company entered into an Omnibus Waiver and Amendment Agreement (Waiver and Amendment Agreement) with
the Required Holders (as defined in the Certificate of Designations), pursuant to which, the Required Holders agreed (A) to amend (i)
the Certificate of Designations, as described below, by filing a Certificate of Amendment to the Certificate of Designations with the
Secretary of State of the State of Delaware (the March 2025 Certificate of Amendment), and (ii) the Purchase Agreement,
to amend the definition of Excluded Securities such that the definition includes the issuance of common stock issued after
the date of the Purchase Agreement pursuant to an Approved Stock Plan (as defined in the Purchase Agreement), which in the aggregate
does not exceed more than 2% of the shares of common stock issued and outstanding on the date immediately prior to the date of the Purchase
Agreement (the Excluded Securities Modification), and (B) to waive certain restrictive covenants contained in the Purchase
Agreement as described therein.
The
March 2025 Certificate of Amendment amends the Certificate of Designations to (i) amend the restrictive covenant of the Certificate of
Designations such that the Company is required from January 1, 2025 until no shares of Series H-7 Preferred Stock are outstanding, to
maintain unencumbered, unrestricted cash and cash equivalents on hand in amount equal to at least 120% of the aggregate Stated Value
(as defined in the Certificate of Designations) of the Series H-7 Preferred Stock then outstanding, (ii) amend the definition of Excluded
Securities substantially similar to the Excluded Securities Modification, and (iii) remove the restrictive covenant provision
relating to the Segregated Cash (as defined in the Certificate of Designations) requirement. The March 2025 Certificate of Amendment
was filed with the Secretary of State of the State of Delaware, effective as of March 31, 2025.
On
August 4, 2025, the Company entered into an Omnibus Waiver, Consent, Notice and Amendment (the Series H-7 Agreement) with
the Required Holders. Pursuant to the Series H-7 Agreement, the Required Holders agreed to (i) amend the Series H-7 Purchase Agreement
to amend the definition of Excluded Securities as set forth in the Series H-7 Amendment, (ii) waive certain rights under
the Series H-7 Purchase Agreement, Series H-7 Warrants and Series H-7 Certificate of Designations in respect of the issuance of the Preferred
Stock and entrance by the Company into the Purchase Agreement, and (iii) consent to the issuance of the Preferred Stock, as required
pursuant to certain terms of the Series H-7 Certificate of Designations, the Series H-7 Purchase Agreement and the Series H-7 Warrants,
as applicable. In consideration of the foregoing, the Company agreed to pay to the Required Holders an aggregate of $350,000 by September
30, 2025, which may be paid in the form of cash, or, at the holders sole election, added to the outstanding aggregate stated value
of the Series H-7 Preferred Stock.
The
Company and the Required Holders further agreed pursuant to the Series H-7 Agreement to amend the Series H-7 Certificate of Designations
by filing a Certificate of Amendment to the Series H-7 Certificate of Designations (the Certificate of Amendment) with
the Secretary of State of the State of Delaware. The Certificate of Amendment amends the Series H-7 Certificate of Designations to (i)
extend the maturity date to February 4, 2027, (ii) revise the applicable payment dates and corresponding payable amounts of Dividends
and Installment Amounts (each as defined in the Series H-7 Certificate of Designations), (iii) modify the definition of Excluded
Securities and (iv) modify the schedule of Installment Dates (as defined in the Series H-7 Certificate of Designations). The Certificate
of Amendment to the Series H-7 Certificate of Designations was filed with the Secretary of State for the State of Delaware on August
6, 2025.
*Series
I Preferred Stock*
**
On
August 4, 2025, the Company entered into the Series I Purchase Agreement with certain accredited investors, pursuant to which it agreed
to sell (i) an aggregate of 7,000 shares of the Companys newly-designated Series I Convertible Preferred Stock, with a par value
of $0.0001 per share and a stated value of $1,000 per share, initially convertible into up to 875,000 shares of the Companys common
stock at an initial conversion price of $8.00 per share and (ii) warrants to acquire up to an aggregate of 875,000 Series I Warrants
at an exercise price of $8.00 per share. The closing of the Private Placement occurred on August 8, 2025. The aggregate gross proceeds
from the Private Placement were $7,000,000.
Among
other covenants, the Series I Purchase Agreement requires the Company to hold a meeting of its stockholders not later than October 3,
2025, to seek approval for the issuance of shares of common stock in excess of 19.99% of the Companys issued and outstanding shares
of common stock at prices below the Minimum Price (as defined in Rule 5635 of the Rules of the Nasdaq Stock Market) on
the date of the Series I Purchase Agreement pursuant to the terms of the Series I Preferred Stock and the applicable Series I Warrants.
| 39 | |
In
connection with the Private Placement, pursuant to (A) an engagement letter (the GPN Agreement) with GP Nurmenkari Inc.
(GPN) and (B) an engagement letter (the Palladium Agreement, and collectively with the GPN Agreement, the
Engagement Letters) with Palladium Capital Group, LLC (Palladium, and collectively with GPN, the Placement
Agents), the Company engaged the Placement Agents to act as non-exclusive placement agents in connection with the Private Placement,
pursuant to which, the Company agreed to (i) pay each Placement Agent a cash fee equal to 4% of the gross proceeds of the Private Placement
(including any cash proceeds realized by the Company from the exercise of any outstanding warrants of the Company), (ii) reimbursement
and payment of certain expenses, and (iii) issue to each of the Placement Agents on the closing date, warrants to purchase up to an aggregate
number of shares of common stock equal to 4% of the aggregate number of shares of common stock underlying the securities issued in the
Private Placement, including upon exercise of any outstanding warrants of the Company, with terms identical to the Series I Warrants
(the Series I Placement Agent Warrants and, together with the Series I Warrants and the Consultant Warrants the Private
Placement Warrants).
In
connection with the Purchase Agreement, the Company and the investors entered into a Registration Rights Agreement (the Registration
Rights Agreement), pursuant to which the Company is required to file a resale registration statement (the Registration
Statement) with the SEC to register for resale 200% of the shares of common stock issuable upon conversion of the Series I Preferred
Stock and upon exercise of the Series I Warrants promptly following the closing date, but in no event later than 30 calendar days after
the closing date, and to have such Registration Statement declared effective by the Effectiveness Deadline (as defined in the Registration
Rights Agreement). On September 8, 2025, the Company filed the Registration Statement with the SEC and subsequently amended the Registration
Statement on October 10, 2025. On January 9, 2026, the SEC declared the Registration Statement effective.
The
terms of the Series I Preferred Stock are as set forth in the form of Certificate of Designations of the Series I Convertible Preferred
Stock (Series I Certificate of Designations) which was filed with the Secretary of State for the State of Delaware on August
6, 2025. All shares of capital stock of the Company rank junior to shares of the Series I Preferred Stock, with respect to the preferences
as to dividends, distributions and payments upon the liquidation, dissolution and winding up of the Company. Further to the foregoing,
the shares of Series I Preferred Stock rank junior to shares of Series H-7 Convertible Preferred Stock with respect to the preferences
as to dividends, distributions and payments upon the liquidation, dissolution and winding up of the Company.
The
shares of Series I Preferred Stock are convertible into shares of common stock at the election of the holder at any time at an initial
conversion price of $8.00 per share (the Series I Conversion Price). The Series I Conversion Price is subject to customary
adjustments for stock dividends, stock splits, reclassifications, stock combinations and the like and dilutive issuances (in each case,
subject to certain exceptions). The Company is required to redeem the Series I Preferred Stock in equal installments, commencing on November
30, 2025, and thereafter on the last trading day of the third calendar month immediately following the previous Installment Date, until
the maturity date of February 4, 2027.
The
Installment Amount (as defined in the Series I Certificate of Designations) due upon such redemption are payable, at the Companys
election, in cash at 107% of the applicable Installment Redemption Price (as defined in the Series I Certificate of Designations).
The
holders of the Series I Preferred Stock are entitled to dividends of 7% per annum, compounded each calendar quarter, which are payable
in arrears (i) quarterly on each Installment Date (as defined in the Series I Certificate of Designations), in cash out of funds legally
available therefor and, (ii) prior to the first Installment Date, payable by way of inclusion of the dividends in the Conversion Amount
(as defined in the Series I Certificate of Designations) on each conversion date occurring prior to the first Installment Date. Upon
the occurrence and during the continuance of a Triggering Event (as defined in the Series I Certificate of Designations), the Series
I Preferred Stock accrue dividends at the rate of 15% per annum. The holders of the Series I Preferred Stock are entitled to vote with
holders of the common stock on an as-converted basis, with the number of votes to which each holder of Series I Preferred Stock is entitled
to be calculated assuming a conversion price of $7.628 per share, which was the Minimum Price (as defined in Rule 5635 of the Rules of
the Nasdaq Stock Market) applicable immediately before the execution and delivery of the Series I Purchase Agreement, subject to certain
beneficial ownership limitations as set forth in the Series I Certificate of Designations.
| 40 | |
Notwithstanding
the foregoing, the Companys ability to settle conversions using shares of common stock is subject to certain limitations set forth
in the Series I Certificate of Designations. Further, the Series I Certificate of Designations contains a certain beneficial ownership
limitation after giving effect to the issuance of shares of Common Stock issuable upon conversion of the Series I Preferred Stock under
the Series I Certificate of Designations.
The
Series I Certificate of Designations includes certain Triggering Events, including, among other things, the Companys failure to
pay any amounts due to the holders of the Series I Preferred Stock when due. In connection with a Triggering Event, each holder of Series
I Preferred Stock will be able to require the Company to redeem in cash any or all of the holders Series I Preferred Stock at
a premium set forth in the Series I Certificate of Designations.
The
Company is subject to certain affirmative and negative covenants regarding the incurrence of indebtedness, the existence of liens, the
repayment of indebtedness, the payment of cash in respect of dividends (other than dividends pursuant to the Series I Certificate of
Designations), distributions or redemptions, and the transfer of assets, among other matters. In addition, the Company is required to
maintain at all times unencumbered, unrestricted cash and cash equivalents on hand in amount equal to at least 50% of the aggregate Stated
Value of the outstanding shares of Series I Preferred Stock then outstanding.
The
Series I Warrants are exercisable for shares of common stock immediately, at an exercise price of $8.00 per share and expire five years
from the date of issuance. The exercise price of each Series I Warrant is subject to customary adjustments for stock dividends, stock
splits, reclassifications, stock combinations and the like and dilutive issuances (in each case, subject to certain exceptions).
**Summary
of Cash Flows**
The
following table summarizes the Companys cash flows:
| 
| | 
For the Years Ended December 31, | | |
| 
| | 
2025 | | | 
2024 | | |
| 
Cash Flows: | | 
| | | | 
| | | |
| 
Net cash used in operating activities | | 
$ | (7,695,572 | ) | | 
$ | (13,315,402 | ) | |
| 
Net cash used in investing activities | | 
$ | (2,860,648 | ) | | 
$ | (3,064,499 | ) | |
| 
Net cash used in financing activities | | 
$ | (551,875 | ) | | 
$ | (10,860,809 | ) | |
****
**Operating
Activities**
During
the year ended December 31, 2025, we used $7,695,572 in cash from operating activities, a decrease in use of $5,619,830 compared to the
cash used in operating activities of $13,315,402 during the year ended December 31, 2024. During the year ended December 31, 2025, the
Company recognized net loss after non-cash adjustments of $7,253,585, a $2,278,201 improvement compared with a $9,531,786 adjusted net
loss during the same period in 2024. During the year ended December 31, 2025, cash used in inventory was $0 as compared to $1,794,806
for the same period in 2024, a decrease of $1,1794,806, mainly due to the temporary pause on procurement of material and manufacturing
activities while re-engineering the Vanish. For the year ended December 31, 2025, cash used in accrued expenses and other current liabilities
was $317,227 as compared to $1,149,677 for the same period in 2024, a decrease of $832,450, mainly due to the Company not purchasing
inventory related to the Vanish and a decrease in headcount due to the Companys 2024 internal restructuring.
Our
ability to generate cash from operations in future periods will depend in large part on completing our re-engineering of the Vanish product
and being able to market the Vanish again to generate revenue and our ability to manage other areas of working capital.
**Investing
Activities**
During
the year ended December 31, 2025, we used $2,860,648 in cash from investing activities, a decrease of $203,851 compared to the cash
used in investing activities during the year ended December 31, 2024. We used $31,500,546 to invest in marketable securities and received
$32,739,898 in proceeds from the sale of marketable securities, as compared to $68,997,205 to invest in marketable securities and received
$66,132,029 in proceeds from the sale of marketable securities during the year ended December 31, 2024. The Company purchased $4,100,000
in digital assets during the year ended December 31, 2025, as compared to $0 during the year ended December 31, 2024.
| 41 | |
**Financing
Activities**
During
the year ended December 31, 2025, we used cash of $551,875 in financing activities as compared to $10,860,809 of cash used in financing
activities for the year ended December 31, 2024, a decrease of $10,308,934. The decrease in cash used was due to cash redemptions of
the Series H-7 Preferred Stock of $7,881,528 in 2025, a decrease of $2,317,401 as compared to 2024 and proceeds of $6,314,297 and $1,015,356
from the sale of Series I Preferred Stock and exercise of Series H-7 Preferred warrants, respectively, during the year ended December
31, 2025 as compared to $0 and $0, respectively, during the year ended December 31, 2024.
**Known
Trends, Events, and Uncertainties**
The
emergence and effects of public health crises, such as pandemics and epidemics, along with geopolitical conflicts, including the consequences
of the ongoing war between Russia and Ukraine and between Israel and various factors in the Middle East, including related sanctions
and countermeasures, are difficult to predict, and could adversely impact geopolitical and macroeconomic conditions, the global economy,
and contribute to increased market volatility, which may in turn adversely affect our business and operations.
Other
than as discussed above and elsewhere in this report, we are not aware of any trends, events or uncertainties that are likely to have
a material effect on our financial condition.
**Critical
Accounting Estimates**
Our
managements discussion and analysis of our financial condition and results of operations is based on our consolidated financial
statements, which have been prepared in accordance with U.S. generally accepted accounting principles (GAAP). The preparation
of our consolidated financial statements and related disclosures requires us to make estimates, assumptions and judgments that affect
the reported amount of assets, liabilities, revenue, costs and expenses and related disclosures. We base our assumptions, estimates and
judgments on historical experience, current trends and other factors that management believes to be relevant at the time our consolidated
financial statements are prepared. Accordingly, we evaluate our estimates and assumptions on an ongoing basis. Our actual results may
differ from these estimates under different assumptions and conditions.
We
consider an accounting estimate to be critical if: (1) the accounting estimate requires us to make assumptions about matters that were
highly uncertain at the time the accounting estimate was made, and (2) changes in the estimate that are reasonably likely to occur from
period to period, or use of different estimates that we reasonably could have used in the current period, would have a material impact
on our financial condition or results of operations.
Management
has discussed the development and selection of these critical accounting estimates with the Audit Committee of our Board of Directors.
*Digital
Assets*
The
Company accounts for its digital assets, which currently are comprised of various cryptocurrencies, as indefinite-lived intangible assets in accordance
with ASC Topic 350-60, *Intangibles Goodwill and Other Crypto Assets.* The Company has ownership of
and control over its digital assets and may use third-party custodial services to secure it. The Companys digital assets are initially
recorded at cost and are subsequently remeasured on the balance sheet at fair value.
The
Company determines the fair value of its digital assets on a recurring basis in accordance with ASC 820 based on quoted prices on the
active exchange that the Company has determined is its principal market for such digital assets (Level 1 inputs). The Company determines
the cost basis of digital assets using the specific identification of each unit received. Realized and unrealized gains and losses from
changes in the fair value of digital assets are recognized in the consolidated statements of operations.
| 42 | |
The
Company purchases various digital assets for long-term investment. It intends to hold its digital assets for long-term gains and treats
them as long-term capital assets for tax purposes. Unrealized gains/losses are treated as capital gains/losses for tax purposes. See
Note 6. Digital Assets for additional information regarding the Companys purchases and sales of digital assets.
*Fair
Market Value*
Digital
assets are measured at their fair market values using the last close price of the day in the Coordinated Universal Time zone at each
reporting period end on the balance sheet. The Companys digital assets are presented as current assets.
*Fair
Value of Financial Assets and Liabilities - Derivative Instruments*
We
measure the fair value of financial assets and liabilities in accordance with GAAP, which defines fair value, establishes a framework
for measuring fair value, and requires certain disclosures about fair value measurements. We do not use derivative financial instruments
to hedge exposures to cash-flow, market or foreign-currency risks. However, we have entered into certain financial instruments and contracts,
such as debt financing arrangements, the issuance of preferred stock with detachable common stock warrants features that are either i)
not afforded equity classification, ii) embody risks not clearly and closely related to host contracts, or iii) may be net-cash settled
by the counterparty. These instruments are required to be carried as derivative liabilities, at fair value.
*Warrant
Liabilities*
We
account for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrants specific
terms and applicable authoritative guidance in ASC 480, Distinguishing Liabilities from Equity (ASC 480) and ASC 815, Derivatives
and Hedging (ASC 815). The assessment considers whether the warrants are freestanding financial instruments pursuant to
ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification
under ASC 815, including whether the warrants are indexed to the Companys own common stock and whether the warrant holders could
potentially require net cash settlement in a circumstance outside of the Companys control, among other conditions
for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance
and as of each subsequent quarterly period end date while the warrants are outstanding.
For
issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component
of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification,
the warrants are required to be recorded at their initial fair value on the date of issuance, or date of modification, and each balance
sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements
of operations.
**ITEM
7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.**
Not
applicable.
**ITEM
8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.**
The
information required by this Item 8 is included at the end of this Annual Report on Form 10-K beginning on page F-1.
| 43 | |
**ITEM
9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.**
**Marcum
LLP Dismissal**
Based
on information provided by Marcum LLP (Marcum), the Companys former independent registered public accounting firm,
CBIZ CPAs P.C. (CBIZ CPAs) acquired the attest business of Marcum, effective November 1, 2024. Marcum continued to serve
as the Companys independent registered public accounting firm through April 10, 2025. On April 10, 2025, the Company terminated
its relationship with Marcum as the Companys independent registered accounting firm and, with the approval of the Audit Committee
of the Companys Board of Directors, engaged CBIZ CPAs as the Companys independent registered public accounting firm for
the fiscal year ending December 31, 2025.
Prior
to engaging CBIZ CPAs, the Company did not consult with CBIZ CPAs regarding (i) the application of accounting principles to a specified
transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Companys consolidated financial
statements, or (ii) any matter that was either the subject of a disagreement (as described in Item 304(a)(1)(iv) of Regulation S-K and
the related instructions) or a reportable event (as described in Item 304(a)(1)(v) of Regulation S-K and the related instructions).
The
reports of Marcum regarding the Companys consolidated financial statements for the fiscal years ended December 31, 2024 and 2023,
included in the Companys Annual Report on Form 10-K for the year ended December 31, 2024, did not contain any adverse opinion
or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope, or accounting principles, except that the
report for the fiscal year ended December 31, 2024 included an explanatory paragraph relating to substantial doubt about the Companys
ability to continue as a going concern.
During
the fiscal years ended December 31, 2024 and 2023, and through April 10, 2025, the date of Marcums termination, there were (a)
no disagreements (as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions) between the Company and Marcum on
any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedures, which disagreements,
if not resolved to the satisfaction of Marcum, would have caused Marcum to make reference to such disagreement in its reports and (b)
no reportable events (as defined in Item 304(a)(1)(v) of Regulation S-K and the related instructions), except for the material
weakness in the Companys internal control over financial reporting due to: (i) the fact that the Company was unable to document,
formalize, implement and revise where necessary controls, policies and procedure documentation to evidence a system of controls, inclusive
of IT controls, including testing of such controls that is consistent with the Companys current personnel and available resources;
(ii) the failure to document, maintain and test effective control activities over the Companys control environment, risk assessment,
information technology and monitoring components; and (iii) the Companys insufficient segregation of duties, oversight of work
performed and lack of compensating controls in the Companys finance and accounting functions, including, without limitation, the
processing, review and authorization of all routine and non-routine transactions, due to limited personnel and resources, each as disclosed
in the Companys Annual Report for the fiscal year ended December 31, 2024.
****
**CBIZ
CPAs P.C. Dismissal**
**
*Dismissal
of Independent Registered Public Accounting Firm*
**
On
September 18, 2025, the Audit Committee of the Board of Directors (the Committee) of the Company approved the dismissal
of CBIZ CPAs P.C. (CBIZ CPAs) as the Companys independent registered public accounting firm, effective as of the
same date.
As
previously disclosed in a Current Report on Form 8-K filed on April 11, 2025, on April 10, 2025, Marcum LLP was dismissed, and CBIZ CPAs
was appointed, as the Companys independent registered public accounting firm. CBIZ CPAs did not issue any audit report during
the period of its engagement.
From
April 10, 2025 through September 18, 2025, the date of CBIZ CPAs dismissal, there were (a) no disagreements (as defined in Item
304(a)(1)(iv) of Regulation S-K and the related instructions) between the Company and CBIZ CPAs on any matter of accounting principles
or practices, financial statement disclosure, or auditing scope or procedures, which disagreements, if not resolved to the satisfaction
of CBIZ CPAs, would have caused CBIZ CPAs to make reference to such disagreement in its reports, if such reports had been issued, and
(b) no reportable events (as defined in Item 304(a)(1)(v) of Regulation S-K and the related instructions), except for the
material weakness in the Companys internal control over financial reporting due to: (i) the fact that the Company was unable to
document, formalize, implement and revise where necessary controls, policies and procedure documentation to evidence a system of controls,
inclusive of IT controls, including testing of such controls that is consistent with the Companys current personnel and available
resources; (ii) the failure to document, maintain and test effective control activities over the Companys control environment,
risk assessment, information technology and monitoring components; and (iii) the Companys insufficient segregation of duties,
oversight of work performed and lack of compensating controls in the Companys finance and accounting functions, including, without
limitation, the processing, review and authorization of all routine and non-routine transactions, due to limited personnel and resources,
each as disclosed in the Companys Annual Report for the fiscal year ended December 31, 2024.
The
Company provided CBIZ CPAs with a copy of this Current Report on Form 8-K prior to its filing with the U.S. Securities and Exchange Commission
(the SEC) and requested that CBIZ CPAs furnish the Company with a letter addressed to the SEC, pursuant to Item 304(a)(3)
of Regulation S-K, stating whether it agrees with the above statements and, if it does not agree, the respects in which it does not agree.
A copy of the letter, dated September 22, 2025, is filed as Exhibit 16.1 (which is incorporated by reference herein) to this Current
Report on Form 8-K.
| 44 | |
**
*Appointment
of New Independent Registered Public Accounting Firm*
**
On
September 19, 2025, the Committee engaged Stephano Slack LLC (Stephano) as the Companys independent registered public
accounting firm for the fiscal year ending December 31, 2025, effective immediately. During the fiscal years ended December 31, 2024,
and December 31, 2023, and the subsequent interim period through September 19, 2025, neither the Company nor anyone on its behalf has
consulted with Stephano regarding (i) the application of accounting principles to any specified transaction, either completed or proposed,
or the type of audit opinion that might be rendered on the Companys financial statements, and neither a written report nor oral
advice was provided to the Company that Stephano concluded was an important factor considered by the Company in reaching a decision as
to any accounting, auditing, or financial reporting issue, or (ii) any matter that was either the subject of a disagreement,
as defined in Item 304(a)(1)(iv) of Regulation S-K, or a reportable event, as defined in Item 304(a)(1)(v) of Regulation
S-K.
**ITEM
9A. CONTROLS AND PROCEDURES.**
**Disclosure
Controls and Procedures**
Under
the supervision and with the participation of management, including our principal executive and principal financial officers, we evaluated
the effectiveness of our disclosure controls and procedures as of December 31, 2025. The term disclosure controls and procedures,
as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act), means
controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the
reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified
in the SECs rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed
to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated
and communicated to the companys management, including its principal executive and principal financial officers, as appropriate
to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed
and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in
evaluating the cost-benefit relationship of possible controls and procedures.
Based
on the evaluation of our disclosure controls and procedures as of December 31, 2025, our Executive Chairman concluded that, as of such
date, our disclosure controls and procedures were ineffective due to the material weakness in internal control over financial reporting
discussed below. A material weakness is a significant deficiency or a combination of significant deficiencies in internal control over
financial reporting such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements
will not be prevented or detected on a timely basis.
**Managements
Report on Internal Control Over Financial Reporting**
Our
management performed an assessment of the effectiveness of our internal control over financial reporting as of December 31, 2025 and
concluded our internal control over financial reporting was not effective as of December 31, 2025, due to the fact that (i) we were unable
to document, formalize, implement and revise where necessary controls, policies and procedure documentation to evidence a system of controls,
inclusive of IT controls, including testing of such controls that is consistent with our current personnel and available resources; (ii)
we failed to document, maintain and test effective control activities over our control environment, risk assessment, information technology
and monitoring components; and (iii) we had insufficient segregation of duties, oversight of work performed and lack of compensating
controls in our finance and accounting functions, including, without limitation, the processing, review and authorization of all routine
and non-routine transactions, due to limited personnel and resources.
**Planned
Remediation of Material Weaknesses**
Our
management has been engaged in developing and implementing remediation plans to address the material weaknesses described above. Until
we have sufficient technical accounting resources, we have engaged external consultants to provide support and to assist us in our evaluation
of more complex applications of GAAP to aid in the remediation efforts of the material weakness.
We
continue to enhance corporate oversight over process-level controls and structures to ensure that there is appropriate assignment of
authority, responsibility, and accountability to enable remediation of our material weaknesses. As we continue to evaluate, and work
to improve, our internal control over financial reporting, management may determine that additional measures to address control deficiencies
or modifications to the remediation plan are necessary.
**Changes
in Internal Control over Financial Reporting**
Except
as disclosed above, there were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f)
and 15d-15(f) of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially
affect, our internal control over financial reporting.
**ITEM
9B. OTHER INFORMATION.**
None.
**ITEM
9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS.**
Not
applicable.
| 45 | |
**PART
III**
**ITEM
10. DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE.**
The
following table sets forth certain information regarding our Directors and Executive Officers. The age of each Director and Executive
Officer listed below is given as of March 30, 2026.
| 
Name | 
| 
Age | 
| 
Position | |
| 
Joshua Silverman | 
| 
54 | 
| 
Chairman of the Board, Chief
Executive Officer | |
| 
Joseph Ramelli | 
| 
57 | 
| 
Chief Financial Officer | |
| 
Gilbert Villarreal | 
| 
60 | 
| 
President of AYRO Operating Company, Inc. | |
| 
Non-Employee Directors | 
| 
| 
| 
| |
| 
Sebastian Giordano | 
| 
67 | 
| 
Director | |
| 
Greg Schiffman | 
| 
67 | 
| 
Director | |
| 
Zvi Joseph | 
| 
58 | 
| 
Director | |
| 
Wayne R. Walker | 
| 
65 | 
| 
Director | |
The
following sets forth biographical information and the qualifications and skills for each director nominee:
**Joshua
Silverman.** Mr. Silverman has been our director since May 28, 2020, and currently serves as our Chief Executive Officer and
Chairman. Prior to his appointment to such positions Mr. Silverman served as the Companys interim principal financial officer
and principal accounting officer until August 2025. Prior to the Merger, Mr. Silverman had served as a member of the DropCar Board
of Directors since the 2018 Merger (as defined below). Mr. Silverman currently serves as the managing member of Parkfield Funding
LLC. Mr. Silverman was the co-founder of, and was previously a principal and managing partner of, Iroquois Capital Management, LLC
(Iroquois), an investment advisory firm. From its inception in 2003 until July 2016, Mr. Silverman served as co-chief
investment officer of Iroquois. While at Iroquois, he designed and executed complex transactions, structuring and negotiating
investments in both public and private companies, and was often called upon by such companies to solve inefficiencies relating to
corporate structure, cash flow, and management. From 2000 to 2003, Mr. Silverman served as co-chief investment officer of Vertical
Ventures, LLC, a merchant bank. Prior to forming Iroquois, Mr. Silverman was a director of Joele Frank, a boutique consulting firm
specializing in mergers and acquisitions. Previously, Mr. Silverman served as assistant press secretary to the President of the
United States. Mr. Silverman currently serves as a director of Q/C Technologies, Inc. (NASDAQ: QCLS), Pharmacyte, Inc. (NASDAQ:
PMCB), Synaptogenix, Inc. (NASDAQ: SNPX) and Petros Pharmaceutical, Inc. (NASDAQ: PTPI), all of which are public companies. He
previously served as a director of National Holdings Corporation from July 2014 through August 2016 and as a director of Marker
Therapeutics, Inc. from August 2016 until October 2018. Mr. Silverman received his B.A. from Lehigh University in 1992. Mr.
Silvermans qualifications to sit on the Board include his experience as an investment banker, management consultant and
director of numerous public companies.
**Joseph
Ramelli.** Mr. Ramelli was appointed Chief Financial Officer in August 2024. Mr. Ramelli has nearly 30 years of experience in the
Biotechnology, Biopharmaceutical and Financial Services industries. He is a seasoned investor and consultant who specializes in business
strategic planning and development, capital raising, talent acquisition, and corporate governance. Mr. Ramelli is currently an investor
and strategic advisor with Ramelli Asset Management. Since 2023, Mr. Ramelli has also served as the Vice President of Business Development
at Origin Agritech Ltd. Previously, Mr. Ramelli served as Interim Chief Financial Officer from 2020 to 2021 and was a founding member
of ValenzaBio, a privately held biopharmaceutical company, where he established and grew all the finance functions of the company. He
also served as Chief Executive Officer of Marina Biotech from 2016 to 2018 where he helped close a business development deal to keep
the company afloat and negotiated and closed merger to navigate the company out of bankruptcy and forge a successful path forward. Mr.
Ramelli also has over 15 years of experience in varied roles at investment firms. Mr. Ramelli graduated from the University of California,
Santa Barbara with a B.A. in Business Economics.
**Gilbert Villarreal**. Mr. Villarreal was
appointed to the position of President of the Companys subsidiary, AYRO Operating Company, Inc., effective as August 21, 2024,
and previously served as a former consultant to the Company. Mr. Villarreal has over 32 years of wide manufacturing experience that spreads
from Aerospace, Automotive, and Marine industries. As an industrialist with a diverse portfolio, Mr. Villarreal has successfully restructured
companies in both the automotive and marine yacht building industries. Mr. Villarreal is the co-founder and chief executive officer of
VLF Automotive LLC. Mr. Villarreal is also the founder of GLV Ventures, a leader in the design and production of a variety of vehicles
including electric vehicles. The Company is known for its advanced manufacturing in a timely, cost-effective manner. Founded by Mr. Villarreal,
GLV Ventures has operated in the space for 25 years. GLV and its affiliate, EVESSA, are Tier 1 consulting and manufacturing companies
that have produced electric vehicles and non-electric vehicles for several of the leading OEMs and Fortune 100 companies. Mr. Villarreal
is a former United States Marine and holds a B.A. in Business Administration. After serving active duty in the Marine Air Wing as an Aircraft
Aviation Specialist on numerous Naval aircraft, Mr. Villarreal continued his career in aerospace with the Boeing Aircraft Company on the
767 and 747 aircraft production lines in Everett, Washington. After 10 years in Aerospace manufacturing, Mr. Villarreal transitioned into
the automotive and marine industries with UTA United Technologies Automotive with The Becker Group, and as the chief executive
officer with Acord Incorporated, a leader in automotive interior trim systems and chief executive officer of Concorde Marine, a luxury
yacht manufacturer in Washington State.
| 46 | |
**Sebastian
Giordano.**Mr. Giordano served as a member of the DropCar Board of Directors since the completion of the business combination
with DropCar, Inc. (Private DropCar) and DC Acquisition Corporation, pursuant to which Private DropCar became a wholly
owned subsidiary of WPCS International Incorporated (WPCS), which then changed its name to DropCar on January 30, 2018
(the 2018 Merger), and, prior to that time, served as a director of WPCS since February 2013, and has continued to serve
as a director of the Company following the Merger. Mr. Giordano served as the Interim Chief Executive Officer of WPCS from August 2013
until April 25, 2016, when the interim label was removed from his title. He served as the Chief Executive Officer of WPCS since such
time through the closing of the 2018 Merger. Mr. Giordano has served as Chairman and Chief Executive Officer of Transportation and Logistics
Systems, Inc. (OTC PINK: TLSS) since January 2022. Since 2002, Mr. Giordano has been Chief Executive Officer of Ascentaur, LLC, a business
consulting firm providing comprehensive strategic, financial and business development services to start-up, turnaround and emerging growth
companies. From 1998 to 2002, Mr. Giordano was Chief Executive Officer of Drive One, Inc., a safety training and education business.
From 1992 to 1998, Mr. Giordano was Chief Financial Officer of Sterling Vision, Inc., a retail optical chain. Mr. Giordano received B.B.A.
and MBA degrees from Iona College. Mr. Giordanos qualifications to sit on the Board include his broad management experience, including
having served as Chief Executive Officer of WPCS.
**Greg
Schiffman.**Mr. Schiffman served as a member of the DropCar Board of Directors since the closing of the 2018 Merger, and has
continued to serve as a director of the Company following the Merger. Mr. Schiffman previously served as Chief Financial Officer of
Absci Corporation from April 2020 until his retirement in August 2023. He previously served as the Chief Financial Officer of
Vineti, Inc. from October 2017 through April 2018. He also previously served as the Chief Financial Officer of each of Iovance
Biotherapeutics (formerly Lion Biotechnologies), from October 2016 through June 2017, Stem Cells, Inc., from January 2014 through
September 2016, Dendreon Corporation, from December 2006 through December 2013, and Affymetrix Corporation, from August 2001 through
November 2006. In November 2014, Dendreon Corporation filed for Chapter 11 bankruptcy protection. He previously served on the board
of directors of Nanomix Corporation (OTCQB: NNMX) through April 2025 and currently serves on the board of directors for BioEclipse
Therapeutics, Inc. and Eido Bio. Mr. Schiffman holds a B.S. in Accounting from DePaul University and an MM (MBA) from Northwestern
University Kellogg Graduate School of Management. Mr. Schiffmans qualifications to sit on the Board include his financial
background, business experience and education.
**Zvi
Joseph.**Mr. Joseph served as a member of the DropCar Board of Directors since the closing of the 2018 Merger, and has continued
to serve as a director of the Company following the Merger. He has served as Deputy General Counsel of Amdocs Limited, a publicly traded
corporation that provides software and services to communications and media companies, since October 2005. He received his A.A.S. in
Business Administration from Rockland Community College, his B.A. in Literature from New York University and his J.D. from Fordham University
School of Law. He also holds a Certificate in Business Excellence from Columbia University School of Business and a Corporate Director
Certificate, Corporate Governance, from Harvard Business School. Mr. Joseph is NACD Directorship Certified. Mr. Josephs qualifications
to sit on the Board include his legal experience and education.
**Wayne
R. Walker.**Mr. Walker has over 35 years of experience in corporate governance, turnaround management, corporate restructuring
and bankruptcy matters. In 1998, Mr. Walker founded Walker Nell Partners, Inc., an international business consulting firm, and has served
as its president from its founding to the present. Before founding Walker Nell Partners, Inc., Mr. Walker worked for 15 years at the
DuPont Company in Wilmington, Delaware in the Securities and Bankruptcy group, where he worked in the Corporate Secretarys office
and served as Senior Counsel. From 2018 to the present, Mr. Walker has served as a director of Wrap Technologies, Inc. (NASDAQ: WRAP),
an innovator of modern policing solutions, where he also serves as Chair of the Nominating and Governance Committee and of the Compensation
Committee. From 2018 to the present, Mr. Walker has served as a director of Pitcairn Company and as the Chair of its Compensation Committee.
From 2013 to 2014, Mr. Walker served as Chairman of the Board of Directors of BridgeStreet Worldwide, Inc., a global provider of extended
corporate housing. From 2016 to 2018, Mr. Walker served as Chairman of the Board of Directors of Last Call Operating Companies, an owner
of various national restaurants. From 2013 to 2020, Mr. Walker served as Chairman of the Board of Trustees of National Philanthropic
Trust, a public charity. From 2018 to 2020, Mr. Walker served as Vice President of the Board of Education of the City of Philadelphia.
From 2020 to the present, Mr. Walker has served as a director of Petros Pharmaceuticals, Inc. (NASDAQ: PTPI), which focuses on mens
health, where he also serves as Chair of the Nominating and Governance Committee. Mr. Walker has also served on the board of directors
for the following companies and foundations: Seaborne Airlines, Inc., Green Flash Brewery, Inc., and Eagleville Hospital and Foundation.
Mr. Walker has a Doctor of Jurisprudence from Catholic University (Washington, DC) and a Bachelor of Arts from Loyola University (New
Orleans). He is an attorney licensed by the State Bar of Georgia. He is a member of the State Bar Association of Georgia, American Bar
Association, American Bankruptcy Institute and Turnaround Management Association. Mr. Walkers qualifications to sit on the Board
include his business experience and his extensive board experience.
| 47 | |
The
Board regards all of the individuals above as competent professionals with many years of experience in the business community. The Board
believes that the overall experience and knowledge of the members of Board will contribute to the overall success of our business.
There
is no arrangement or understanding between any of the directors identified above and any other person pursuant to which he was selected
as a director or director nominee. None of the directors or director nominees identified above is, or has been, a participant in any
transaction involving the Company, and is not a participant in any proposed transaction with the Company, in each case, required to be
disclosed pursuant to Item 404(a) of Regulation S-K, other than as described in Certain Relationships and Related Person Transactions
herein.
StableX,
with the oversight of the Board and its committees, operates within a comprehensive plan of corporate governance for the purpose of defining
independence, assigning responsibilities, setting high standards of professional and personal conduct and assuring compliance with such
responsibilities and standards. We regularly monitor developments in the area of corporate governance.
**Corporate
Code of Conduct and Ethics and Whistleblower Policy**
****
We
have adopted a Corporate Code of Conduct and Ethics and Whistleblower Policy (the Code of Conduct) that applies to all
of our associates, as well as each of our directors and certain persons performing services for us. The Code of Conduct addresses, among
other things, competition and fair dealing, conflicts of interest, protection and proper use of Company assets, government relations,
compliance with laws, rules and regulations and the process for reporting violations of the Code of Conduct, employee misconduct, improper
conflicts of interest or other violations. Our Code of Conduct is available on our website at *https://stablextechnologies.com/*in
the Committee Charters section found under the Corporate Governance tab. We intend to disclose any amendments
to, or waivers from, our Code of Conduct at the same web address provided above.
**Board
Composition**
****
Our
Amended and Restated Certificate of Incorporation, as amended (the Charter), and our Amended and Restated Bylaws, as amended
(Bylaws), provide that our Board will consist of such number of directors as determined from time to time by resolution
adopted by our Board. Any vacancies or newly created directorships resulting from an increase in the authorized number of directors may
be filled by a majority of the directors then in office. As of March 30, 2026, the Board consists of Joshua Silverman, Wayne R. Walker,
Sebastian Giordano, Zvi Joseph, and Greg Schiffman.
**Board
Diversity**
****
We
have no formal policy regarding Board diversity. The Company values diversity on a Company-wide basis and seeks to achieve a mix of directors
that represent a diversity of background and experience, including with respect to age, gender, race, ethnicity, and occupation. Although
the Board does not establish specific goals with respect to diversity, the Boards overall diversity is a significant consideration
in the director nomination process.
**Director
Independence**
****
We
are currently listed on the Nasdaq Capital Market and therefore rely on the definition of independence set forth in the Nasdaq Listing
Rules (Nasdaq Rules). Under the Nasdaq Rules, a director will only qualify as an independent director if,
in the opinion of our Board, that person does not have a relationship that would interfere with the exercise of independent judgment
in carrying out the responsibilities of a director. Based upon information requested from and provided by each director and director
nominee concerning his background, employment, and affiliations, including family relationships, we have determined that our current
directors Messrs. Giordano, Schiffman, Joseph, and Walker have no material relationship with us that would interfere with the
exercise of independent judgment and are independent directors as that term is defined in the Nasdaq Listing Rules.
| 48 | |
**Board
Committees, Meetings and Attendance**
****
During
the fiscal year ended December 31, 2025, the Board held 14 meetings. We expect our directors to attend Board meetings, meetings of any
committees and subcommittees on which they serve, and each annual meeting of stockholders, either in person or by teleconference. During
the fiscal year ended December 31, 2025, each director attended, either in person or telephonically, at least 75% of the aggregate Board
meetings and meetings of committees on which he served during his tenure as a director or committee member, and none of our directors
attended the Companys 2025 annual meeting of stockholders. The Board has adopted a policy under which each member of the Board
is encouraged to attend each annual meeting of our stockholders.
The
Board delegates various responsibilities and authority to different Board committees. Committees regularly report on their activities
and actions to the full Board. Currently, the Board has established an Audit Committee, a Compensation and Human Resources Committee
and a Nominating and Corporate Governance Committee. Committee assignments are re-evaluated annually. Each of these committees operates
under a charter that has been approved by our Board. The current charter of each of these committees is available on our website at https://stablextechnologies.com/
in the Committee Charters section under the Corporate Governance tab.
As
of March 30, 2026, the following table sets forth the membership of each of the Board committees listed above.
| 
Name | 
| 
Audit Committee | 
| 
Compensation and Human
Resources Committee | 
| 
Nominating and Corporate
Governance Committee | |
| 
Sebastian
Giordano | 
| 
Member | 
| 
| 
| 
| |
| 
Greg Schiffman | 
| 
Chairman | 
| 
Member | 
| 
Chairman | |
| 
Zvi Joseph | 
| 
Member | 
| 
Chairman | 
| 
Member | |
****
**Audit
Committee**
****
Our
Audit Committee is responsible for, among other matters:
| 
| approving
and retaining the independent auditors to conduct the annual audit of our financial statements; | |
| 
| reviewing
the proposed scope and results of the audit; | |
| 
| reviewing
and pre-approving audit and non-audit fees and services; | |
| 
| reviewing
accounting and financial controls with the independent auditors and our financial and accounting
staff; | |
| 
| reviewing
and approving transactions between us and our directors, officers and affiliates; | |
| 
| recognizing
and preventing prohibited non-audit services; | |
| 
| establishing
procedures for complaints received by us regarding accounting matters; | |
| 
| overseeing
internal audit functions, if any, and; | |
| 
| preparing
the report of the audit committee that the rules of the SEC require to be included in our
annual meeting proxy statement. | |
Our
audit committee is composed of Greg Schiffman (chairman), Zvi Joseph, and Sebastian Giordano. Our Board has determined that Messrs. Schiffman,
Joseph, and Giordano are independent in accordance with Nasdaq Rules and Rule 10A-3 under the Exchange Act. Our Board has also reviewed
the education, experience, and other qualifications of each member of the Audit Committee. Based upon that review, our Board has determined
that Greg Schiffman qualifies as an audit committee financial expert, as defined by the rules of the SEC and has the requisite
financial sophistication under the applicable rules and regulations of Nasdaq. During the year ended December 31, 2025, the Audit Committee
held 4 meetings.
| 49 | |
**Compensation
and Human Resources Committee**
****
Our
Compensation and Human Resources Committee is responsible for, among other matters:
| 
| reviewing
and approving the compensation arrangements for management, including the compensation for
our chief executive officer; | |
| 
| appointing,
compensating, and overseeing the work of any compensation consultant, legal counsel, or other
advisor retained by the Compensation and Human Resources Committee; | |
| 
| establishing
and reviewing general compensation policies with the objective to attract and retain superior
talent, to reward individual performance and to achieve our financial goals; | |
| 
| administering
our incentive compensation plans; | |
| 
| preparing
the report of the Compensation and Human Resources Committee if such report is required by
the SEC to be included in our annual meeting proxy statement or Annual Report on Form 10-K; | |
| 
| reviewing
and approving any employment agreements and any severance arrangements or plans; | |
| 
| reviewing
and approving employment benefit plans; | |
| 
| reviewing
director compensation for Board and committee services; | |
| 
| reviewing
the Companys diversity and inclusion initiatives; and | |
| 
| reviewing
the effectiveness of the Companys human resources and human capital management policies,
practices, strategies, and goals. | |
Our
Compensation and Human Resources Committee is composed of Greg Schiffman and Zvi Joseph (chairman). Our Board has determined that
Messrs. Schiffman, and Joseph are independent in accordance with NASDAQ Rules. The Compensation and Human Resources
Committee has the authority to delegate to subcommittees of the Compensation and Human Resources Committee any of the
responsibilities of the full committee. The Compensation and Human Resources Committee may invite such members of management to its
meetings as it deems appropriate. However, no officer may be present during Compensation and Human Resources Committee deliberations
or voting at which his or her compensation is discussed or determined. During the fiscal year ended December 31, 2025, the
Compensation and Human Resources Committee held 2 meetings. In the fiscal year ended December 31, 2025, the Company did not retain
the services of any compensation consultants.
**Nominating
and Corporate Governance Committee**
Our
Nominating and Corporate Governance Committee is responsible for, among other matters:
| 
| evaluating
the current composition, organization, and governance of the Board and its committees, and
making recommendations for changes thereto; | |
| 
| reviewing
each director and nominee annually; | |
| 
| determining
desired Board member skills and attributes and conducting searched for prospective members
accordingly; | |
| 
| evaluating
nominees, and making recommendations to the Board concerning the appointment of directors
to Board committees, the selection of Board committee chairs, proposal of the slate of directors
for election to the Board, and the termination of membership of individual directors in accordance
with the Boards governance principles; | |
| 
| overseeing
the process of succession planning for the chief executive officer and, as warranted, other
senior officers of the Company; | |
| 
| developing,
adopting, and overseeing the implementation of a code of business conduct and ethics; and | |
| 
| administering
the annual Board performance evaluation process. | |
Our
Nominating and Corporate Governance Committee is composed of Greg Schiffman (chairman) and Zvi Joseph. Our Board has determined that Messrs. Schiffman and Joseph are independent
in accordance with Nasdaq Rules. During the fiscal year ended December
31, 2025, the Nominating and Corporate Governance Committee did not hold any meetings.
| 50 | |
**Director
Nominations**
****
Our
Nominating and Corporate Governance Committee considers all qualified candidates identified by members of the Board, by senior management
and by stockholders. The Nominating and Corporate Governance Committee follows the same process and uses the same criteria for evaluating
candidates proposed by stockholders, members of the Board and members of senior management. We did not pay fees to any third party to
assist in the process of identifying or evaluating director candidates during the fiscal year ended December 31, 2025.
Our
Bylaws contain provisions that address the process by which a stockholder may nominate an individual to stand for election to the Board
at our Annual Meeting. To recommend a nominee for election to the Board, a stockholder must submit his or her recommendation to our Secretary
at our corporate offices at 1185 Avenue of the Americas, New York, New York 10036. Such nomination must satisfy the notice, information
and consent requirements set forth in our Bylaws and must be received by us prior to the date set forth under Submission of Future
Stockholder Proposals below. A stockholders recommendation must be accompanied by the information with respect to stockholder
nominees as specified in our Bylaws, including among other things, the name, age, address and occupation of the recommended person, the
proposing stockholders name and address, the ownership interests of the proposing stockholder and any beneficial owner on whose
behalf the nomination is being made (including the number of shares beneficially owned, any hedging, derivative, short or other economic
interests and any rights to vote any shares) and any material monetary or other relationships between the recommended person and the
proposing stockholder and/or the beneficial owners, if any, on whose behalf the nomination is being made.
In
evaluating director nominees, the Nominating and Corporate Governance Committee considers the following factors:
| 
| the
appropriate size and diversity of our Board; | |
| 
| our
needs with respect to the particular knowledge skills and experience of nominees, including
experience in corporate finance, technology, business, administration and sales, in light
of the prevailing business conditions and the knowledge, skills, and experience already possessed
by other members of the Board; | |
| 
| experience
with accounting rules and practices, and whether such a person qualifies as an audit
committee financial expert pursuant to SEC rules; and | |
| 
| balancing
continuity of our Board with periodic injection of fresh perspectives provided by new Board
members. | |
Our
Board believes that each director should have a basic understanding of our principal operational and financial objectives and plans and
strategies, our results of operations and financial condition and our relative standing in relation to our competitors.
In
identifying director nominees, the Board will first evaluate the current members of the Board willing to continue in service. Current
members of the Board with skills and experience that are relevant to our business and who are willing to continue in service will be
considered for re-nomination.
If
any member of the Board does not wish to continue in service or if the Board decides not to re-nominate a member for re-election, the
Board will identify another nominee with the desired skills and experience described above. The Board takes into consideration the overall
composition and diversity of the Board and areas of expertise that director nominees may be able to offer, including business experience,
knowledge, abilities and customer relationships. Generally, the Board will strive to assemble a Board that brings to us a variety of
perspectives and skills derived from business and professional experience as it may deem are in our and our stockholders best
interests. In doing so, the Board will also consider candidates with appropriate non-business backgrounds.
| 51 | |
**Board
Leadership Structure and Role in Risk Oversight**
The
positions of Chairman of the Board and principal executive officer (PEO) are filled by the same individual. Mr.
Silverman currently serves as our Chief Executive Officer, Chairman of the Board and our PEO. The Board acknowledges that there are
different leadership structures that could allow it to effectively oversee the management of the risks relating to the
Companys operations and believes its current leadership structure enables it to effectively provide oversight with respect to
such risks. However, our Board believes the current structure provides an efficient and effective leadership model for the Company
and that combining the Chairman of the Board and PEO roles fosters clear accountability, effective decision-making and alignment on
corporate strategy. Moreover, the Board believes that its governance practices provide adequate safeguards against any potential
risks that might be associated with having a combined Chairman and PEO.
| 
| four of the five current directors of the Company are independent directors; | |
| 
| all
of the members of the Audit Committee, the Compensation Committee, and the Nominating and
Corporate Governance Committee are independent directors; and | |
| 
| the
Board and its committees remain in close contact with, and receive reports on, various aspects
of the Companys management and enterprise risk directly from, the Companys
senior management and independent auditors. | |
Our
Audit Committee is primarily responsible for overseeing the Companys risk management processes on behalf of the full Board. The
Audit Committee receives reports from management concerning the Companys assessment of risks. In addition, the Audit Committee
reports regularly to the full Board, which also considers the Companys risk profile. The Audit Committee and the full Board focus
on the most significant risks facing the Company and the Companys general risk management strategy. In addition, as part of its
oversight of our Companys executive compensation program, the Compensation and Human Resources Committee considers the impact
of such program, and the incentives created by the compensation awards that it administers, on our Companys risk profile. In addition,
the Compensation and Human Resources Committee reviews all of our compensation policies and procedures, including the incentives that
they create and factors that may reduce the likelihood of excessive risk taking, to determine whether they present a significant risk
to our Company. The Compensation and Human Resources Committee has determined that, for all employees, our compensation programs do not
encourage excessive risk and instead encourage behaviors that support sustainable value creation.
**Communications
with Directors**
The
Board welcomes communication from our stockholders. Stockholders and other interested parties who wish to communicate with a member or
members of our Board or a committee thereof may do so by addressing correspondence to the Board member, members or committee, c/o Secretary,
StableX Technologies, Inc., 1185 Avenue of the Americas, New York, New York 10036. Our Secretary will review and forward correspondence
to the appropriate person or persons.
All
communications received as set forth in the preceding paragraph will be opened by our Secretary for the sole purpose of determining whether
the contents represent a message to our directors. Any contents that are not in the nature of advertising, promotions of a product or
service or patently offensive material will be forwarded promptly to the addressee(s). In the case of communications to the Board or
any group or committee of directors, our Secretary will make sufficient copies of the contents to send to each director who is a member
of the group or committee to whom the communication is addressed. If the amount of correspondence received through the foregoing process
becomes excessive, our Board may consider approving a process for review, organization and screening of the correspondence by our Secretary
or another appropriate person.
**Family
Relationships**
There
are no family relationships among any of our directors and executive officers.
**Involvement
in Certain Legal Proceedings**
None
of our directors, director nominees or executive officers has been involved in any of the following events during the past ten years:
| 
| any
bankruptcy petition filed by or against any business of which such person was a general partner
or executive officer either at the time of the bankruptcy or within two years prior to that
time; | |
| 52 | |
| 
| any
conviction in a criminal proceeding or being subject to a pending criminal proceeding (excluding
traffic violations and other minor offences); | |
| 
| being
subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated,
of any court of competent jurisdiction, permanently or temporarily enjoining, barring, suspending
or otherwise limiting his or her involvement in any type of business, securities or banking
activities; or | |
| 
| being
found by a court of competent jurisdiction (in a civil action), the SEC or the Commodity
Futures Trading Commission to have violated a federal or state securities or commodities
law, and the judgment has not been reversed, suspended, or vacated. | |
There
have been no material legal proceedings that would require disclosure under the federal securities laws that are material to an evaluation
of the ability or integrity of our directors, director nominees or executive officers, or in which any director, director nominee, officer,
nominee or principal stockholder, or any affiliate thereof, is a party adverse to us or has a material interest adverse to us.
**Insider
Trading Policy; Prohibition on Hedges and Pledges**
We
have an insider trading policy that prohibits our directors, executive officers, employees, independent contractors, consultants and
their respective family members from the purchasing or selling our securities while being aware of material, non-public information about
the Company as well as disclosing such information to others who may trade in securities of the Company. Our insider trading policy also
prohibits our directors, executive officers, employees and their respective family members from engaging in hedging activities or other
short-term or speculative transactions in the Companys securities such as short sales, options trading, holding the Companys
securities in a margin account or pledging the Companys securities as collateral for a loan, without the advance approval of our
Chief Financial Officer. Our insider trading policy is filed as an exhibit to our Annual Report on Form 10-K.
**Delinquent
Section 16(a) Reports**
Section
16(a) of the Securities Exchange Act of 1934, as amended (the Exchange Act), requires our officers and directors and persons
who beneficially own more than 10% of our ordinary shares to file reports of ownership and changes in ownership of such ordinary shares
with the SEC. These persons are required by SEC regulations to furnish us with copies of all Section 16(a) forms they file. As a matter
of practice, our legal team assists our officers and directors in preparing initial reports of ownership and reports of changes in ownership
and files those reports on their behalf. Based solely on our review of the copies of such forms we have received, we believe that all
required Section 16(a) reports were timely filed during our fiscal year ended December 31, 2025, except for the below.
On May 7, 2025, a Form 4 for Joseph Ramelli was filed late to report the grant of stock options on April 30, 2025.
**Director
Compensation**
The
following table sets forth summary information concerning the total compensation earned by the non-employee directors during the fiscal
year ended December 31, 2025, for services to the Company:
| 
Name | | 
Fees Earned or
Paid in Cash
($) | | | 
Stock Awards
($)(1) | | | 
All
Other Compensation
($) | | | 
Total
($) | | |
| 
Greg Schiffman | | 
| 65,188 | | | 
| 142,019 | | | 
| - | | | 
| 207,207 | | |
| 
Sebastian Giordano | | 
| 46,687 | | | 
| 142,019 | | | 
| 40,000 | | | 
| 228,706 | | |
| 
Zvi Joseph | | 
| 58,186 | | | 
| 142,019 | | | 
| - | | | 
| 200,205 | | |
| 
George Devlin(2) | | 
| 66,375 | | | 
| - | | | 
| - | | | 
| 66,375 | | |
| 
Wayne R. Walker | | 
| 46,687 | | | 
| 142,019 | | | 
| - | | | 
| 188,706 | | |
| 
(1) | Amounts
reflect the full grant-date fair value of stock awards granted during the relevant fiscal
year computed in accordance with ASC 718, rather than the amounts paid to or realized by
the named individual. We provided information regarding the assumptions used to calculate
the value of all stock awards and option awards made to our executive officers in Note 8
to the audited consolidated financial statements for the year ended December 31, 2025. | |
| 
| | | |
| 
(2) | George
Devlin tendered his resignation as a member of the Board of the Company and as a member of
all committees of the Board, effective September 2, 2025. In connection with Mr. Devlins
resignation, the Board approved a one-time payment to Mr. Devlin of $35,438, an amount equal
to the director cash fees that would otherwise be owed to Mr. Devlin for his services as
a director for the period beginning September 2025 through May 2026 pursuant to the Boards
compensation policy. | |
| 53 | |
**ITEM
11. EXECUTIVE COMPENSATION.**
As
a smaller reporting company, we are permitted to provide a scaled executive compensation disclosure under Item 402(m)-(r) of Regulation
S-K.
**Compensation Philosophy and
Process**
The responsibility for establishing, administering
and interpreting our policies governing the compensation and benefits for our executive officers and making compensation decisions with
respect to such executive officers lies with our Compensation and Human Resources Committee. In the fiscal year ended December 31, 2025,
the Company did not retain the services of any compensation consultants.
The goals of our executive compensation
program are to attract, motivate and retain individuals with the skills and qualities necessary to support
and develop our business within the framework of our size and available resources. In the fiscal year ended December 31, 2024, we designed
our executive compensation program to achieve the following objectives:
| 
| attract
and retain executives experienced in developing and delivering products such as our own; | |
| 
| | | |
| 
| motivate
and reward executives whose experience and skills are critical to our success; | |
| 
| reward
performance; and | |
| 
| align
the interests of our executive officers and other key employees with those of our stockholders
by motivating our executive officers and other key employees to increase stockholder value. | |
****
**Summary
Compensation Table**
The
following table sets forth all compensation earned, in all capacities, during the fiscal years ended December 31, 2025 and 2024 by (i)
all individuals who served as our PEO during the fiscal year ended December 31, 2025, (ii) if applicable, our two most highly compensated
executive officers, other than individuals who served as our PEO, who were serving as executive officers, as determined in accordance
with the rules and regulations promulgated by the SEC, as of December 31, 2025, with compensation during the fiscal year ended December
31, 2025 of $100,000 or more, and (iii) up to two additional individuals for whom disclosure would have been provided pursuant to clause
(ii) but for the fact that such individuals were not serving as executive officers on December 31, 2025 (the individuals falling within
categories (i), (ii) and (iii), the Named Executive Officers).
| 
Name and Principal Position | | 
Year | | 
Salary ($) | | | 
Bonus ($) | | | 
Stock Awards ($) (1) | | | 
Option Awards ($) (1) | | | 
All other compensation ($) | | | 
Total ($) | | |
| 
Joshua Silverman (2) | | 
2025 | | 
| 300,000 | | | 
| - | | | 
| - | | | 
| 1,378,206 | | | 
| - | | | 
| 1,678,206 | | |
| 
Chief Executive Officer (Principal Executive Officer) | | 
2024 | | 
| 280,000 | | | 
| - | | | 
| 180,132 | | | 
| - | | | 
| - | | | 
| 460,132 | | |
| 
| | 
| | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | |
| 
Gilbert Villareal (3) | | 
2025 | | 
| 240,000 | | | 
| - | | | 
| - | | | 
| 46,321 | | | 
| 1,294,975 | | | 
| 1,341,296 | | |
| 
President of Ayro Operating Company, Inc. | | 
2024 | | 
| 80,000 | | | 
| - | | | 
| - | | | 
| - | | | 
| 394,042 | | | 
| 474,042 | | |
| 
| | 
| | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | |
| 
Joseph Ramelli(4) | | 
2025 | | 
| 120,000 | | | 
| - | | | 
| - | | | 
| 23,159 | | | 
| - | | | 
| 143,159 | | |
| 
Chief Financial Officer | | 
2024 | | 
| 40,000 | | | 
| - | | | 
| - | | | 
| - | | | 
| - | | | 
| 40,000 | | |
| 
(1) | 
The dollar amounts in this
column represent the aggregate grant date fair value of stock and option awards granted during the applicable fiscal year, computed
in accordance with FASB ASC Topic 718. These amounts reflect the accounting value of the awards at the date of grant and do not represent
amounts actually realized by the named executive officer. | |
| 
| 
| |
| 
(2) | 
On
March 1, 2024, in connection with Mr. Silvermans appointment to the position of Interim Principal Financial Officer and Principal
Accounting Officer and Mr. Silvermans service as the Companys Executive Chairman and Principal Executive Officer, the
Board increased Mr. Silvermans annual cash compensation to $280,000, effective as of December 1, 2023. Since the appointment
of Mr. Ramelli to the position of Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, effective
as of August 21, 2024, Mr. Silverman no longer serves the position of Interim Principal Financial Officer or Principal Accounting
Officer.
On
December 2, 2024, the Company granted Mr. Silverman 15,214 shares of restricted common stock pursuant to the Companys equity
incentive plan in connection with his service as Chairman of the Board. The shares vested immediately upon grant. | |
| 54 | |
| 
| 
On
August 14, 2025, in connection with Mr. Silvermans position as Chief Executive Officer, the Board increased Mr. Silvermans
annual cash compensation to $300,000, effective January 1, 2025. | |
| 
| 
| |
| 
(3) | 
Mr. Villarreal was appointed to the position of President of the Companys subsidiary, AYRO Operating Company,
Inc., effective as August 21, 2024. | |
| 
| 
| |
| 
(4) | 
Mr.
Ramelli was appointed Chief Financial Officer on August 21, 2024. | |
**Narrative
Disclosure to Summary Compensation Table**
The
material terms of the employment agreements with the Named Executive Officers of the Company are summarized below.
*Executive
Employment Agreement with Joshua Silverman*
**
On
August 14, 2025, the Company entered into an Executive Compensation Agreement with Mr. Silverman in connection with his appointment as
Chief Executive Officer. The agreement provides for an annual base salary of $300,000, effective January 1, 2025, and eligibility to
participate in the Companys annual performance bonus program. Mr. Silverman is also eligible to receive equity awards under the
Companys long-term incentive plan, including annual equity awards with a target grant date fair value equal to 300% of his base
salary, with the terms of such awards to be determined by the Board of Directors or the Compensation Committee. He is not entitled to
separate compensation for service as a director.
Mr.
Silverman is also eligible to participate in the Companys employee benefit plans available to senior executives generally, including
medical, dental, vision, life insurance and 401(k) benefits, and is entitled to reimbursement of reasonable business expenses. In addition,
he is entitled to five weeks of annual vacation and two weeks of paid sick leave, subject to Company policy.
If
Mr. Silvermans employment is terminated by the Company without cause or by him for good reason, he is entitled to accrued compensation,
severance equal to two times the sum of his base salary and prorated target bonus for the year of termination, payable over 24 months,
and accelerated vesting of outstanding unvested equity awards, subject to his execution and non-revocation of a release of claims. If
such termination occurs in connection with a change in control, the severance multiple increases to three times that amount and is payable
in a lump sum. The agreement also provides for certain benefits in the event of death or disability, including accelerated vesting of
equity awards.
On
October 31, 2025, the Company granted Mr. Silverman options to purchase 220,513 shares of common stock at an exercise price of $6.25
per share. The grant date fair value of the options, calculated in accordance with ASC 718, was $1,378,206. Seventy-five percent of the
options vested immediately and the remaining 25% vested on December 31, 2025.
*Consulting
Agreement with Joseph Ramelli*
On
August 20, 2024, the Company entered into a consulting agreement with Joseph Ramelli in connection with his engagement as Chief Financial
Officer. Pursuant to the agreement, Mr. Ramelli provides services to the Company as Chief Financial Officer and reports to the Companys
Board of Directors or such other representatives as the Company may designate.
| 55 | |
Under
the agreement, Mr. Ramelli receives consulting fees of $10,000 per month, payable semi-monthly in accordance with the Companys
normal payroll practices. Mr. Ramelli may also be eligible to receive equity awards under the Companys long-term incentive plan,
subject to approval by the Board of Directors.
Mr.
Ramelli serves as an independent contractor and is not eligible to participate in the Companys employee benefit plans. The consulting
agreement may be terminated by either party at any time, with or without notice, and without further obligation or liability other than
payment of fees earned through the termination date.
On
April 30, 2025, the Company granted Mr. Ramelli options to purchase 4,688 shares of common stock at an exercise price of $8.08 per share.
The grant date fair value of the options, calculated in accordance with ASC 718, was $23,159. The options were fully vested and exercisable
on the date of grant.
*Appointment
of Gilbert Villarreal*
**
On
August 21, 2024, Gilbert Villarreal was appointed to the position of President of the Companys subsidiary, Ayro Operating Company,
Inc. (Operating Subsidiary), effective as August 21, 2024. In connection with Mr. Villarreals appointment, Mr. Villarreal
is entitled to compensation of $30,000 per month, which may be increased to $50,000 per month if Mr. Villarreal is requested to work
on the reengineering of the Companys product, the Vanish.
**Outstanding
Equity Awards at Fiscal Year End**
The
following table provides information regarding outstanding equity awards held by our named executive officers as of December 31, 2025:
| 
Named Executive Officer | | 
Number of securities underlying unexercised options (#) exercisable | | | 
Number of securities underlying unexercised options (#) unexercisable | | | 
Option exercise price($) | | | 
Option expiration date | | | 
Number of shares or units of stock that have not yet vested (#) | | | 
Market value of shares or units of stock that have not vested($) | | |
| 
Joshua Silverman
Executive Chairman, Chief Executive Officer | | 
| 220,513 | | | 
| - | | | 
| 6.25 | | | 
| 2035 | | | 
| - | | | 
$ | - | | |
| 
Joseph Ramelli
Chief Financial Officer | | 
| 4,688 | | | 
| - | | | 
| 8.08 | | | 
| 2035 | | | 
| - | | | 
$ | - | | |
| 
Gilbert Villareal
President of Ayro Operating Company, Inc. | 
| 
| 
9,375 | 
| 
| 
| 
- | 
| 
| 
| 
8.08 | 
| 
| 
| 
2035 | 
| 
| 
| 
- | 
| 
| 
$ | 
- | 
| |
**ITEM
12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.**
*Security
Ownership of Directors and Executive Officers*
The
following table sets forth information with respect to the beneficial ownership of our voting securities as of March 30, 2026 by:
| 
| each
person known by us to beneficially own more than 5.0% of our voting securities; | |
| 
| each
of our directors and nominees; | |
| 
| each
of our Named Executive Officers; and | |
| 
| all
of our directors and executive officers as a group. | |
| 56 | |
The
percentages of voting securities beneficially owned are reported on the basis of regulations of the SEC governing the determination of
beneficial ownership of securities. Under the rules of the SEC, a person is deemed to be a beneficial owner of a security if that person
has or shares voting power, which includes the power to vote or to direct the voting of the security, or investment power, which includes
the power to dispose of or to direct the disposition of the security. Shares of Common Stock beneficially owned and the respective percentages
of beneficial ownership of Common Stock assumes the exercise of all options, warrants and other securities convertible into Common Stock
beneficially owned by such person or entity currently exercisable or exercisable within 60 days of the Record Date subject to any applicable
beneficial ownership blockers. Except as indicated in the footnotes to this table, to our knowledge and subject to community property
laws where applicable, each beneficial owner named in the table below has sole voting and sole investment power with respect to all shares
beneficially owned and each persons address is c/o StableX Technologies, Inc., 1185 Avenue of the Americas, New York, New York
10036.
| 
Name and Address of Beneficial Owner | | 
Number of Shares of Common Stock Beneficially Owned (1) | | | 
Percentage of Class (1) | | | 
Number of Shares of Series H-6 Preferred Stock Beneficially Owned (1) | | | 
Percentage of Class (1) | | | 
Number of Shares of Series H-7 Preferred Stock Beneficially Owned (1) | | | 
Percentage of Class (1) | | | 
Number of Shares of Series I Preferred Stock Beneficially Owned (1) | | | 
Percentage of Class (1) | | |
| 
5% Stockholders | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | |
| 
Alpha Capital Anstalt (2) | | 
| 76,469 | | | 
| 4.99 | % | | 
| - | | | 
| - | | | 
| - | | | 
| - | | | 
| 1,500 | | | 
| 21.43 | % | |
| 
Iroquois Capital Management L.L.C.(3) | | 
| 157,781 | | | 
| 9.99 | % | | 
| 50 | | | 
| 100 | % | | 
| 829.4 | | | 
| 100 | % | | 
| 2,850 | | | 
| 40.71 | % | |
| 
The Hewlett Fund LP (4) | | 
| 76,469 | | | 
| 4.99 | % | | 
| - | | | 
| - | | | 
| - | | | 
| - | | | 
| 500 | | | 
| 7.14 | % | |
| 
Mainfield Enterprises, Inc. (5) | | 
| 76,469 | | | 
| 4.99 | % | | 
| - | | | 
| - | | | 
| - | | | 
| - | | | 
| 1,000 | | | 
| 14.29 | % | |
| 
| | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | |
| 
Named Executive Officers and Directors | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | |
| 
Sebastian Giordano (6) | | 
| 24,492 | | | 
| 1.66 | % | | 
| - | | | 
| - | | | 
| - | | | 
| - | | | 
| - | | | 
| - | | |
| 
Wayne R. Walker (7) | | 
| 24,095 | | | 
| 1.63 | % | | 
| - | | | 
| - | | | 
| - | | | 
| - | | | 
| - | | | 
| - | | |
| 
Zvi Joseph (8) | | 
| 24,294 | | | 
| 1.64 | % | | 
| - | | | 
| - | | | 
| - | | | 
| - | | | 
| - | | | 
| - | | |
| 
Joshua Silverman (9) | | 
| 223,604 | | | 
| 13.33 | % | | 
| - | | | 
| - | | | 
| - | | | 
| - | | | 
| - | | | 
| - | | |
| 
Greg Schiffman (10) | | 
| 24,445 | | | 
| 1.65 | % | | 
| - | | | 
| - | | | 
| - | | | 
| - | | | 
| - | | | 
| - | | |
| 
Gilbert Villarreal | | 
| - | | | 
| - | | | 
| - | | | 
| - | | | 
| - | | | 
| - | | | 
| - | | | 
| - | | |
| 
Joseph Ramelli (11) | | 
| 4,688 | | | 
| * | | | 
| - | | | 
| - | | | 
| - | | | 
| - | | | 
| - | | | 
| - | | |
| 
| | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | |
| 
All directors and executive officers as a group (7 persons) | | 
| 325,618 | | | 
| 18.32 | % | | 
| - | | | 
| - | | | 
| - | | | 
| - | | | 
| - | | | 
| - | | |
| 
(1) | Percentage
of Common Stock ownership is based on (i) 1,455,975 shares of Common Stock issued and outstanding
as of March 30, 2026, (ii) 50 shares of Series H-6 Preferred Stock, (iii) 829.4 shares of
Series H-7 Preferred Stock and (iv) 7,000 shares of Series I Preferred Stock issued and outstanding
as of March 30, 2026. | |
| 
(2) | Based
on certain information made available to the Company. Includes (i) warrants to purchase up
to 1,791,071 shares of Common Stock exercisable within 60 days of March 30, 2026 (subject
to a 4.99% beneficial ownership blocker), and (ii) 187,500 shares of Common Stock issuable
upon conversion of 1,500 shares of Series I Preferred Stock (subject to a 4.99% beneficial
ownership blocker). | |
The
shares are held by Alpha Capital Anstalt (Alpha). Each of Nicola Feuerstein and Konrad Ackermann, as directors of Alpha,
have voting and dispositive control with respect to the securities reported herein. As such, Nicola Feuerstein and Konrad Ackermann may
be deemed to be the beneficial owner (as determined under Section 13(d) of the Exchange Act) of the securities held by Alpha. The address
of Alpha is Altenbach 8, FL-9490 Vaduz, Furstentums, Liechtenstein.
| 57 | |
| 
(3) | Based
on a Schedule 13G/A jointly filed on August 14, 2025, by Richard Abbe (Mr. Abbe),
Kimberly Page (Ms. Page) and Iroquois Capital Management L.L.C. and on certain
information made available to the Company. | |
Shares
beneficially owned by Iroquois Capital Investment Group LLC (ICIG) include (i) 22,342 shares of Common Stock, (ii) warrants
exercisable within 60 days of the March 30, 2026 to purchase up to 3,142,372 shares of Common Stock (subject to a 9.99% beneficial ownership
blocker), (iii) 17 shares of Series H-6 Preferred Stock, convertible into up to 14 shares of Common Stock within 60 days of March 30,
2026 (subject to a 9.99% beneficial ownership blocker), (iv) 514.15 shares of Series H-7 Preferred Stock, convertible within 60 days
of March 30, 2026 into up to 83,017 shares of Common Stock (subject to a 9.99% beneficial ownership blocker), and (v) 137,500 shares
of Common Stock issuable upon conversion of 1,100 shares of Series I Preferred Stock (subject to a 9.99% beneficial ownership blocker).
Shares
beneficially owned by Iroquois Master Fund Ltd. (IMF) include (i) 12,030 shares of Common Stock, (ii) warrants exercisable
within 60 days of March 30, 2026 to purchase up to 1,869,100 shares of Common Stock (subject to a 9.99% beneficial ownership blocker),
(iii) 33 shares of Series H-6 Preferred Stock, convertible into up to 27 shares of Common Stock within 60 days of March 30, 2026 (subject
to a 9.99% beneficial ownership blocker), (iv) 966.66 shares of Series H-7 Preferred Stock, convertible within 60 days of March 30, 2026
into up to 156,081 shares of Common Stock (subject to a 9.99% beneficial ownership blocker), and (v) 29,216 shares of Common Stock issuable
upon conversion of 1,750 shares of Series I Preferred Stock (subject to a 4.99% beneficial ownership limitation).
Mr.
Abbe exercises sole voting and dispositive power over the shares held by ICIG and shares voting and dispositive power over the shares
held by IMF with Ms. Page. As such, Mr. Abbe may be deemed to be the beneficial owner of all shares of Common Stock held by and underlying
the warrants and shares of preferred stock (each subject to certain beneficial ownership blockers) held by ICIG and IMF and Ms. Page
may be deemed to be the beneficial owner of all shares of Common Stock held by and underlying the warrants and shares of preferred stock
(each subject to certain beneficial ownership blockers) held by IMF.
| 
(4) | Based
on certain information made available to the Company. The Hewlett Fund LP (Hewlett)
is the beneficial owner of (i) warrants to purchase up to 780,555 shares of Common Stock
exercisable within 60 days of March 30, 2026 (subject to a 4.99% beneficial ownership blocker),
and (ii) 62,500 shares of Common Stock issuable upon conversion of 500 shares of Series I
Preferred Stock (subject to a 4.99% beneficial ownership blocker). | |
The
shares are held by Hewlett. Martin Chopp, as General Partner of Hewlett, has voting and dispositive power over the securities held by
Hewlett. As such, Mr. Chopp may be deemed to be the beneficial owner (as determined under Section 13(d) of the Exchange Act) of the securities
held by Hewlett. Hewletts address is 100 Merrick Road, Suite 400W, Rockville Centre, NY 11570.
| 
(5) | Based
on certain information made available to the Company. Mainfield Enterprises Inc. (Mainfield)
is the beneficial owner of (i) warrants to purchase up to 1,368,913 shares of Common Stock
exercisable within 60 days of March 30, 2026 (subject to a 4.99% beneficial ownership blocker),
and (ii) 125,000 shares of Common Stock issuable upon conversion of 1,000 shares of Series
I Preferred Stock (subject to a 4.99% beneficial ownership blocker). | |
The
shares are held by Mainfield. Raz Steinmetz has voting and dispositive power over the securities held by Mainfield. As such, Mr. Steinmetz
may be deemed to be the beneficial owner (as determined under Section 13(d) of the Exchange Act) of the securities held by Mainfield.
Mainfields address is Ariel House, 74 Charlotte Street, London W1T4QJ, United Kingdom.
| 
(6) | Mr.
Giordanos total includes (i) 888 shares of Common Stock, (ii) 881 shares of Common
Stock issuable upon the settlement of vested restricted stock units and (iii) 22,723 shares
of Common Stock issuable upon exercise of certain stock options. | |
| 
(7) | Mr.
Walkers total includes (i) 491 shares of Common Stock, (ii) 881 shares of Common Stock
issuable upon the settlement of vested restricted stock units and (iii) 22,723 shares of
Common Stock issuable upon exercise of certain stock options. | |
| 58 | |
| 
(8) | Mr.
Josephs total includes (i) 690 shares of Common Stock, (ii) 881 shares of Common Stock
issuable upon the settlement of vested restricted stock units and (iii) 22,723 shares of
Common Stock issuable upon exercise of certain stock options. | |
| 
| | | |
| 
(9) | Mr.
Silvermans total includes (i) 1,549 shares of Common Stock, (ii) 1,542 shares of Common
Stock issuable upon the settlement of vested restricted stock units and (iii) 220,513 shares
of Common Stock issuable upon exercise of certain stock options. | |
| 
| | | |
| 
(10) | Mr.
Schiffmans total includes (i) 841 shares of Common Stock, (ii) 881 shares of Common
Stock issuable upon the settlement of vested restricted stock units, and (iii) 22,723 shares
of Common Stock issuable upon exercise of certain stock options. | |
| 
| | | |
| 
(11) | Mr.
Ramellis total includes 4,688 shares of Common Stock issuable upon the settlement
of vested restricted stock units. | |
*Securities
Authorized for Issuance Under Existing Equity Compensation Plan*
**Equity
Compensation Plan Information**
****
The
following table provides certain information as of December 31, 2025, with respect to our equity compensation plans under which our equity
securities are authorized for issuance:
| 
Plan Category | | 
Number of Securities to be Issued Upon Exercise of Outstanding Options | | | 
Weighted-Average Exercise Price of Outstanding Options | | | 
Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in Column (a)) | | |
| 
| | 
(a) | | | 
(b) | | | 
(c) | | |
| 
Equity compensation plans approved by security holders: StableX Technologies Long-Term Incentive Plan (Options)(1) | | 
| 325,468 | | | 
$ | 6.33 | | | 
| 92 | | |
| 
Equity compensation plans not approved by security holders: 2017 LTIP (Options)(2) | | 
| - | | | 
| - | | | 
| - | | |
| 
Equity compensation plans approved by security holders: 2014 DropCar (Options)(3) | | 
| 422 | | | 
| 3,241 | | | 
| - | | |
| 
Other equity compensation plans not approved by security holders | | 
| - | | | 
| - | | | 
| - | | |
| 
Total | | 
| 325,890 | | | 
$ | 10.52 | | | 
| 92 | | |
| 
(1) | 
Represents 325,468 shares
of common stock issuable upon exercise of options under the StableX Technologies, Inc. Long-Term Incentive Plan, as amended. | |
| 
(2) | 
Represents shares of common
stock issuable upon exercise of options under the AYRO, Inc. 2017 Long Term Incentive Plan adopted by AYRO Operating prior to the
Merger (as amended, 2017 LTIP, or AYRO Operating Equity Plan). | |
| 
(3) | 
Represents shares of common
stock issuable upon exercise of options under the DropCar Amended and Restated 2014 Equity Incentive Plan (as amended, 2014
DropCar). | |
For
a description of these plans, See Note 8 to our 2025 Consolidated Financial Statements included in this Annual Report on Form 10-K for
the year ended December 31, 2025.
| 59 | |
**ITEM
13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE.**
SEC rules require us to disclose any transaction or
currently proposed transaction in which we are a participant and in which any related person has or will have a direct or indirect material
interest involving an amount that exceeds the lesser of $120,000 or one percent (1%) of the average of the Companys total assets
as of the end of the last two completed fiscal years. A related person is any executive officer, director, nominee for director, or holder
of 5% or more of the Companys Common Stock, or an immediate family member of any of those persons.
Beginning
August 2024, Gilbert Villarreal, the president of AYRO Operating Company, Inc., through GLV Ventures and Electric Power, entities owned
and controlled by Mr. Villarreal, has been providing consulting services to the Company in connection with the reengineering of the Companys
Vanish at a rate of $30,000 per month. During the year ended December 31, 2025, the Company has paid Mr. Villarreal an aggregate of $1,534,975
for such services performed, which is in addition to the compensation paid to Mr. Villarreal as President of AYRO Operating Company,
Inc.
*August
2025 Private Placement*
On
August 4, 2025, the Company entered into a Securities Purchase Agreement (the Series I Purchase Agreement) with certain
accredited investors, pursuant to which it agreed to sell (i) an aggregate of 7,000 shares of the Companys newly-designated Series
I Preferred Stock, with a par value of $0.0001 per share and a stated value of $1,000 per share (Stated Value), initially
convertible into up to 875,000 shares of the Companys common stock at an initial conversion price of $8.00 per share pursuant
to the Certificate of Designations of the Series I Preferred Stock (the Series I Certificate of Designations) and (ii)
warrants to acquire up to an aggregate of 875,000 shares of common stock (the Series I Warrants) at an exercise price of
$8.00 per share (collectively, the Private Placement). The closing of the Private Placement occurred on August 8, 2025.
The aggregate gross proceeds from the Private Placement were $7,000,000. In connection with the Private Placement, the Company received
investments of (i) $2,825,000 from affiliates of Mr. Abbe and Iroquois Capital Management L.L.C., (ii) $1,500,000 from Alpha Capital
Anstalt, (iii) $1,000,000 from Mainfield Enterprises, and (iv) $500,000 from The Hewlett Fund LP, each of whom is the beneficial owner
of 5.0% or more of our voting securities.
*Employment Agreements*
We have employment agreements with certain of our
executive officers as discussed under the heading, Item 11. Executive Compensation.
**ITEM
14. PRINCIPAL ACCOUNTANT FEES AND SERVICES.**
The
Companys independent registered public accounting firm is Stephano Slack LLC (PCAOB Firm ID No.: 3523) located in Wayne, Pennsylvania. Stephano
Slack LLC was engaged during the third quarter of 2025 and served as the Companys independent registered public accounting firm
for the audit of the Companys consolidated financial statements for the fiscal year ended December 31, 2025.
**Fees
Paid to Stephano Slack LLC**
****
The
following table sets forth the aggregate fees billed by Stephano Slack LLC for professional services rendered for the fiscal years ended
December 31, 2025 and 2024.
| 
Services | | 
2025 | | | 
2024 | | |
| 
Audit fees | | 
$ | 57,737 | | | 
$ | - | | |
| 
Audit-related fees | | 
| - | | | 
| - | | |
| 
Tax fees | | 
| - | | | 
| - | | |
| 
All other fees | | 
| - | | | 
| - | | |
| 
Total fees | | 
$ | 57,737 | | | 
$ | - | | |
*Audit
Fees*
Audit
fees consist of fees billed for professional services rendered for the audit of the Companys annual consolidated financial statements
for the fiscal year ended December 31, 2025, the review of the Companys financial statements for the quarter ended September 30,
2025, and services that are normally provided by the independent registered public accounting firm in connection with the statutory and
regulatory filings or engagements.
| 60 | |
**Audit
Committee Pre-Approval Policy**
The
Audit Committee pre-approves all audit and permissible non-audit services provided by the Companys independent registered public
accounting firm. All services provided by the independent registered public accounting firms during the fiscal years ended December 31,
2025 and December 31, 2024 were approved by the Audit Committee in accordance with this policy.
**PART
IV**
**ITEM
15. EXHIBITS, AND FINANCIAL STATEMENT SCHEDULES.**
(a)
The following documents are filed as part of this Annual Report on Form 10-K:
(1)
Financial Statements:
| 
Report of Independent Registered Public Accounting Firm (PCAOB ID#3523) Stephano Slack LLC covers year ended December 31, 2025 | 
F-2 | |
| 
Report of Independent Registered Public Accounting Firm (PCAOB ID#688) Marcum LLP covers year ended December 31, 2024 | 
F-4 | |
| 
Consolidated Balance Sheets as of December 31, 2025 and 2024 | 
F-5 | |
| 
Consolidated Statements of Operations for the years ended December 31, 2025 and 2024 | 
F-6 | |
| 
Consolidated Statements of Changes in Mezzanine Equity and Stockholders Equity for the years ended December 31, 2025 and 2024 | 
F-7 | |
| 
Consolidated Statements of Cash Flows for the years ended December 31, 2025 and 2024 | 
F-8 | |
| 
Notes to Consolidated Financial Statements | 
F-9 | |
(2)
Financial Statement Schedules:
None.
Financial statement schedules have not been included because they are not applicable, or the information is included in the consolidated
financial statements or notes thereto.
(3)
Exhibits:
See
Index to Exhibits for a description of our exhibits.
**ITEM
16. FORM 10-K SUMMARY.**
Not
applicable.
| 61 | |
**Index
to Exhibits**
| 
Exhibit
No. | 
| 
Description | |
| 
| 
| 
| |
| 
2.1 | 
| 
Agreement and Plan of Merger and Reorganization by and among DropCar, Inc., ABC Merger Sub, Inc. and AYRO, Inc. dated December 19, 2019 (incorporated by reference to Exhibit 2.1 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on December 20, 2019) | |
| 
| 
| 
| |
| 
2.2 | 
| 
Asset Purchase Agreement, by and among DropCar, Inc., DropCar Operating Company, Inc., DC Partners Acquisition, LLC, Spencer Richardson and David Newman, dated December 19, 2019 (incorporated by reference to Exhibit 2.5 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on December 20, 2019) | |
| 
| 
| 
| |
| 
2.3 | 
| 
Amendment to Asset Purchase Agreement, by and among DropCar, Inc., DropCar Operating Company, Inc., DC Partners Acquisition, LLC, Spencer Richardson and David Newman, dated May 28, 2020 (incorporated by reference to Exhibit 2.3 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on May 29, 2020) | |
| 
| 
| 
| |
| 
3.1 | 
| 
Amended and Restated Certificate of Incorporation, effective May 28, 2020 (incorporated by reference to Exhibit 3.2 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on May 29, 2020) | |
| 
| 
| 
| |
| 
3.1.1 | 
| 
Certificate of Amendment to Amended and Restated Certificate of Incorporation, effective May 28, 2020 (incorporated by reference to Exhibit 3.3 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on May 29, 2020) | |
| 
| 
| 
| |
| 
3.1.2 | 
| 
Certificate of Amendment to Amended and Restated Certificate of Incorporation, effective September 15, 2023 (incorporated by reference to Exhibit 3.1 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on September 15, 2023) | |
| 
| 
| 
| |
| 
3.1.3 | 
| 
Certificate of Amendment to Amended and Restated Certificate of Incorporation, effective September 15, 2023 (incorporated by reference to Exhibit 3.2 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on September 15, 2023) | |
| 
| 
| 
| |
| 
3.1.4 | 
| 
Certificate of Amendment to the Amended and Restated Certificate of Incorporation of AYRO, Inc. (incorporated by reference to Exhibit 3.1 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on May 23, 2025). | |
| 
| 
| 
| |
| 
3.1.5 | 
| 
Certificate of Amendment to the Amended and Restated Certificate of Incorporation of AYRO, Inc. (incorporated by reference to Exhibit 3.1 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on June 27, 2025). | |
| 
| 
| 
| |
| 
3.1.6 | 
| 
Certificate of Amendment to Amended and Restated Certificate of Incorporation of StableX Technologies, Inc. (incorporated by reference to Exhibit 3.1 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on August 26, 2025). | |
| 
| 
| 
| |
| 
3.2 | 
| 
Certificate of Designations of Series H-7 Convertible Preferred Stock (incorporated by reference to Exhibit 3.3 to the Companys Quarterly Report on Form 10 Q filed with the Securities and Exchange Commission on November 20, 2023) | |
| 
| 
| 
| |
| 
3.2.1 | 
| 
Certificate of Amendment of Certificate of Designations of Series H-7 Convertible Preferred Stock of AYRO, Inc. (incorporated by reference to Exhibit 3.1 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on February 9, 2024). | |
| 62 | |
| 
3.2.2 | 
| 
Certificate of Amendment of Certificate of Designations of Series H-7 Convertible Preferred Stock (incorporated by reference to Exhibit 3.1 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on December 2, 2024). | |
| 
| 
| 
| |
| 
3.2.3 | 
| 
Certificate of Amendment of Certificate of Designations of Series H-7 Convertible Preferred Stock (incorporated by reference to Exhibit 3.2.3 to the Companys Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 31, 2025). | |
| 
| 
| 
| |
| 
3.2.4 | 
| 
Certificate of Amendment of Certificate of Designations of Series H-7 Convertible Preferred Stock of AYRO, Inc. (incorporated by reference to Exhibit 3.2 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on August 12, 2025). | |
| 
| 
| 
| |
| 
3.3 | 
| 
Amended and Restated Bylaws, effective May 28, 2020 (incorporated by reference to Exhibit 3.4 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on May 29, 2020) | |
| 
| 
| 
| |
| 
3.3.1 | 
| 
First Amendment to the Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on July 8, 2020) | |
| 
| 
| 
| |
| 
3.3.2 | 
| 
Second Amendment to the Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on October 19, 2021) | |
| 
| 
| 
| |
| 
3.3.3 | 
| 
Third Amendment to the Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on October 12, 2023) | |
| 
| 
| 
| |
| 
3.4 | 
| 
Certificate of Designations, Preferences and Rights of the Series H Convertible Preferred Stock, filed with the Secretary of State of the State of Delaware on June 30, 2015 (incorporated by reference to Exhibit 3.1 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on July 1, 2015) | |
| 
| 
| 
| |
| 
3.5 | 
| 
Certificate of Designations, Preferences and Rights of the Series H-3 Convertible Preferred Stock, filed with the Secretary of State of the State of Delaware on March 30, 2017 (incorporated by reference to Exhibit 3.1 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on April 4, 2017). | |
| 
| 
| 
| |
| 
3.6 | 
| 
Certificate of Designations, Preferences and Rights of the Series H-6 Preferred Stock (incorporated by reference to Exhibit 3.1 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on February 5, 2020). | |
| 
| 
| 
| |
| 
3.7 | 
| 
Certificate of Designations of Series A Junior Participating Preferred Stock (incorporated by reference to Exhibit 3.1 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on August 1, 2025). | |
| 
| 
| 
| |
| 
3.8 | 
| 
Form of Certificate of Designations of Series I Convertible Preferred Stock (incorporated by reference to Exhibit 3.1 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on August 12, 2025). | |
| 
4.1 | 
| 
Form of Warrant issued in connection with the August 2023 Offering (incorporated by reference to Exhibit 4.1 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on August 8, 2023) | |
| 
| 
| 
| |
| 
4.2 | 
| 
Rights Agreement, dated as of July 31, 2025, between AYRO, Inc. and Equiniti Trust Company LLC, as Rights Agent (incorporated by reference to Exhibit 4.1 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on August 1, 2025). | |
| 63 | |
| 
4.3 | 
| 
Form of Warrant (incorporated by reference to Exhibit 4.1 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on August 5, 2025). | |
| 
| 
| 
| |
| 
4.4 | 
| 
Form of Consulting Warrant (incorporated by reference to Exhibit 4.2 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on August 5, 2025). | |
| 
| 
| 
| |
| 
4.5 | 
| 
Form of Omnibus Amendment (incorporated by reference to Exhibit 4.1 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on August 26, 2025). | |
| 
| 
| 
| |
| 
4.6** | 
| 
Description of Capital Stock. | |
| 
| 
| 
| |
| 
10.1 | 
| 
StableX Technologies, Inc. 2020 Long-Term Equity Incentive Plan (formerly the AYRO, Inc. Long-Term Incentive Plan) (incorporated by reference to Exhibit 99.1 to the Companys Registration Statement on Form S-8 filed with the Securities and Exchange Commission on August 3, 2020) | |
| 
| 
| 
| |
| 
10.1.1 | 
| 
First Amendment to the StableX Technologies, Inc. 2020 Long-Term Incentive Plan, dated December 17, 2020 (formerly the AYRO, Inc. Long-Term Incentive Plan) (incorporated by reference to Exhibit 10.1 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on December 22, 2020) | |
| 
| 
| 
| |
| 
10.1.2 | 
| 
Second Amendment to the StableX Technologies, Inc. 2020 Long-Term Incentive Plan, dated September 14, 2023 (formerly the AYRO, Inc. Long-Term Incentive Plan) (incorporated by reference to Exhibit 10.1 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on September 15, 2023). | |
| 
| 
| 
| |
| 
10.1.3 | 
| 
Third Amendment to the StableX Technologies, Inc. Long-Term Incentive Plan (formerly the AYRO, Inc. 2020 Long-Term Incentive Plan) (incorporated by reference to Exhibit 10.1 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on December 31, 2024). | |
| 
| 
| 
| |
| 
10.1.4 | 
| 
Fourth Amendment to the StableX Technologies, Inc. 2020 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on October 6, 2025). | |
| 
| 
| 
| |
| 
10.2 | 
| 
Form of ISO Award Agreement (incorporated by reference to Exhibit 10.9 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on May 29, 2020) | |
| 
| 
| 
| |
| 
10.3 | 
| 
Form of NQSO Award Agreement (incorporated by reference to Exhibit 10.10 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on May 29, 2020) | |
| 
| 
| 
| |
| 
10.4 | 
| 
Form of RSU Award Agreement (incorporated by reference to Exhibit 10.11 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on May 29, 2020) | |
| 
10.5 | 
| 
AYRO Operating, Inc. 2017 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.17 to the Companys Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 14, 2020) | |
| 
| 
| 
| |
| 
10.6 | 
| 
Form of NQSO Award Agreement under the AYRO Operating, Inc. 2017 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.18 to the Companys Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 14, 2020) | |
| 
| 
| 
| |
| 
10.7 | 
| 
Form of Purchase Agreement, dated August 7, 2023, by and among the Company and the purchasers thereto (incorporated by reference to Exhibit 10.1 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on August 8, 2023) | |
| 
| 
| 
| |
| 
10.8 | 
| 
Form of Registration Rights Agreement, dated August 7, 2023, by and among the Company and the purchasers thereto (incorporated by reference to Exhibit 10.2 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on August 8, 2023) | |
| 64 | |
| 
10.9 | 
| 
Form of Omnibus Waiver and Amendment Agreement, dated March 30, 2025, by and between AYRO, Inc. and the investors party thereto (incorporated by reference to Exhibit 10.23 to the Companys Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 31, 2025). | |
| 
| 
| 
| |
| 
10.10 | 
| 
Form of Purchase Agreement (incorporated by reference to Exhibit 10.1 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on August 5, 2025). | |
| 
| 
| 
| |
| 
10.11 | 
| 
Form of Registration Rights Agreement (incorporated by reference to Exhibit 10.2 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on August 5, 2025). | |
| 
| 
| 
| |
| 
10.12 | 
| 
Consulting Services Agreement, dated as of August 4, 2025, by and between the Company, James Altucher and Z-List Media, Inc. (incorporated by reference to Exhibit 10.3 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on August 5, 2025). | |
| 
| 
| 
| |
| 
10.13 | 
| 
Form of Omnibus Waiver, Consent, Notice and Amendment, by and among AYRO, Inc. and the investors party thereto (incorporated by reference to Exhibit 10.4 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on August 5, 2025). | |
| 
| 
| 
| |
| 
10.14 | 
| 
Employment Agreement, by and between Ayro, Inc. and Joshua Silverman, dated as of August 14, 2025 (incorporated by reference to Exhibit 10.5 to the Companys Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 14, 2025). | |
| 
| 
| 
| |
| 
16.1 | 
| 
Letter from CBIZ CPAs P.C. to the Securities and Exchange Commission dated September 22, 2025 (incorporated by reference to Exhibit 16.1 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on September 22, 2025). | |
| 
| 
| 
| |
| 
16.2 | 
| 
Letter from Marcum LLP dated April 10, 2025 (incorporated by reference to Exhibit 16.1 to the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on April 11, 2025). | |
| 
| 
| 
| |
| 
19.1 | 
| 
AYRO, Inc. Insider Trading Policy (incorporated by reference to Exhibit 19.1 to the Companys Annual Report on Form 10-K/A filed with the Securities and Exchange Commission on April 26, 2024). | |
| 
| 
| 
| |
| 
21.1 | 
| 
Subsidiaries of the Company (incorporated by reference to Exhibit 21.1 to the Companys Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 30, 2020) | |
| 
| 
| 
| |
| 
23.1** | 
| 
Consent of Stephano Slack LLC. | |
| 
| 
| 
| |
| 
23.2** | 
| 
Consent of Marcum LLP | |
| 
| 
| 
| |
| 
31.1** | 
| 
Certification of the Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
| 
| 
| 
| |
| 
31.2** | 
| 
Certification of the Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
| 
| 
| 
| |
| 
32.1*** | 
| 
Certification of the Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
| 
| 
| 
| |
| 
32.2*** | 
| 
Certification of the Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
| 
| 
| 
| |
| 
97.1 | 
| 
AYRO, Inc. Compensation Recovery Policy (incorporated by reference to Exhibit 97.1 to the Companys Annual Report on Form 10-K filed with the Securities and Exchange Commission on April 1, 2024) | |
| 
| 
| 
| |
| 
101 INS** | 
| 
Inline XBRL Instance Document | |
| 
101 SCH** | 
| 
Inline XBRL Taxonomy Extension
Schema Document | |
| 
101 CAL** | 
| 
Inline XBRL Taxonomy Calculation
Linkbase Document | |
| 
101 DEF** | 
| 
Inline XBRL Taxonomy Extension
Definition Linkbase Document | |
| 
101 LAB** | 
| 
Inline XBRL Taxonomy Labels
Linkbase Document | |
| 
101 PRE** | 
| 
Inline XBRL Taxonomy Presentation
Linkbase Document | |
| 
104 | 
| 
Cover Page Interactive Data
File - The cover page iXBRL tags are embedded within the inline XBRL document. | |
| 
** | 
Filed herewith. | |
| 
| 
| |
| 
*** | 
Furnished herewith. | |
| 
| 
| |
| 
+ | 
Certain portions of this
exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K. The omitted information is (i) not material and (ii)
would likely cause competitive harm to the Company if publicly disclosed. The Company agrees to furnish supplementally an unredacted
copy of the exhibit to the SEC upon its request. | |
| 
| 
Management or compensatory
plan or arrangement | |
| 65 | |
**SIGNATURES**
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
| 
| 
StableX
Technologies, INC. | |
| 
| 
| 
| |
| 
Dated: March 30, 2026 | 
By: | 
/s/
Joshua Silverman | |
| 
| 
| 
Joshua Silverman | |
| 
| 
| 
Executive Chairman | |
| 
| 
| 
(Principal
Executive Officer) | |
| 
| 
| 
| |
| 
Dated: March 30, 2026 | 
By: | 
/s/
Joseph Ramelli | |
| 
| 
| 
Joseph Ramelli | |
| 
| 
| 
Chief Financial Officer | |
| 
| 
| 
(Principal Financial Officer
and Principal Accounting Officer) | |
Pursuant
to the requirements of the Securities and Exchange Act of 1934, this report has been signed by the following persons in the capacities
and on the dates indicated below.
| 
Name | 
| 
Title | 
| 
Date | |
| 
| 
| 
| 
| 
| |
| 
/s/
Joshua Silverman | 
| 
Executive
Chairman | 
| 
March 30,
2026 | |
| 
Joshua
Silverman | 
| 
(Principal
Executive Officer) | 
| 
| |
| 
| 
| 
| 
| 
| |
| 
/s/
Sebastian Giordano | 
| 
Director | 
| 
March 30,
2026 | |
| 
Sebastian
Giordano | 
| 
| 
| 
| |
| 
| 
| 
| 
| 
| |
| 
/s/
Zvi Joseph | 
| 
Director | 
| 
March 30,
2026 | |
| 
Zvi
Joseph | 
| 
| 
| 
| |
| 
| 
| 
| 
| 
| |
| 
/s/
Greg Schiffman | 
| 
Director | 
| 
March 30,
2026 | |
| 
Greg
Schiffman | 
| 
| 
| 
| |
| 
| 
| 
| 
| 
| |
| 
/s/
Wayne R. Walker | 
| 
Director | 
| 
March 30,
2026 | |
| 
Wayne
R. Walker | 
| 
| 
| 
| |
| 66 | |
**STABLEX
TECHNOLOGIES, INC.**
**CONSOLIDATED
FINANCIAL STATEMENTS AS OF DECEMBER 31, 2025 and 2024**
**Table
of Contents**
| 
| 
Page | |
| 
| 
| |
| 
Report of Independent Registered Public Accounting Firm (PCAOB ID#3523) Stephano Slack LLC covers year ended December 31, 2025 | 
F-2 | |
| 
| 
| |
| 
Report of Independent Registered Public Accounting Firm (PCAOB ID#688) Marcum LLP covers year ended December 31, 2024 | 
F-4 | |
| 
| 
| |
| 
CONSOLIDATED
FINANCIAL STATEMENTS: | 
| |
| 
| 
| |
| 
Consolidated Balance Sheets as of December 31, 2025 and 2024 | 
F-5 | |
| 
| 
| |
| 
Consolidated Statements of Operations For the Years Ended December 31, 2025 and 2024 | 
F-6 | |
| 
| 
| |
| 
Consolidated Statements of Changes in Mezzanine Equity and Stockholders Equity For the Years Ended December 31, 2025 and 2024 | 
F-7 | |
| 
| 
| |
| 
Consolidated Statements of Cash Flows For the Years Ended December 31, 2025 and 2024 | 
F-8 | |
| 
| 
| |
| 
Notes to Consolidated Financial Statements For the Years Ended December 31, 2025 and 2024 | 
F-9 | |
| F-1 | |
**REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**
To the Board of Directors and Stockholders of
StableX Technologies, Inc. and Subsidiary
**Opinion on the Consolidated Financial Statements**
We have audited the accompanying consolidated
balance sheet of StableX, Technologies, Inc. and subsidiary (the Company) as of December 31, 2025 and the related
consolidated statements of operations, changes in mezzanine and stockholders equity, and cash flows for the year ended
December 31, 2025, and the related notes (collectively referred to as the consolidated financial statements). In our opinion, the
consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31,
2025, and the results of its operations and its cash flows for the year then ended, in conformity with accounting principles
generally accepted in the United States of America.
**Substantial Doubt About the Companys Ability
to Continue as a Going Concern**
****
The accompanying consolidated financial statements
have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the consolidated financial statements,
the Company has experienced a net loss and negative cash flows from operations for the year ended December 31, 2025, which raises substantial
doubt about their ability to continue as a going concern. Managements plans in regard to these matters are also described in Note
2. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
**Basis for Opinion**
These consolidated financial statements are the responsibility
of the Companys management. Our responsibility is to express an opinion on the Companys consolidated financial statements
based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB)
and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable
rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards
of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated
financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were
we engaged to perform, an audit of their internal control over financial reporting. As part of our audit, we are required to obtain an
understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of
the Companys internal control over financial reporting. Accordingly, we express no such opinion.
Our audit included performing procedures to assess
the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures
that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the
consolidated financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by
management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audit provides
a reasonable basis for our opinion.
**Critical Audit Matters**
****
The critical audit matters communicated below are
matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated
to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and
(2) involved our especially challenging, subjective, or complex judgments. The communication of the critical audit matters does not alter
in any way our opinion on the consolidated financial statements taken as a whole, and we are not, by communicating the critical audit
matters below, providing a separate opinion on the critical audit matters or on the accounts or disclosures to which they relate.
*Valuation of Series H-7 Preferred Stock and Embedded Derivative*
As
discussed in Note 7 to the consolidated financial statements, on August 7, 2023, the Company sold 22,000 shares of Series H-7 Convertible
Preferred Stock (SeriesH-7 Preferred Stock), with various embedded features. The Preferred Stock was determined to be more
akin to a debt-like host than an equity-like host. The Company concluded that the embedded features were not clearly and closely related
to the debt host instrument and thus were deemed to be bifurcated embedded derivatives (Embedded Derivative). The Embedded
Derivative liabilities are measured at fair value at inception and then are required to be re-measured and reported at fair value at
each reporting period. Managements estimate of the Embedded Derivative liabilities as of December 31, 2025 was $ - .
| F-2 | |
Management
estimates the fair value of the Series H-7 Preferred Stock and Embedded Derivative liabilities using a Monte Carlo simulation model that
incorporates significant assumptions, including the fair value of the Companys common stock, equity volatility, probability of
default, discount rates, and contractual terms such as conversion features and settlement provisions. The valuation also utilizes a with-and-without
method to isolate the value of the embedded derivative. Given the complexity of the valuation model and the significant judgment required
in selecting and evaluating key assumptions, we determined that the valuation of the Series H-7 Preferred Stock and Embedded Derivative
is a critical audit matter.
Addressing
the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated
financial statements. These procedures included the following:
| 
| With
the involvement of our fair value specialists, we evaluated the appropriateness of the Monte
Carlo simulation model and the application of the with-and-without methodology. | |
| 
| We
evaluated the reasonableness of significant assumptions, including equity volatility, probability
of default, discount rates, and other key inputs. | |
| 
| We
tested the completeness and accuracy of the underlying data used in the valuation, including
contractual terms of the instrument. | |
| 
| We
developed an independent estimate of fair value for comparison to managements estimate
and evaluated any significant differences. | |
| 
| For
remeasurement periods, we evaluated managements historical accuracy in estimating
fair value. | |
*Valuation
of Series I Preferred Stock and Embedded Derivative*
As
discussed in Note 7 to the consolidated financial statements, on August 4, 2025, the Company sold 7,000 shares of Series I Convertible
Preferred Stock (Series I Preferred Stock), which includes various embedded features. The Preferred Stock was determined
to be more akin to a debt-like host than an equity-like host. The Company concluded that certain embedded features were not clearly and
closely related to the debt host instrument and therefore were required to be bifurcated as embedded derivatives (the Embedded
Derivative). The Embedded Derivative is measured at fair value at inception and remeasured at fair value at each reporting period.
Management estimated the fair value of the Embedded Derivative liability to be $24,000 at inception and $19,000 at December 31, 2025.
Management
estimates the fair value of the Series I Preferred Stock and Embedded Derivative using a probability-weighted expected return methodology
that considers multiple potential settlement scenarios, including a maturity scenario and a liquidation event scenario. The valuation
incorporates significant assumptions, including probability of liquidation, expected future cash flows, discount rates reflective of
the instruments credit risk, equity volatility, and the value of the holders optional conversion feature, which is estimated
using an option pricing model. Given the judgment involved in selecting the valuation methodology, developing probability-weighted scenarios,
and determining key assumptions, we determined that the valuation of the Series I Preferred Stock and Embedded Derivative is a critical
audit matter.
Addressing
the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated
financial statements. These procedures included the following:
| 
| With
the involvement of our fair value specialists, we evaluated the appropriateness of the valuation
methodology, including the use of a probability-weighted expected return approach and option
pricing techniques. | |
| 
| We
evaluated the reasonableness of significant assumptions, including probability of liquidation,
discount rates, expected cash flows, and volatility. | |
| 
| We
tested the completeness and accuracy of the underlying data used in the valuation, including
contractual terms of the Series I Preferred Stock. | |
| 
| We
developed an independent estimate of fair value for comparison to managements estimate
and evaluated any significant differences. | |
| 
| We
evaluated the mathematical accuracy of the model and its consistency with with the Companys
accounting policies and fair value measurement framework. | |
/s/ Stephano
Slack LLC
We have served as the Companys auditor since 2025.
Wayne, Pennsylvania
March 30, 2026
| F-3 | |
****
**REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM**
To
the Stockholders and Board of Directors of
StableX
Technologies, Inc.
**Opinion
on the Financial Statements**
****
We
have audited the accompanying consolidated balance sheet of StableX Technologies, Inc. (the Company) as of December 31,
2024, the related consolidated statements of operations, changes in mezzanine equity and stockholders equity and cash flows for
the year ended December 31, 2024, and the related notes (collectively referred to as the financial statements). In our
opinion, based on our audit,the financial statements present fairly, in all material respects, the financial position of the Company
as ofDecember 31, 2024, and the results of its operations and its cash flows for the year ended December 31, 2024, in conformity with
accounting principles generally accepted in the United States of America.
**Explanatory
Paragraph Going Concern**
****
The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As more fully described
in Note 2, the Company has incurred significant losses and needs to raise additional funds to meet its obligations and sustain its operations.
These conditions raise substantial doubt about the Companys ability to continue as a going concern. Managements plans in
regard to these matters are also described in Note 2. The financial statements do not include any adjustments that might result from
the outcome of this uncertainty.
**Basis
for Opinion**
These
financial statements are the responsibility of the Companys management. Our responsibility is to express an opinion on the Companys
financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal
securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We
conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit
we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion
on the effectiveness of the Companys internal control over financial reporting. Accordingly, we express no such opinion.
Our
audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or
fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding
the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides
a reasonable basis for our opinion.
/s/
Marcum LLP
Marcum
LLP
We
have served as the Companys auditor from 2020 to 2025.
New
York, NY ****March 31, 2025 (except for the Reverse Stock Split effective as of June 26, 2025 described in Note 1 , as to which the date is March
30, 2026)
| F-4 | |
**STABLEX
TECHNOLOGIES, INC. AND SUBSIDIARIES**
**CONSOLIDATED
BALANCE SHEETS**
| 
| | 
2025 | | | 
2024 | | |
| 
| | 
December 31, | | |
| 
| | 
2025 | | | 
2024 | | |
| 
ASSETS | | 
| | | | 
| | | |
| 
Current assets: | | 
| | | | 
| | | |
| 
Cash and cash equivalents | | 
$ | 4,981,798 | | | 
$ | 16,035,475 | | |
| 
Restricted cash | | 
| 110,264 | | | 
| 164,682 | | |
| 
Marketable securities | | 
| 3,168,362 | | | 
| 4,089,832 | | |
| 
Prepaid expenses and other current assets | | 
| 951,175 | | | 
| 972,245 | | |
| 
Total current assets | | 
| 9,211,599 | | | 
| 21,262,234 | | |
| 
| | 
| | | | 
| | | |
| 
Operating lease right-of-use asset | | 
| 227,171 | | | 
| 429,819 | | |
| 
Digital assets | | 
| 1,948,999 | | | 
| | | |
| 
Deposits and other assets | | 
| 20,883 | | | 
| 46,665 | | |
| 
Total assets | | 
$ | 11,408,652 | | | 
$ | 21,738,718 | | |
| 
| | 
| | | | 
| | | |
| 
LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS EQUITY | | 
| | | | 
| | | |
| 
Current liabilities: | | 
| | | | 
| | | |
| 
Accounts payable | | 
$ | 916,685 | | | 
$ | 1,863,045 | | |
| 
Accrued expenses and other current liabilities | | 
| 476,592 | | | 
| 793,819 | | |
| 
Accrued preferred stock redemption payable (H-7) | | 
| | | | 
| 1,285,680 | | |
| 
Current portion lease obligation operating lease | | 
| 250,517 | | | 
| 219,085 | | |
| 
Total current liabilities | | 
| 1,643,794 | | | 
| 4,161,629 | | |
| 
| | 
| | | | 
| | | |
| 
Derivative liability | | 
| 19,000 | | | 
| 2,661,000 | | |
| 
Warrant liability | | 
| | | | 
| 2,362,900 | | |
| 
Lease obligation - operating lease, net of current portion | | 
| 33,225 | | | 
| 283,742 | | |
| 
Total liabilities | | 
| 1,696,019 | | | 
| 9,469,271 | | |
| 
| | 
| | | | 
| | | |
| 
Mezzanine equity: | | 
| | | | 
| | | |
| 
Redeemable Series H-7 Convertible Preferred Stock, ($0.0001 par value per share and $1,000 face value per share; authorized - 22,000 shares; issued and outstanding 1,180 and 10,167 shares, at December 31, 2025 and December 31, 2024, respectively). Liquidation preference of $0 as of December 31, 2025. | | 
| 1,551,232 | | | 
| 7,587,518 | | |
| 
Redeemable Series I Convertible Preferred Stock, ($0.0001 par value per share and $1,000 face value per share; authorized - 7,000 shares; issued and outstanding 7,000 and 0 shares, at December 31, 2025 and December 31, 2024, respectively). Liquidation preference of $0 as of December 31, 2025. | | 
| 4,451,040 | | | 
| | | |
| 
Redeemable Preferred Stock, value | | 
| 4,451,040 | | | 
| | | |
| 
| | 
| | | | 
| | | |
| 
Stockholders equity: | | 
| | | | 
| | | |
| 
Preferred Stock, (authorized 20,000,000 shares) | | 
| | | | 
| | | |
| 
Series H Convertible Preferred Stock, ($0.0001 par value per share; authorized 8,500 shares; issued and outstanding 8 shares as of December 31, 2025 and December 31, 2024, respectively) Liquidation preference of $0 as of December 31, 2025. | | 
| | | | 
| | | |
| 
Convertible Preferred Stock Series H-3, ($0.0001 par value; authorized 8,461 shares; issued and outstanding 1,234 shares as of December 31, 2025 and December 31, 2024, respectively) Liquidation preference of $20 as of December 31, 2025. | | 
| | | | 
| | | |
| 
Series H-6 Convertible Preferred Stock, ($0.0001 par value per share; authorized 50,000 shares; issued and outstanding 50 shares as of December 31, 2025 and December 31, 2024, respectively) Liquidation preference of $96 as of December 31, 2025. | | 
| | | | 
| | | |
| 
Preferred Stock, value | | 
| | | | 
| | | |
| 
Common Stock, ($0.0001 par value; authorized 1,200,000,000 and 200,000,000 shares as of December 31, 2025, and December 31, 2024, respectively; issued and outstanding 1,455,975 and 533,842 shares as of December 31, 2025, and December 31, 2024, respectively) | | 
| 146 | | | 
| 53 | | |
| 
Additional paid-in capital | | 
| 141,884,878 | | | 
| 121,767,394 | | |
| 
Accumulated deficit | | 
| (138,174,663 | ) | | 
| (117,085,518 | ) | |
| 
Total stockholders equity | | 
| 3,710,361 | | | 
| 4,681,929 | | |
| 
Total liabilities, mezzanine equity and stockholders equity | | 
$ | 11,408,652 | | | 
$ | 21,738,718 | | |
**The accompanying notes
are an integral part of these consolidated financial statements.**
****
| F-5 | |
****
**STABLEX
TECHNOLOGIES, INC. AND SUBSIDIARIES**
**CONSOLIDATED
STATEMENTS OF OPERATIONS**
| 
| | 
2025 | | | 
2024 | | |
| 
| | 
Year Ended December 31, | | |
| 
| | 
2025 | | | 
2024 | | |
| 
Revenue | | 
$ | | | | 
$ | 63,777 | | |
| 
Cost of goods sold | | 
| 956,160 | | | 
| 6,650,979 | | |
| 
Gross loss | | 
| (956,160 | ) | | 
| (6,587,202 | ) | |
| 
| | 
| | | | 
| | | |
| 
Operating expenses: | | 
| | | | 
| | | |
| 
Research and development | | 
| 1,394,905 | | | 
| 1,493,202 | | |
| 
Sales and marketing | | 
| | | | 
| 990,471 | | |
| 
General and administrative | | 
| 8,104,834 | | | 
| 8,646,301 | | |
| 
Loss on impairment of long-lived assets | | 
| | | | 
| 1,659,835 | | |
| 
Total operating expenses | | 
| 9,499,739 | | | 
| 12,789,809 | | |
| 
| | 
| | | | 
| | | |
| 
Loss from operations | | 
| (10,455,899 | ) | | 
| (19,377,011 | ) | |
| 
| | 
| | | | 
| | | |
| 
Other income (expense): | | 
| | | | 
| | | |
| 
Interest income | | 
| 126,620 | | | 
| 484,325 | | |
| 
Change in fair value - warrant liability | | 
| (11,627,100 | ) | | 
| 10,956,900 | | |
| 
Change in fair value - derivative liability | | 
| 2,854,000 | | | 
| 6,739,000 | | |
| 
Unrealized loss on digital assets | | 
| (2,151,001 | ) | | 
| | | |
| 
Unrealized gain (loss) on marketable securities | | 
| (91,936 | ) | | 
| (98,315 | ) | |
| 
Realized gain on marketable securities | | 
| 409,818 | | | 
| 1,322,971 | | |
| 
Legal settlement | | 
| | | | 
| (1,096,222 | ) | |
| 
Vendor settlement | | 
| | | | 
| (647,833 | ) | |
| 
Consent and waiver fee - Series H-7 | | 
| (350,000 | ) | | 
| | | |
| 
Other income (expense), net | | 
| 196,353 | | | 
| (39,294 | ) | |
| 
Total other income (expense), net | | 
| (10,633,246 | ) | | 
| 17,621,532 | | |
| 
| | 
| | | | 
| | | |
| 
Net income (loss) prior to provision for income taxes | | 
$ | (21,089,145 | ) | | 
$ | (1,755,479 | ) | |
| 
| | 
| | | | 
| | | |
| 
Provision for income taxes | | 
| | | | 
| | | |
| 
| | 
| | | | 
| | | |
| 
Net income (loss) | | 
$ | (21,089,145 | ) | | 
$ | (1,755,479 | ) | |
| 
| | 
| | | | 
| | | |
| 
Dividends earned on Series H-7 convertible preferred stock | | 
| (1,997,443 | ) | | 
| (2,425,599 | ) | |
| 
Accretion of discounts to redemption value of Series H-7 convertible preferred stock | | 
| (5,131,858 | ) | | 
| (8,255,150 | ) | |
| 
| | 
| | | | 
| | | |
| 
Net loss attributable to common stockholders | | 
$ | (28,218,446 | ) | | 
$ | (12,436,228 | ) | |
| 
| | 
| | | | 
| | | |
| 
Net loss per share basic | | 
$ | (32.24 | ) | | 
$ | (32.25 | ) | |
| 
Net loss per share diluted | | 
$ | (32.24 | ) | | 
$ | (32.25 | ) | |
| 
| | 
| | | | 
| | | |
| 
Basic weighted average Common Stock outstanding | | 
| 875,190 | | | 
| 385,652 | | |
| 
Diluted weighted average Common Stock outstanding | | 
| 875,190 | | | 
| 385,652 | | |
**The accompanying notes are an integral
part of these consolidated financial statements.**
****
| F-6 | |
****
**STABLEX
TECHNOLOGIES, INC. AND SUBSIDIARIES**
**CONSOLIDATED
STATEMENT OF CHANGES IN MEZZANINE EQUITY AND STOCKHOLDERS EQUITY**
| 
| | 
Shares | | | 
Amount | | | 
Shares | | | 
Amount | | | 
Shares | | | 
Amount | | | 
Shares | | | 
Amount | | | 
Shares | | | 
Amount | | | 
Shares | | | 
Amount | | | 
Capital | | | 
(Deficit) | | | 
Total | | |
| 
| | 
Year
Ended December 31, 2025 | | |
| 
| | 
Series
I | | | 
Series
H-7 | | | 
Series
H | | | 
Series
H-3 | | | 
Series
H-6 | | | 
| | | 
Additional | | | 
| | | 
| | |
| 
| | 
Preferred
Stock | | | 
Preferred
Stock | | | 
Preferred
Stock | | | 
Preferred
Stock | | | 
Preferred
Stock | | | 
Common
Stock | | | 
Paid-in | | | 
Accumulated | | | 
| | |
| 
| | 
Shares | | | 
Amount | | | 
Shares | | | 
Amount | | | 
Shares | | | 
Amount | | | 
Shares | | | 
Amount | | | 
Shares | | | 
Amount | | | 
Shares | | | 
Amount | | | 
Capital | | | 
(Deficit) | | | 
Total | | |
| 
Balance,
January 1, 2025 | | 
| | | | 
$ | | | | 
| 10,167 | | | 
$ | 7,587,518 | | | 
| 8 | | | 
$ | | | | 
| 1,234 | | | 
$ | | | | 
| 50 | | | 
$ | | | | 
| 533,842 | | | 
$ | 53 | | | 
$ | 121,767,394 | | | 
$ | (117,085,518 | ) | | 
$ | 4,681,929 | | |
| 
Stock-based
compensation | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| 1,235,417 | | | 
| | | | 
| 1,235,417 | | |
| 
Preferred
stock redemptions and conversions including cash premium | | 
| | | | 
| | | | 
| (13,364 | ) | | 
| (15,739,302 | ) | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| 743,809 | | | 
| 75 | | | 
| 4,794,753 | | | 
| | | | 
| 4,794,828 | | |
| 
Issuance
of convertible preferred stock, net of discounts and transaction costs | | 
| 7,000 | | | 
| 2,427,112 | | | 
| 4,377 | | | 
| 5,269,500 | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| (87,016 | ) | | 
| | | | 
| (87,016 | ) | |
| 
Common
stock issued for exercise of Series H-7 Preferred Warrants | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| 178,200 | | | 
| 18 | | | 
| 1,015,338 | | | 
| | | | 
| 1,015,356 | | |
| 
Deemed
dividend | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| (635,602 | ) | | 
| | | | 
| (635,602 | ) | |
| 
Preferred
stock dividends | | 
| | | | 
| 140,972 | | | 
| | | | 
| 1,184,615 | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| (1,361,841 | ) | | 
| | | | 
| (1,361,841 | ) | |
| 
Accretion
of discounts to redemption value of convertible preferred stock | | 
| | | | 
| 1,882,956 | | | 
| | | | 
| 3,248,901 | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| (5,131,858 | ) | | 
| | | | 
| (5,131,858 | ) | |
| 
Reclassification
of warrants liability to equity | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| 18,608,000 | | | 
| | | | 
| 18,608,000 | | |
| 
Issuance
of consultant warrants | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| 1,680,293 | | | 
| | | | 
| 1,680,293 | | |
| 
Issuance
of round up shares | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| 124 | | | 
| | | | 
| | | | 
| | | | 
| | | |
| 
Net
loss | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| (21,089,145 | ) | | 
| (21,089,145 | ) | |
| 
Balance,
December 31, 2025 | | 
| 7,000 | | | 
$ | 4,451,040 | | | 
| 1,180 | | | 
$ | 1,551,232 | | | 
| 8 | | | 
$ | | | | 
| 1,234 | | | 
$ | | | | 
| 50 | | | 
$ | | | | 
| 1,455,975 | | | 
$ | 146 | | | 
$ | 141,884,878 | | | 
$ | (138,174,663 | ) | | 
$ | 3,710,361 | | |
| 
| | 
Year Ended December 31, 2024 | | |
| 
| | 
Series I | | | 
Series H-7 | | | 
Series H | | | 
Series H-3 | | | 
Series H-6 | | | 
| | | 
Additional | | | 
| | | 
| | |
| 
| | 
Preferred Stock | | | 
Preferred Stock | | | 
Preferred Stock | | | 
Preferred Stock | | | 
Preferred Stock | | | 
Common Stock | | | 
Paid-in | | | 
Accumulated | | | 
| | |
| 
| | 
Shares | | | 
Amount | | | 
Shares | | | 
Amount | | | 
Shares | | | 
Amount | | | 
Shares | | | 
Amount | | | 
Shares | | | 
Amount | | | 
Shares | | | 
Amount | | | 
Capital | | | 
(Deficit) | | | 
Total | | |
| 
Balance, January 1, 2024 | | 
| | | | 
$ | | | | 
| 22,000 | | | 
$ | 11,193,939 | | | 
| 8 | | | 
$ | | | | 
| 1,234 | | | 
$ | | | | 
| 50 | | | 
$ | | | | 
| 307,119 | | | 
$ | 31 | | | 
$ | 129,467,735 | | | 
$ | (115,330,039 | ) | | 
$ | 14,137,727 | | |
| 
Balance | | 
| | | | 
$ | | | | 
| 22,000 | | | 
$ | 11,193,939 | | | 
| 8 | | | 
$ | | | | 
| 1,234 | | | 
$ | | | | 
| 50 | | | 
$ | | | | 
| 307,119 | | | 
$ | 31 | | | 
$ | 129,467,735 | | | 
$ | (115,330,039 | ) | | 
$ | 14,137,727 | | |
| 
Stock based compensation | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| 8,160 | | | 
| | | | 
| 8,160 | | |
| 
Vested restricted stock | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| 57,160 | | | 
| 6 | | | 
| 705,583 | | | 
| | | | 
| 705,589 | | |
| 
Repurchase of cash-settled restricted stock | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| (23,459 | ) | | 
| (3 | ) | | 
| (285,247 | ) | | 
| | | | 
| (285,250 | ) | |
| 
Share buy-back | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| (26,155 | ) | | 
| (3 | ) | | 
| (376,627 | ) | | 
| | | | 
| (376,630 | ) | |
| 
Shares issued for services | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| 4,688 | | | 
| | | | 
| 126,000 | | | 
| | | | 
| 126,000 | | |
| 
Preferred stock redemptions and conversion including cash premium | | 
| | | | 
| | | | 
| (11,833 | ) | | 
| (13,740,284 | ) | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| 214,489 | | | 
| 22 | | | 
| 2,802,539 | | | 
| | | | 
| 2,802,561 | | |
| 
Deemed dividend | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| (546,886 | ) | | 
| | | | 
| (546,886 | ) | |
| 
Preferred stock dividends | | 
| | | | 
| | | | 
| | | | 
| 1,878,713 | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| (1,878,713 | ) | | 
| | | | 
| (1,878,713 | ) | |
| 
Accretion of discounts to redemption value of Series H-7 convertible preferred stock | | 
| | | | 
| | | | 
| | | | 
| 8,255,150 | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| (8,255,150 | ) | | 
| | | | 
| (8,255,150 | ) | |
| 
Net loss | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| (1,755,479 | ) | | 
| (1,755,479 | ) | |
| 
Balance, December 31, 2024 | | 
| | | | 
$ | | | | 
| 10,167 | | | 
$ | 7,587,518 | | | 
| 8 | | | 
$ | | | | 
| 1,234 | | | 
$ | | | | 
| 50 | | | 
$ | | | | 
| 533,842 | | | 
$ | 53 | | | 
$ | 121,767,394 | | | 
$ | (117,085,518 | ) | | 
$ | 4,681,929 | | |
| 
Balance | | 
| | | | 
$ | | | | 
| 10,167 | | | 
$ | 7,587,518 | | | 
| 8 | | | 
$ | | | | 
| 1,234 | | | 
$ | | | | 
| 50 | | | 
$ | | | | 
| 533,842 | | | 
$ | 53 | | | 
$ | 121,767,394 | | | 
$ | (117,085,518 | ) | | 
$ | 4,681,929 | | |
**The
accompanying notes are an integral part of these consolidated financial statements.**
****
| F-7 | |
****
**STABLEX
TECHNOLOGIES, INC. AND SUBSIDIARIES**
**CONSOLIDATED
STATEMENTS OF CASH FLOWS**
| 
| | 
2025 | | | 
2024 | | |
| 
| | 
Years
Ended December 31, | | |
| 
| | 
2025 | | | 
2024 | | |
| 
CASH FLOWS
FROM OPERATING ACTIVITIES: | | 
| | | | 
| | | |
| 
Net loss | | 
$ | (21,089,145 | ) | | 
$ | (1,755,479 | ) | |
| 
Adjustments
to reconcile net loss to net cash used in operating activities: | | 
| | | | 
| | | |
| 
Depreciation
and amortization | | 
| 25,282 | | | 
| 1,709,985 | | |
| 
Loss on
disposal of fixed asset | | 
| | | | 
| 359,965 | | |
| 
Loss on
impairment of long-lived assets | | 
| | | | 
| 1,659,835 | | |
| 
Stock-based
compensation | | 
| 1,896,596 | | | 
| 713,749 | | |
| 
Shares
issued for services | | 
| | | | 
| 126,000 | | |
| 
Series
H-7 preferred stock waiver | | 
| 350,000 | | | 
| | | |
| 
Series
I financing costs | | 
| 754,815 | | | 
| | | |
| 
Change
in fair value - derivative liability | | 
| (2,854,000 | ) | | 
| (6,739,000 | ) | |
| 
Change
in fair value - warrant liability | | 
| 11,627,100 | | | 
| (10,956,900 | ) | |
| 
Amortization
of right-of-use asset | | 
| 202,648 | | | 
| 197,457 | | |
| 
Bad debt
expense | | 
| | | | 
| 189,092 | | |
| 
Unrealized
loss on digital assets | | 
| 2,151,001 | | | 
| | | |
| 
Unrealized
gain on marketable securities | | 
| 91,936 | | | 
| 98,315 | | |
| 
Realized
gain on marketable securities | | 
| (409,818 | ) | | 
| (1,322,971 | ) | |
| 
Impairment of inventory | | 
| | | | 
| 4,909,190 | | |
| 
Impairment
of prepaid inventory | | 
| | | | 
| 731,129 | | |
| 
Vendor
settlements | | 
| | | | 
| 547,847 | | |
| 
Change
in operating assets and liabilities: | | 
| | | | 
| | | |
| 
Accounts
receivable | | 
| | | | 
| 29,908 | | |
| 
Inventory | | 
| | | | 
| (1,794,806 | ) | |
| 
Prepaid
expenses and other current assets | | 
| 1,040,184 | | | 
| (76,484 | ) | |
| 
Deposits
and other assets | | 
| 500 | | | 
| 22,491 | | |
| 
Accounts
payable | | 
| (946,359 | ) | | 
| (618,362 | ) | |
| 
Accrued
expenses and other current liabilities | | 
| (317,227 | ) | | 
| (1,149,677 | ) | |
| 
Lease
obligations - operating leases | | 
| (219,085 | ) | | 
| (196,686 | ) | |
| 
Net
cash used in operating activities | | 
| (7,695,572 | ) | | 
| (13,315,402 | ) | |
| 
| | 
| | | | 
| | | |
| 
CASH FLOWS
FROM INVESTING ACTIVITIES: | | 
| | | | 
| | | |
| 
Purchase
of property and equipment | | 
| | | | 
| (199,323 | ) | |
| 
Proceeds
from sale of marketable securities, net | | 
| 32,739,898 | | | 
| 66,132,029 | | |
| 
Purchase
of digital assets | | 
| (4,100,000 | ) | | 
| | | |
| 
Purchase
of marketable securities | | 
| (31,500,546 | ) | | 
| (68,997,205 | ) | |
| 
Net
cash used in investing activities | | 
| (2,860,648 | ) | | 
| (3,064,499 | ) | |
| 
| | 
| | | | 
| | | |
| 
CASH FLOWS
FROM FINANCING ACTIVITIES: | | 
| | | | 
| | | |
| 
Proceeds
from sale of preferred stock (I), net of transaction costs | | 
| 6,314,297 | | | 
| | | |
| 
Proceeds
from exercise of Series H-7 Preferred warrants | | 
| 1,015,356 | | | 
| | | |
| 
Payment
of preferred stock redemption (Series H-7) | | 
| (7,881,528 | ) | | 
| (10,198,929 | ) | |
| 
Payment of shares buyback | | 
| | | | 
| (376,630 | ) | |
| 
Repurchase
of cash-settled restricted stock | | 
| | | | 
| (285,250 | ) | |
| 
Net
cash used in financing activities | | 
| (551,875 | ) | | 
| (10,860,809 | ) | |
| 
| | 
| | | | 
| | | |
| 
Net change in cash, cash equivalents
and restricted cash | | 
| (11,108,095 | ) | | 
| (27,240,710 | ) | |
| 
Cash,
cash equivalents and restricted cash, beginning of period | | 
| 16,200,157 | | | 
| 43,440,867 | | |
| 
Cash,
cash equivalents and restricted cash, end of period | | 
$ | 5,092,062 | | | 
$ | 16,200,157 | | |
| 
| | 
| | | | 
| | | |
| 
Supplemental
disclosure of cash and non-cash transactions: | | 
| | | | 
| | | |
| 
Fixed asset additions included
in accounts payable and accrued expenses | | 
$ | | | | 
$ | 57,791 | | |
| 
Accrual of Series H-7 convertible
preferred stock dividends | | 
$ | 1,759,618 | | | 
$ | 1,878,713 | | |
| 
Deemed dividend Series H-7
warrants | | 
$ | 662,551 | | | 
$ | 564,886 | | |
| 
Accretion of discounts to
redemption value of H-7 convertible preferred stock | | 
$ | 8,706,401 | | | 
$ | 8,255,150 | | |
| 
Accretion of discounts to
redemption value of I convertible preferred stock | | 
$ | 1,882,957 | | | 
$ | | | |
| 
Accrued Series H-7 preferred
stock redemption payable | | 
$ | 11,071,253 | | | 
$ | 1,285,680 | | |
| 
Accrual of Series I Convertible
Preferred Stock Dividends | | 
$ | 140,972 | | | 
$ | | | |
| 
Non-cash redemption of Series
H-7 preferred stock | | 
$ | 4,794,828 | | | 
$ | 2,802,561 | | |
| 
Reclassification of warrant
liability to equity (H-7) | | 
$ | 13,891,000 | | | 
$ | | | |
| 
Reclassification of warrant
liability to equity (I) | | 
$ | 4,080,034 | | | 
$ | | | |
| 
Accrued waiver fee related
to Series H-7 preferred stock | | 
$ | 350,000 | | | 
$ | | | |
| 
Prepaid insurance financed
through accrued expenses | | 
$ | 110,208 | | | 
$ | 286,955 | | |
| 
| | 
| | | | 
| | | |
| 
Supplemental
disclosure of restricted cash: | | 
| | | | 
| | | |
| 
Cash and cash equivalents | | 
$ | 4,981,798 | | | 
$ | 16,035,475 | | |
| 
Restricted
cash | | 
| 110,264 | | | 
| 164,682 | | |
| 
Total
cash, cash equivalents and restricted cash | | 
$ | 5,092,062 | | | 
$ | 16,200,157 | | |
**The
accompanying notes are an integral part of these consolidated financial statements.**
| F-8 | |
**STABLEX
TECHNOLOGIES, INC. AND SUBSIDIARIES**
**NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS**
**NOTE
1. ORGANIZATION AND NATURE OF OPERATIONS**
**Organization**
StableX
Technologies, Inc. (StableX or the Company) is a Delaware corporation headquartered in New York, New York.
The Company operates through its wholly-owned subsidiary, AYRO Operating Company, Inc. (AYRO Operating).
On
August 21, 2025, the Company amended its Amended and Restated Certificate of Incorporation to change its name from AYRO, Inc.
to StableX Technologies, Inc. effective August 22, 2025. The Companys common stock ticker symbol changed from AYRO
to SBLX and began trading under the new symbol on The Nasdaq Capital Market on August 25, 2025.
**Nature
of Operations**
During
2025, the Company initiated a strategic transition toward a business model focused on digital asset initiatives related to the stablecoin
ecosystem. As part of this strategy, the Company intends to acquire and hold certain digital assets associated with protocols, networks
and platforms that support stablecoin infrastructure and related technologies. These assets are intended to be held primarily for treasury
purposes and to potentially benefit from growth in the stablecoin sector.
In
connection with this strategic shift, the Company has begun acquiring certain digital asset tokens associated with its investment strategy.
These assets are intended to be held on a passive basis, and the Company currently does not intend to stake such assets. The Companys
ability to expand its digital asset holdings will depend on available capital, market conditions and regulatory considerations.
The
Company has paused active development and commercialization activities related to its electric vehicle business while it evaluates strategic
alternatives for that business line. The electric vehicle operations have not been discontinued, and the Company continues to evaluate
potential opportunities related to those assets.
The
Companys digital asset strategy is in the early stages of implementation. The extent to which the Company expands its digital
asset holdings and related activities will depend on factors including available capital, market conditions, regulatory developments
and the performance of the underlying digital asset ecosystem.
**Reverse
Stock Split**
On
June 25, 2025, the Company effected a 1-for-16 reverse stock split of its common stock, which began trading on a split-adjusted basis
on June 26, 2025. Every 16 shares of issued and outstanding common stock were reclassified as one share of common stock. The reverse
stock split had no impact on the par value of the Companys common stock ($0.0001 per share) or the authorized number of shares
of common stock. Fractional shares resulting from the reverse stock split were rounded up to the next whole number of shares, resulting
in the issuance of 124 additional shares in June 2025. All share and per share information in these consolidated financial statements
have been retroactively adjusted to reflect the reverse stock split for all periods presented.
| F-9 | |
**NOTE
2. SUBSTANTIAL DOUBT ABOUT THE COMPANYS ABILITY TO CONTINUE AS A GOING
CONCERN**
The
consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States
(GAAP), which contemplates continuation of the Company as a going concern. The Company is subject to a number of risks
similar to those of earlier stage commercial companies, including dependence on key individuals and products, the difficulties inherent
in the development of a commercial market, the potential need to obtain additional capital, competition from larger companies, other
technology companies, and other technologies. The Company has a limited operating history and the sales and income potential of its business
and market are unproven.
As
of December 31, 2025, the Company had cash and cash equivalents balance totaling $4,981,798,
restricted cash of $110,264,
and marketable securities of $3,168,362.
The Company incurred net loss of $21,089,145 
and had negative cash flow used in operations of $7,695,572
for the year ended December 31, 2025. In addition, overall
working capital decreased by $9,532,800 during
the year ended December 31, 2025. Management believes that the existing cash as of December 31, 2025, will not be sufficient to fund operations
for at least the next twelve months following the issuance of these consolidated financial statements. These factors raise substantial
doubt about the Companys ability to continue as a going concern for a period of one year from the issuance of these consolidated
financial statements. In order to have sufficient cash to fund the Companys operations in the future, the Company will need to
raise additional equity or debt capital and cannot provide any assurance that the Company will be successful in doing so. If the Company
is unable to raise sufficient capital to fund the Companys operations, the Company may need to delay, reduce or eliminate certain
research and development programs or other operations, sell some or all of its assets or merge with another entity. As a result of these
factors, management has concluded that there is substantial doubt about the Companys ability to continue as a going concern for
a period of one year after the date of the financial statements. The Companys consolidated financial statements do not include
any adjustments that might result from the outcome of this uncertainty.
**NOTE
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**
**Basis
of Presentation and Principles of Consolidation**
The accompanying consolidated financial statements have been prepared in
accordance with accounting principles generally accepted in the United States of America (GAAP) and in conformity with the
instructions on Form 10-K and Article 8 of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission
(the SEC). The consolidated financial statements include the amounts of the Company and its wholly-owned subsidiary. All
significant intercompany accounts and transactions have been eliminated in consolidation. The consolidated financial statements reflect
all adjustments that, in the opinion of management, are necessary for the fair presentation of the consolidated financial statements in
accordance with GAAP.
**Use
of Estimates**
The
preparation of these consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities, as well as the disclosure of contingent assets and liabilities, at the date
of and during the reported period of the consolidated financial statements. Actual results could differ from those estimates. The Company
evaluates estimates and assumptions on an ongoing basis.
**Cash
and Cash Equivalents**
Cash
and cash equivalents consist of cash on hand and highly liquid investments with original maturities of three months or less. The Company
maintains deposits in several financial institutions, which may at times exceed amounts covered by insurance provided by the U.S. Federal
Deposit Insurance Corporation (FDIC). The Company has not experienced any losses related to amounts in excess of FDIC limits.
As of December 31, 2025, the Company had cash in excess of FDIC limits of $4,381,515.
| F-10 | |
**Restricted
Cash**
As
of December 31, 2025, the Company held a restricted cash balance of $110,264
related to certain restrictive provisions within the certificate of designation for the Series H-7 Preferred Shares.
As of December 31, 2024, the Company held a restricted cash balance of $164,682.
The Company made a deposit to the bank for their credit cards in the amount of $53,862
and is classified as restricted cash as of December 31, 2024.
The remaining $110,980 is held in accordance with the certificate of designation
for the Series H-7 Preferred Shares.
**Marketable
Securities**
Marketable
securities include investments in fixed income bonds and U.S. Treasury securities with original maturities greater than three months
that are considered to be highly liquid and easily tradeable. The marketable securities are considered trading securities and are
measured at fair value with unrealized gains and losses recognized in earnings within other income (expense), net in accordance with the Financial Accounting Standards Boards Accounting Standards Codification (ASC) 320,
*Investments-Debt and Equity Securities*.
Interest income is recognized when earned and is included
in interest income in the accompanying statements of operations. Realized gains and losses from the sale of marketable securities are
determined using the specific identification method and are recorded in other income (expense), net.
The classification of marketable securities within
the fair value hierarchy is disclosed in Note 10. Fair Value Measurements.
The
Company held $3,168,362
and $4,089,832
in marketable securities as of December 31, 2025 and 2024, respectively.
**Derivative
Financial Instruments**
The
Company evaluates embedded features in financial instruments, including convertible debt instruments and other hybrid contracts, in
accordance with ASC 815, *Derivatives and Hedging Activities*. Certain conversion options and redemption features
are required to be bifurcated from their host instrument and accounted for as free-standing derivative financial instruments should
certain criteria be met.
The Company applies significant judgment to identify and evaluate the terms
and conditions of all of its financial instruments to determine whether such instruments are derivatives or contain derivatives that require
bifurcation. Embedded derivatives are separately measured at fair value if the requirements for bifurcation are met.
Derivative financial instruments, including bifurcated
embedded derivatives, are recorded as assets or liabilities on the balance sheet at fair value, with changes in fair value recognized
in the statements of operations within other income (expense), net.
The fair value and classification of derivative instruments
are disclosed in Note 10. Fair Value Measurements.
**Fair
Value Measurements**
The
Company measures fair value in accordance with ASC 820, *Fair Value Measurement*, as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between
market participants at the measurement date. ASC 820
establishes a three-level hierarchy that prioritizes the inputs used in measuring fair value:
Level
1: Quoted prices in active markets for identical assets or liabilities.
Level
2: Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities in active markets, quoted prices
for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable by or corroborated
by observable market data.
Level
3: Significant unobservable inputs that are not corroborated by market data.
The categorization of a financial instrument within
the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement.
Additional information regarding the Companys fair value measurements,
including the fair value measurements, including the fair value hierarchy and quantitative disclosures, is included in Note 10. Fair Value
Measurements.
The
carrying amounts of cash and cash equivalents, accounts receivable, inventories, prepaid expenses, accounts payable, accrued expenses,
and customer deposits approximate their fair value due to their short-term nature. 
The
carrying amounts of the Companys debt approximates fair value as the stated interest rates are consistent with current market rates
for similar instruments.
The
Company measures certain non-financial assets, including long-lived assets, at fair value on a non-recurring basis when events or changes
in circumstances indicate that impairment may exist.
| F-11 | |
**Warrants
and Preferred Shares**
The
accounting treatment of warrants and preferred share series issued is determined pursuant to the guidance provided by ASC 480, *Distinguishing
Liabilities from Equity*, and ASC 815, *Derivatives and Hedging*, as applicable. Each feature of a freestanding
financial instrument including, without limitation, any rights relating to subsequent dilutive issuances, dividend issuances, equity
sales, rights offerings, forced conversions, optional redemptions, automatic monthly conversions, dividends, and exercise is assessed
with determinations made regarding the proper classification in the Companys audited consolidated financial statements.
**Redeemable
Preferred Stock**
Applicable
accounting guidance requires an equity instrument that is redeemable for cash or other assets to be classified outside of permanent equity
if it is redeemable (a) at a fixed or determinable price on a fixed or determinable date, (b) at the option of the holder, or (c) upon
the occurrence of an event that is not solely within the control of the issuer.
**Leases**
The
Company accounts for leases in accordance with ASC Topic 842, *Leases*. The Company determines whether a contract
is a lease at contract inception or for a modified contract at the modification date. Contracts containing a lease are further evaluated
for classification as a ROU operating lease or a finance lease.
At
inception or modification, the Company recognizes ROU assets and related lease liabilities on the balance sheet for all leases greater
than one year in duration. Lease liabilities and their corresponding ROU assets are initially measured at the present value of the unpaid
lease payments as of the lease commencement date. If the lease contains a renewal and/or termination option, the exercise of the option
is included in the term of the lease if the Company is reasonably certain that a renewal or termination option will be exercised. As
the Companys leases do not provide an implicit rate, the Company uses an estimated incremental borrowing rate (IBR)
based on the information available at the commencement date of the respective lease to determine the present value of future payments.
The IBR is determined by estimating what it would cost the Company to borrow a collateralized amount equal to the total lease payments
over the lease term based on the contractual terms of the lease and the location of the leased asset.
Operating
lease payments are recognized as an expense on a straight-line basis over the lease term in equal amounts of rent expense attributed
to each period during the term of the lease, regardless of when actual payments are made. This generally results in rent expense in excess
of cash payments during the early years of a lease and rent expense less than cash payments in later years. The difference between rent
expense recognized and actual rental payments is typically represented as the spread between the ROU asset and lease liability.
When
calculating the present value of minimum lease payments, the Company accounts for leases as one single lease component if a lease has
both lease and non-lease components. Variable lease and non-lease components are expensed as incurred. The Company does not recognize
ROU assets and lease liabilities for short-term leases that have an initial lease term of 12 months or less.
**Segment
Reporting**
The
Company currently operates as one
operating segment, which is also its single reportable segment.
The Companys chief operating decision maker (CODM), the Executive Chairman and Principal Executive Officer, reviews
consolidated net income (loss) and total assets to assess performance and allocate resources. Accordingly, the Companys measure
of segment profit or loss is consolidated net income (loss) and segment assets are consolidated net assets. During the third quarter
of 2025, the Company adopted a digital asset treasury management strategy; these activities are managed centrally and are included in
the single operating segment, as discrete operating results are not regularly reviewed separately by the CODM.
| F-12 | |
**Digital
Assets**
The Company accounts for its digital assets, which currently are comprised
of various cryptocurrencies in accordance with ASC Topic 350-60, *Intangibles Goodwill and Other Crypto Assets*.
The Company has ownership of and control over its digital assets and may use third-party custodial services to secure them. The Companys
digital assets are initially recorded at cost and are subsequently remeasured on the balance sheet at fair value.
The
Company determines the fair value of its digital assets on a recurring basis in accordance with ASC 820 based on quoted prices on the
active exchange that the Company has determined is its principal market for such digital assets (Level 1 inputs). The Company determines
the cost basis of digital assets using the specific identification of each unit received. Realized and unrealized gains and losses from
changes in the fair value of digital assets are recognized in the consolidated statements of operations. The cost basis of the digital assets sold or otherwise disposed of is determined using the first-in, first-out (FIFO)
method, whereby the cost of the earliest acquired digital asset is used to calculate realized gains and losses upon disposal.
**Revenue
Recognition**
The
Company recognizes revenue in accordance with ASC 606, *Revenue from Contracts with Customers*, the core principle of which is that
an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration
which the entity expects to be entitled to receive in exchange for those goods or services. To achieve this core principle, five basic
criteria must be met before revenue can be recognized: (1) identify the contract with a customer; (2) identify the performance obligations
in the contract; (3) determine the transaction price; (4) allocate the transaction price to performance obligations in the contract;
and (5) recognize revenue when or as the Company satisfies a performance obligation.
Nature
of goods and services
The
following is a description of the Companys products and services from which the Company generates revenue, as well as the nature,
timing of satisfaction of performance obligations, and significant payment terms for each:
Product
revenue
Product
revenue from customer contracts is recognized on the sale of each electric vehicle as vehicles are shipped to customers. The majority
of the Companys vehicle sales orders generally have only one performance obligation: the sale and delivery of complete vehicles.
Ownership and risk of loss transfers to the customer based on FOB shipping point and freight charges are the responsibility of the customer.
Revenue is typically recognized at the point control transfers or in accordance with payment terms customary to the business. The Company
provides product warranties to assure that the product assembly complies with agreed upon specifications. The Companys product
warranty is similar in all material respects to the product warranties provided by the Companys suppliers, therefore minimizing
the warranty liability to the standard labor rates associated with the defective part replacement. Customers do not have the option to
purchase a warranty separately; as such, a warranty is not accounted for as a separate performance obligation. The Companys policy
is to exclude taxes collected from a customer from the transaction price of automotive contracts.
Shipping
revenue
Amounts
billed to customers related to shipping and handling are classified as shipping revenue. The Company has elected to recognize the cost
for freight and shipping when control over vehicles has been transferred to the customer as an operating expense. The Company has reported
shipping expenses of $0 and expense of $21,699 for the years ended December 31, 2025 and 2024, respectively, included in General and
Administrative Expenses.
| F-13 | |
Services
and other revenue
Services
and other revenue consist of non-warranty after-sales vehicle services. Revenue is typically recognized at a point in time when services
and replacement parts are provided.
Miscellaneous
income
Miscellaneous
income consists of late fees charged for receivables not paid within the terms of the customer agreement based upon the outstanding customer
receivable balance. This revenue is earned when a customers receivable balance becomes delinquent, and its collection is reasonably
assured and is calculated using a stated late fee rate multiplied by the outstanding balance that is subject to a late fee charge.
**Research
and development costs**
In
accordance with ASC Topic 730, *Research and Development*, the Company expenses research and development costs as
incurred. Such costs include labor, stock-based compensation, training, software subscriptions, and consulting. These amounts are charged
to the consolidated statement of operations as incurred. Total research and development expenses included were $1,394,905 and $1,493,202
for the years ended December 31, 2025 and 2024, respectively.
**Stock-Based
Compensation**
Stock-based
awards granted to qualified employees, non-employee directors and consultants are measured at fair value and recognized as an expense
in accordance with ASC Topic 718, *Share-Based Payments*. For service-based awards, stock-based compensation is recognized
on a straight-line basis over the requisite service period, which is generally the vesting period. The fair value of stock options is
estimated using a Black-Scholes option valuation model. Restricted stock awards are valued based on the closing stock price on the date
of grant. The Company has elected to recognize forfeitures as they occur.
**Impairment
of Long-Lived Assets**
The
Company reviews the carrying value of long-lived assets, such as property and equipment, capitalized software, and right-of-use (ROU)
assets for impairment in accordance with ASC Topic 360, *Property, Plant, and Equipment*, whenever events or changes
in circumstances indicate the carrying amount of the assets might not be recoverable. These events and circumstances may include significant
decreases in the market price of an asset or asset group, significant changes in the extent or manner in which an asset or asset group
is being used by the Company or in its physical condition, a significant change in legal factors or in the business climate, a history
or forecast of future operating or cash flow losses, significant disposal activity, a significant decline in the Companys share
price, a significant decline in revenue or adverse changes in the economic environment.
If
such facts indicate a potential impairment, the Company assesses the recoverability of an asset group by determining if the carrying
value of the asset group exceeds the sum of the projected undiscounted cash flows expected to result from the use and eventual
disposition of the assets over the remaining economic life of the primary asset in the asset group. If the recoverability test
indicates that the carrying value of the asset group is not recoverable, the Company will estimate the fair value of the asset group
using appropriate valuation methodologies, which would typically include an estimate of discounted cash flows. Any impairment would
be measured as the difference between the asset groups carrying amount and its estimated fair value. During the years ended
December 31, 2025, there were no impairments of long-lived assets. During the year ended December 31, 2024, the Company recognized an impairment charge of $1,615,660 related to idle
fixed assets that were intended to be used in the production of the Vanish.
****
| F-14 | |
****
**Loss
Per Share**
Basic
loss per share is calculated by dividing net loss by the weighted average number of shares of common stock outstanding during each period.
Diluted loss per share is calculated by adjusting the weighted average number of shares of common stock outstanding for the dilutive
effect, if any, of common stock equivalents. Common stock equivalents whose effect would be antidilutive are not included in diluted
loss per share. The Company uses the treasury stock method to determine the dilutive effect, which assumes that all common stock equivalents
have been exercised at the beginning of the period and that the funds obtained from those exercises were used to repurchase shares of
common stock of the Company at the average closing market price during the period.
As
of December 31, 2025 and 2024, securities that could potentially dilute basic earnings per share in the future that were excluded
from the computation of diluted loss per share amounted to approximately 5,779,813
shares and 1,092,717
shares, consisting of stock options, warrants to purchase common stock, and convertible preferred stock. See Note 7.
Stockholders Equity and Note 8. Stock-Based Compensation for the terms and conditions of the Companys outstanding
convertible preferred stock, warrants and stock options, respectively
**Income
Taxes**
Deferred
tax assets and liabilities are recognized for future tax consequences attributable to differences between the consolidated financial
statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets, including tax loss
and credit carry forwards, and liabilities measured using enacted tax rates expected to apply to taxable income in the years in which
those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in
tax rates is recognized in income in the period that includes the enactment date.
The
Company utilizes ASC 740, *Income Taxes*, which requires the recognition of deferred tax assets and liabilities for
the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. The Company
accounts for income taxes using the asset and liability method to compute the differences between the tax basis of assets and liabilities
and the related financial amounts, using currently enacted tax rates. A valuation allowance is recorded when it is more likely
than not that a deferred tax asset will not be realized. At December 31, 2025 and 2024, the Companys net deferred tax asset
has been fully reserved.
For
uncertain tax positions that meet a more likely than not threshold, the Company recognizes the benefit of uncertain tax
positions in the consolidated financial statements. The Companys practice is to recognize interest and penalties, if any, related
to uncertain tax positions in income tax expense in the consolidated statements of operations when a determination is made that such
expense is likely.
**Recently
Adopted Accounting Pronouncements**
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires
public entities to disclose significant segment expenses and other segment items on an interim and annual basis, and provide in interim
periods all disclosures about a reportable segments profit or loss and assets that are currently required annually. The ASU does
not change how a public entity identifies its operating segments, aggregates them, or applies the quantitative threshold to determine
its reportable segments. The new disclosure requirements are also applicable to entities that account and report as a single operating
segment entity. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years
beginning after December 15, 2024. The Company adopted the guidance for the annual reporting period ended December 31, 2024. There was
no impact on the Companys reportable segments identified and additional required disclosures have been included in Note 12, Segment
Reporting in the Notes to Consolidated Financial Statements.
In
December 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2023-08,
*IntangiblesGoodwill and OtherCrypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets*,
which requires certain crypto assets to be measured at fair value in the statement of operations, with gains and losses from changes
in the fair value of such crypto assets recognized in net income each reporting period. ASU 2023-08 also requires certain interim and
annual disclosures for crypto assets within the scope of the standard. ASU 2023-08 is effective for annual periods beginning after December
15, 2024, including interim periods within those fiscal years. The Company adopted ASU 2023-08 on January 1, 2025. The Company did not
have any crypto assets as of the adoption date of the new standard. As such, the adoption did not have a material impact on the Companys financial
statements.
In
December 2023, the FASB issued ASU 2023-09, *Income Taxes* (Topic 740): *Improvements to Income Tax Disclosures*,
which enhances the transparency and decision usefulness of income tax disclosures by requiring; (1) consistent categories and greater
disaggregation of information in the rate reconciliation and (2) income taxes paid disaggregated by jurisdiction. It also includes certain
other amendments to improve the effectiveness of income tax disclosures. ASU 2023-09 became effective for fiscal years beginning after
December 15, 2024. These amendments are to be applied prospectively, with retrospective application permitted. The Company adopted ASU
2023-09 on January 1, 2025, on a prospective basis. The adoption of ASU 2023-09 did not have a material impact on the Companys consolidated financial
statements.
| F-15 | |
**Recently
Issued Accounting Pronouncements Not Yet Adopted**
In
November 2024, the FASB issued ASU 2024-03, *Income Statement Reporting Comprehensive Income Expense Disaggregation
Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses*, which requires the disaggregated disclosure of
specific expense categories, including purchases of inventory, employee compensation, depreciation, and amortization included in each
relevant expense caption presented on the statement of operations. The standard also requires disclosure of qualitative description of
the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively, as well as the total amount
of selling expenses and an entitys definition of selling expenses. ASU 2024-03 is effective for annual periods beginning after
December 15, 2026, and interim periods beginning after December 15, 2027. The Company is currently evaluating the impact this standard
will have on its financial statements.
The
Company currently believes there are no other issued and not yet effective accounting standards that are materially relevant to its financial
statements.
**NOTE
4. PREPAID EXPENSES AND OTHER CURRENT ASSETS**
Prepaid
expenses and other current assets consisted of the following:
SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS
| 
| | 
December
31, | | | 
December
31, | | |
| 
| | 
2025 | | | 
2024 | | |
| 
Prepayments for
inventory | | 
$ | | | | 
$ | 401,675 | | |
| 
Prepayments for insurance | | 
| 45,920 | | | 
| 172,221 | | |
| 
Prepayments for software | | 
| 61,672 | | | 
| 93,316 | | |
| 
Prepayments for consulting
services | | 
| 661,179 | | | 
| | | |
| 
Prepaid
other | | 
| 182,404 | | | 
| 305,033 | | |
| 
Total
prepaid expenses and other current assets | | 
$ | 951,175 | | | 
$ | 972,245 | | |
**NOTE
5. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES**
Accrued
expenses and other current liabilities consisted of the following:
SCHEDULE OF ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
| 
| | 
December
31, | | | 
December
31, | | |
| 
| | 
2025 | | | 
2024 | | |
| 
Accrued professional
and consulting fees | | 
$ | 155,223 | | | 
$ | 40,009 | | |
| 
Accrued severance | | 
| 233,333 | | | 
| 277,126 | | |
| 
Accrued cash-settled restricted
stock tax withholding | | 
| 14,000 | | | 
| 285,250 | | |
| 
Accrued expenses other | | 
| 47,766 | | | 
| 122,565 | | |
| 
Accrued
current liabilities | | 
| 26,270 | | | 
| 68,869 | | |
| 
Total
accrued expenses and other current liabilities | | 
$ | 476,592 | | | 
$ | 793,819 | | |
**NOTE
6. DIGITAL ASSETS**
The
Company holds various cryptocurrencies as part of its digital asset treasury strategy. The cost basis of these digital assets sold or
otherwise disposed of is determined using the first-in, first-out (FIFO) method, whereby the cost of the earliest acquired digital asset
is used to calculate realized gains and losses upon disposal.
Digital
assets consisted of the following at December 31, 2025:
SCHEDULE OF DIGITAL ASSETS CRYPTOCURRENCIES
| 
| | 
December
31, 2025 | | |
| 
Digital
assets held: | | 
Units | | | 
Cost
Basis | | | 
Fair
Value | | |
| 
$Fluid | | 
| 195,969 | | | 
$ | 1,150,000 | | | 
$ | 510,695 | | |
| 
$Injective | | 
| 130,201 | | | 
| 1,450,000 | | | 
| 544,111 | | |
| 
$ChainLink | | 
| 58,916 | | | 
| 1,250,000 | | | 
| 717,602 | | |
| 
$AAVE | | 
| 1,207 | | | 
| 250,000 | | | 
| 176,591 | | |
| 
Total | | 
| 386,293 | | | 
$ | 4,100,000 | | | 
$ | 1,948,999 | | |
| F-16 | |
The
following table presents a reconciliation of the Companys Digital Asset activity for the year ended December 31, 2025:
SCHEDULE OF DIGITAL ASSET HOLDINGS
| 
| | 
As
of December 31, 2025 | | |
| 
Beginning balance at January 1, 2025 | | 
$ | | | |
| 
Purchase of $Fluid,
at cost | | 
| 1,150,000 | | |
| 
Purchase of $Injective, at
cost | | 
| 1,450,000 | | |
| 
Purchase of $ChainLink, at
cost | | 
| 1,250,000 | | |
| 
Purchase of $AAVE, at cost | | 
| 250,000 | | |
| 
Purchase cost | | 
| 250,000 | | |
| 
Unrealized
losses from changes in fair value | | 
| (2,151,001 | ) | |
| 
Ending balance at December
31, 2025 | | 
$ | 1,948,999 | | |
Unrealized gains and losses from changes in fair value
are recorded in Other Income (Expenses) in the consolidated statement of operations.
**NOTE
7. STOCKHOLDERS EQUITY**
**Common
Stock**
*Increase
of Authorized Shares of Common Stock*
On
May 23, 2025, the Company amended its Amended and Restated Certificate of Incorporation to increase the number of authorized shares of
common stock, from 200,000,000 to 1,200,000,000.
*Issuances*
On
October 29, 2024, the Company entered into a Stock Repurchase Agreement with a certain beneficial owner (the Seller) to
repurchase a total of 26,155 shares of common stock from the Seller, at a purchase price of $14.40 per share, for an aggregate cash purchase
price of $376,630. Pursuant to ASC 505-30-30-3, *Acquisition of Treasury Stock*, the repurchased shares are recorded at cost, with
no gain or loss recognized upon the acquisition of treasury stock, regardless of any premium paid over the prevailing market price. As
a result of the repurchase, the shares were immediately cancelled, thereby reducing total stockholder equity at their recorded
cost.
On
December 2, 2024, the Company modified certain restricted stock units granted under its *Ayro 2020 Long Term Incentive Plan*. As
part of this modification, the Company granted 58,645 restricted stock units effective as of the modification date, to members of the
Board of Directors, and concurrently cancelled 2,971 previously vested restricted stock units, of which 1,486 were issued and outstanding
as of December 31, 2023, resulting in a net issuance of 57,160 shares of common stock. The incremental compensation expense from the
restricted awards modification was $657,275. The modification was accounted for in accordance with ASC 718-20-35-8, *Compensation 
Stock Compensation: Modifications of Awards*, which provides guidance on accounting for modifications that result in an incremental
change in the fair value of the awards.
Upon
the vesting of restricted stock awards, the Company allows recipients to satisfy their tax withholding obligations by electing to have
the Company withhold a portion of the vested shares, rather than receiving the full amount of shares. During the year ended December
31, 2024, the Company withheld 23,459 shares of common stock with a total fair value of $285,250 for recipients tax withholding
obligations, based on closing market price of the Companys stock on the vesting date. The shares withheld for tax withholding
obligations were immediately cancelled. At the end of December 31, 2024, the tax withholding liability of $285,250 was included in accrued
expenses. During the year ended December 31, 2025, no common shares were withheld from vested restricted stock awards by the Company
for tax withholding obligations.
During
the year ended December 31, 2024, the Company issued 4,688 shares of common stock related to vendor services obligations of $126,000.
| F-17 | |
For
the years ended December 31, 2025 and 2024, the Company issued 743,809 and 214,489 shares of common stock upon the redemption and/or
conversion of the Series H-7 Preferred Stock, respectively.
During
the year ended December 31, 2025, the Company issued 178,200 shares of common stock for the exercise of Series H-7 Preferred Warrants
for cash proceeds of $1,103,648.
On
June 25, 2025, in relation to the reverse stock split (see Note 1. Organization and Nature of Operations), the Company issued 124 shares
of common stock to stockholders who would otherwise have been entitled to a fractional share as a result of the split, with such fractional
shares rounded up to the nearest whole share.
**Series
H Convertible Preferred Stock**
Under
the terms of the Series H Certificate of Designation, each share of the Companys Series H Convertible Preferred Stock (the Series
H Preferred Stock) has a stated value of $154.00 and is convertible into shares of the Companys common stock, equal to
the stated value divided by the conversion price of $23,654.10 per share (subject to adjustment in the event of stock splits or dividends).
The Company is prohibited from effecting the conversion of the Series H Preferred Stock to the extent that, as a result of such conversion,
the holder would beneficially own more than 9.99%, in the aggregate, of the issued and outstanding shares of the Companys common
stock calculated immediately after giving effect to the issuance of shares of common stock upon such conversion. In the event of liquidation,
the holders of the Series H Preferred Stock are entitled, pari passu with the holders of common stock, to receive a payment in the amount
the holder would receive if such holder converted the Series H Preferred Stock into common stock immediately prior to the date of such
payment.
**Series
H-3 Convertible Preferred Stock**
Pursuant
to the Series H-3 Certificate of Designation (as defined below), the holders of the Companys Series H-3 Convertible Preferred
Stock (the Series H-3 Preferred Stock) are entitled to elect up to two members of a seven-member Board, subject to certain
step downs; pursuant to the Series H-3 securities purchase agreement, the Company agreed to effectuate the appointment of the designees
specified by the Series H-3 investors as directors of the Company. Under the terms of the Series H-3 Certificate of Designation, each
share of the Series H-3 Preferred Stock has a stated value of $138.00 and is convertible into shares of common stock, equal to the stated
value divided by the conversion price of $21,196.60 per share (subject to adjustment in the event of stock splits and dividends). The
Company is prohibited from effecting the conversion of the Series H-3 Preferred Stock to the extent that, as a result of such conversion,
the holder or any of its affiliates would beneficially own more than 9.99%, in the aggregate, of the issued and outstanding shares of
common stock calculated immediately after giving effect to the issuance of shares of common stock upon the conversion of the Series H-3
Preferred Stock.
In
the event of liquidation, the holders of the Series H-3 Preferred Stock are entitled, pari passu with the holders of common stock, to
receive a payment in the amount the holder would receive if such holder converted the Series H-3 Preferred Stock into common stock immediately
prior to the date of such payment.
**Series
H-6 Convertible Preferred Stock**
On
February 5, 2020, the Company filed the Certificate of Designations, Preferences and Rights of the Series H-6 Preferred Stock (the Series
H-6 Certificate of Designation) with the Secretary of State of the State of Delaware, establishing and designating the rights,
powers and preferences of the Series H-6 Preferred Stock. The Company designated up to 50,000 shares of Series H-6 Preferred Stock and
each share has a stated value of $72.00 (the H-6 Stated Value). Each share of Series H-6 Preferred Stock is convertible
at any time at the option of the holder thereof, into a number of shares of common stock of the Company determined by dividing the H-6
Stated Value by the initial conversion price of $460.80 per share, which was then further reduced to $320.00 under the anti-dilution
adjustment provision, subject to a 9.99% blocker provision and then decreased to $92.16 upon the Companys one-for-eight reverse
stock split effective on September 15, 2023 (Reverse Stock Split). The Series H-6 Preferred Stock has the same dividend
rights as the common stock, except as provided for in the Series H-6 Certificate of Designation or as otherwise required by law. The
Series H-6 Preferred Stock also has the same voting rights as the common stock, except that in no event shall a holder of Series H-6
Preferred Stock be permitted to exercise a greater number of votes than such holder would have been entitled to cast if the Series H-6
Preferred Stock had immediately been converted into shares of common stock at a conversion price equal to $92.16. In addition, a holder
(together with its affiliates) may not be permitted to vote Series H-6 Preferred Stock held by such holder to the extent that such holder
would beneficially own more than 9.99% of the Company common stock. In the event of any liquidation or dissolution, the Series H-6 Preferred
Stock ranks senior to the common stock in the distribution of assets, to the extent legally available for distribution.
| F-18 | |
The
holders of Series H-6 Preferred Stock are entitled to certain anti-dilution adjustments if the Company issues shares of its common stock
at a lower price per share than the applicable conversion price of the Series H-6 Preferred Stock. If any such dilutive issuance occurs
prior to the conversion of the Series H-6 Preferred Stock, the conversion price will be adjusted downward to a price that cannot be less
than $92.16.
**Series
H-7 Preferred Stock**
****
On
August 7, 2023, the Company entered into a Securities Purchase Agreement (the Series H-7 Purchase Agreement), pursuant
to which it agreed to sell to certain existing investors (the Series H-7 Investors) in a private placement (the Series
H-7 Private Placement) (i) an aggregate of 22,000 shares of the Companys newly designated Series H-7 convertible preferred
stock, par value $0.0001 per share, with a stated value of $1,000 per share (Series H-7 Preferred Shares), and (ii) warrants
(the Series H-7 Investor Warrants) initially exercisable for up to an aggregate of 171,875 shares of common stock at
a conversion price of $128.00 per share. The Company raised gross proceeds of $22,000,000 from the sale, which closed on August 10, 2023.
In connection with the Private Placement, pursuant
to an Engagement Letter (the Palladium Engagement Letter), dated August 7, 2023, between the Company and Palladium Capital
Group, LLC (the Placement Agent), the Company agreed to pay the Placement Agent (i) a cash fee equal to6% of the gross
proceeds from any sale of securities in the Private Placement and (ii) warrants (Placement Agent Warrants, and together
with the Investor Warrants, the Warrants) to purchase shares of common stock equal to2% of the number of shares of
common stock that the Preferred Shares are initially convertible into, with an initial exercise price of $128.00per share (subsequently
reduced to $32.00per share pursuant to a Stock Combination Event Adjustment following the one-for-eight Reverse Stock Split (the
2023 Reverse Stock Split) effected on September 15, 2023) and a five-year term.
The
shares of Series H-7 Convertible Preferred Stock, par value $0.0001 per share (Series H-7 Preferred Stock), are convertible
into common stock at the election of the holder at any time with an initial conversion price of $128.00 per share, which pursuant to
a Stock Combination Event, was subsequently reduced to $32.00 per share. On April 30, 2025, in connection with the issuance of stock
options to certain officers of the Company and pursuant to the full ratchet and anti-dilution provisions contained in the Series H-7
Certificate of Designations and the Series H-7 Warrants, (i) the Series H-7 Conversion Price was adjusted from $32.00 per share to $7.616
per share and (ii) the exercise price of the Series H-7 Warrants was adjusted from $32.00 per share to $7.616 per share and the number
of shares of common stock issuable upon exercise of such warrants was adjusted proportionally. On June 25, 2025, in connection with the
Reverse Stock Split pursuant to the stock combination event adjustment provisions contained in the Series H-7 Certificate of Designations,
(i) the Series H-7 Conversion Price was adjusted from $7.616 per share to $6.1933 per share and (ii) the exercise price of the Series
H-7 Warrants was adjusted from $7.616 per share to $6.1933 per share and the number of shares of common stock issuable upon exercise
of such warrants was adjusted proportionally.
On
February 9, 2024, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment of Certificate of
Designations of Series H-7 Convertible Preferred Stock, which became effective upon filing, which amended the commencement of the monthly
installment dates, to be between May 7, 2024, and August 7, 2025. The first such installment dates were May 7, 2024 and August 7, 2024,
as elected by the applicable investor.
On
December 2, 2024, the Company entered into a Waiver and Amendment Agreement (the Amendment) with the Required Holders
(as defined in the Certificate of Designations). Pursuant to the Amendment, the Company and the Required Holders agreed (i) to amend
(a) the Certificate of Designations, by filing a Certificate of Amendment to the Certificate of Designations (the Certificate
of Amendment), and (b) the Purchase Agreement, such that, in each case, the Director Equity Grants are deemed to constitute
Excluded Securities under the Transaction Documents (as such term is defined in the Purchase Agreement), and (ii) that
the Required Holders waive the applicability of certain other provisions of the Transaction Documents with respect to such Director
Equity Grants. The Certificate of Amendment was filed with the Secretary of State of the State of Delaware, effective as of December
2, 2024.
| F-19 | |
On
March 30, 2025, the Company entered into an Omnibus Waiver and Amendment Agreement (Waiver and Amendment Agreement) with
the Required Holders (as defined in the Certificate of Designations (the Series H-7 Certificate of Designations) for the
Series H-7 Preferred Stock, pursuant to which, the Required Holders agreed (A) to amend (i) the Series H-7 Certificate of Designations,
as described below, by filing a Certificate of Amendment to the Series H-7 Certificate of Designations with the Secretary of State of
the State of Delaware (the March 2025 Certificate of Amendment), and (ii) that certain Securities Purchase Agreement, dated
as of August 7, 2023 (the Series H-7 Purchase Agreement) to (A) amend the definition of Excluded Securities
such that the definition includes the issuance of common stock issued after the date of the Series H-7 Purchase Agreement pursuant to
an Approved Stock Plan (as defined in the Series H-7 Purchase Agreement), which in the aggregate does not exceed more than 2% of the
shares of common stock issued and outstanding on the date immediately prior to the date of the Series H-7 Purchase Agreement (the Excluded
Securities Modification), and (B) to waive certain restrictive covenants contained in the Series H-7 Purchase Agreement as described
therein.
In
addition, the March 2025 Certificate of Amendment amends the Series H-7 Certificate of Designations to (i) amend the restrictive covenant
of the Series H-7 Certificate of Designations such that the Company is required from January 1, 2025, until no shares of Series H-7 Preferred
Stock are outstanding, to maintain unencumbered, unrestricted cash and cash equivalents on hand in amount equal to at least 120% of the
aggregate Stated Value (as defined in the Series H-7 Certificate of Designations) of the Series H-7 Preferred Stock then outstanding,
(ii) amend the definition of Excluded Securities substantially similar to the Excluded Securities Modification, and (iii)
remove the restrictive covenant provision relating to the Segregated Cash (as defined in the Series H-7 Certificate of Designations)
requirement. The March 2025 Certificate of Amendment was filed with the Secretary of State of the State of Delaware, effective as of
March 31, 2025.
On
May 13, 2025, the Required Holders (as defined in the Series H-7 Certificate of Designations) executed and delivered a waiver (the May
2025 Waiver) to the Company, pursuant to which, the Required Holders agreed to waive any Equity Conditions Failure (as defined
in the Series H-7 Certificate of Designations) including, without limitation, any rights or remedies in connection with such Equity Conditions
Failure, effective as of March 31, 2025, and as of the date of the May 2025 Waiver.
On
August 4, 2025, the Company entered into an Omnibus Waiver, Consent, Notice and Amendment (the Series H-7 Agreement) with
the Required Holders (as defined in the Series H-7 Certificate of Designations). Pursuant to the Series H-7 Agreement, the Required Holders
agreed to (i) amend the Series H-7 Purchase Agreement to amend the definition of Excluded Securities as set forth in the
Series H-7 Amendment, (ii) waive certain rights under the Series H-7 Purchase Agreement, Series H-7 Warrants and Series H-7 Certificate
of Designations in respect of the issuance of the Companys Series I Convertible Preferred Stock (Series I Preferred Stock),
and (iii) consent to the issuance of the Series I Preferred Stock, as required pursuant to certain terms of the Series H-7 Certificate
of Designations, the Series H-7 Purchase Agreement and the Series H-7 Warrants, as applicable. In consideration of the foregoing, the
Company agreed to pay to the Required Holders an aggregate of $350,000 by September 30, 2025, which may be paid in the form of cash,
or, at the Holders sole election, added to the outstanding aggregate stated value of the Series H-7 Preferred Stock. Accordingly,
the Company recorded the $350,000 in consent and waiver fee Series H-7 on the consolidated statements of operations for the year
ended December 31, 2025, and recorded the $350,000 in accrued preferred stock redemption payable (H-7), which was later settled through the issuance of 4,377 shares of Series
H-7 Preferred Stock, as noted below. 
The
Company and the Required Holders further agreed pursuant to the Series H-7 Agreement to amend the Series H-7 Certificate of Designations
by filing a Certificate of Amendment to the Series H-7 Certificate of Designations (the Certificate of Amendment) with
the Secretary of State of the State of Delaware. The Certificate of Amendment amends the Series H-7 Certificate of Designations to (i)
extend the maturity date to February 4, 2027, (ii) revise the applicable payment dates and corresponding payable amounts of Dividends
and Instalment Amounts (each as defined in the Series H-7 Certificate of Designations), (iii) modify the definition of Excluded
Securities and (iv) modify the schedule of Instalment Dates (as defined in the Series H-7 Certificate of Designations). The Certificate
of Amendment to the Series H-7 Certificate of Designations was filed with the Secretary of State for the State of Delaware on August
6, 2025.
Pursuant to the Series H-7 Agreement, the accrued preferred stock redemption payable related to the Series H-7 Preferred
Stock, at the time of the Series H-7 Agreement, was settled through the issuance of 4,377 shares of Series H-7 Preferred Stock. As a result,
the Company eliminated the accrued preferred stock redemption payable (H-7) balance of $5,309,174 on the consolidated balance sheets,
with a corresponding increase to the carrying value of the Series H-7 Preferred Stock, net of issuance costs.
The
Company identified embedded derivative features in the Series H-7 Preferred Stock that are bifurcated and measured at fair value, with
subsequent changes recognized in earnings (see Note 10. Fair Value Measurements). At issuance, the Company recorded a total discount
of $15,484,324, comprised of the embedded derivative fair value of $5,147,000, issuance costs of $563,324, and fair value of warrants
issued of $9,774,000. The discount is being accreted using the effective interest method, with accretion of $3,248,900 and $8,255,150
recorded as deemed dividends during the years ended December 31, 2025 and 2024, respectively.
| F-20 | |
The
Series H-7 Certificate of Designations requires the Company to maintain unencumbered cash and cash equivalents of at least 120% of the
aggregate stated value of outstanding Series H-7 Preferred Stock. The Company had $110,264 and $164,682 in restricted cash as of December
31, 2025 and 2024, respectively.
The
Series H-7 Certificate of Designations includes triggering events that would allow holders to require redemption at a premium, including
suspension of trading for five consecutive days or failure to pay amounts when due.
During
the year ended December 31, 2025, the Company recognized $1,896,455 of net preferred dividends which is comprised of $635,602 and $1,260,852
of accrued and deemed preferred dividends for cash premium on instalment redemptions ultimately settled in shares of common stock.
During
the year ended December 31, 2024, the Company recognized $2,425,599 of net preferred dividends which is comprised of $1,878,713 and $546,886
of accrued and deemed dividends for cash premium for instalment redemptions ultimately settled in shares of Common Stock.
As
of December 31, 2025, the following table sets forth a summary of the change in the accrued preferred stock redemption payable (H-7):
SCHEDULE OF CHANGE IN THE ACCRUED PREFERRED STOCK REDEMPTION PAYABLE
| 
| | 
Accrued
preferred stock redemption payable (H-7) | | |
| 
Beginning balance at January 1, 2024 | | 
$ | - | | |
| 
New redemptions and cash premiums | | 
| 11,484,609 | | |
| 
Cash payments | | 
| (10,198,929 | ) | |
| 
Ending
balance at December 31, 2024 | | 
$ | 1,285,680 | | |
| 
New redemptions and cash premiums | | 
| 11,555,021 | | |
| 
Waiver consideration | | 
| 350,000 | | |
| 
August
4th Amendment | | 
| (5,309,174 | ) | |
| 
Cash
payments | | 
| (7,881,527 | ) | |
| 
Ending balance at December
31, 2025 | | 
$ | | | |
**Series
I Preferred Stock**
On
August 4, 2025, the Company entered into a Securities Purchase Agreement (the Series I Purchase Agreement) with certain
accredited investors, pursuant to which it agreed to sell (i) an aggregate of 7,000 shares of the Companys newly-designated Series
I Preferred Stock, with a par value of $0.0001 per share and a stated value of $1,000 per share (Stated Value), initially
convertible into up to 875,000 shares of the Companys common stock at an initial conversion price of $8.00 per share pursuant
to the Certificate of Designations of the Series I Preferred Stock (the Series I Certificate of Designations) and (ii)
warrants to acquire up to an aggregate of 875,000 shares of common stock (the Series I Warrants) at an exercise price of
$8.00 per share (collectively, the Private Placement). The closing of the Private Placement occurred on August 8, 2025.
The aggregate gross proceeds from the Private Placement were $7,000,000.
In
connection with the Private Placement, pursuant to (A) an engagement letter (the GPN Agreement) with GP Nurmenkari Inc.
(GPN) and (B) an engagement letter (the Palladium Agreement, and collectively with the GPN Agreement, the
Engagement Letters) with Palladium Capital Group, LLC (Palladium, and collectively with GPN, the Placement
Agents), the Company engaged the Placement Agents to act as non-exclusive placement agents in connection with the Private Placement,
pursuant to which, the Company agreed to (i) pay each Placement Agent a cash fee equal to 4% of the gross proceeds of the Private Placement
(including any cash proceeds realized by the Company from the exercise of any outstanding warrants of the Company), (ii) reimbursement
and payment of certain expenses, and (iii) issue to each of the Placement Agents on the closing date, warrants to purchase up to an aggregate
number of shares of common stock equal to 4% of the aggregate number of shares of common stock underlying the securities issued in the
Private Placement, including upon exercise of any outstanding warrants of the Company, with terms identical to the Series I Warrants
(the Series I Placement Agent Warrants).
The
Series I Preferred Stock is convertible into shares of common stock (the Conversion Shares) at the election of the holder
at any time at an initial conversion price of $8.00 per share (the Conversion Price). The Conversion Price is subject to
customary adjustments for stock dividends, stock splits, reclassifications, stock combinations and the like and dilutive issuances (in
each case, subject to certain exceptions). The Company is required to redeem the Series I Preferred Stock in equal instalments, commencing
on November 30, 2025, and thereafter on the last trading day of the third calendar month immediately following the previous Instalment
Date, until the maturity date of February 4, 2027.
| F-21 | |
The
holders of the Series I Preferred Stock are entitled to dividends of 7% per annum, compounded each calendar quarter, which are payable
in arrears (i) quarterly on each Installment Date (as defined in the Series I Certificate of Designations), in cash out of funds legally
available therefor and, (ii) prior to the first Installment Date, payable by way of inclusion of the dividends in the Conversion Amount
(as defined in the Series I Certificate of Designations) on each conversion date occurring prior to the first Installment Date. Upon
the occurrence and during the continuance of a Triggering Event (as defined in the Series I Certificate of Designations), the Series
I Preferred Stock accrue dividends at the rate of 15% per annum. The holders of the Series I Preferred Stock are entitled to vote with
holders of the Common Stock on an as-converted basis, with the number of votes to which each holder of Series I Preferred Stock is entitled
to be calculated assuming a conversion price of $7.628 per share, which was the Minimum Price (as defined in Rule 5635 of the Rules of
the Nasdaq Stock Market) applicable immediately before the execution and delivery of the Series I Purchase Agreement, subject to certain
beneficial ownership limitations as set forth in the Certificate of Designations.
Notwithstanding
the foregoing, the Companys ability to settle conversions using shares of common stock is subject to certain limitations set forth
in the Series I Certificate of Designations. Further, the Series I Certificate of Designations contains a certain beneficial ownership
limitation after giving effect to the issuance of shares of common stock issuable upon conversion of the Series I Preferred Stock under
the Series I Certificate of Designations.
The
Series I Certificate of Designations includes certain triggering events including, among other things, the suspension from trading or
the failure of the common stock to be trading or listed (as applicable) on an eligible market for a period of five (5) consecutive trading
days, the Companys failure to pay any amounts due to the holders of the Series I Preferred Stock when due. In connection with
a triggering event, each holder of Series I Preferred Stock will be able to require the Company to redeem in cash any or all of the holders
shares of Series I Preferred Stock at a premium set forth in the Series I Certificate of Designations.
The
shares of Series I Preferred Stock were determined to be more akin to a debt-like host than an equity-like host. The Company identified
the following embedded features that are not clearly and closely related to the debt host instrument: 1) make-whole interest upon a contingent
redemption event, 2) make-whole interest upon a conversion event and 3) an increase in the dividend rate related to the occurrence of
a triggering event. These features were bundled together, assigned probabilities of being affected and measured at fair value. Subsequent
changes in fair value of these features are recognized in the Consolidated Statement of Operations. The Company estimated the $23,000
fair value of the bifurcated embedded derivative at issuance using a Monte Carlo simulation model, with the following inputs: (i) estimated
equity volatility of 135.0%, (ii) the time to maturity of 1.49 years, (iii) a discounted market interest rate of 13.76%, (iv) dividend
rate of 7.0%, (v) a penalty dividend rate of 15.0%, and (vi) probability of default of 9%. The fair value of the bifurcated derivative
liability was estimated utilizing the with and without method which uses the probability weighted difference between the scenarios with
the derivative and the plain vanilla maturity scenario without a derivative.
The
discount to the fair value is included as a reduction to the carrying value of the Series I Preferred Stock. During the year ended December
31, 2025, the Company recorded a total discount of $10,887,185 upon issuance of the Series I Preferred Stock, which was comprised of
the issuance date fair value of the associated embedded derivative of $24,000, stock issuance costs of $1,322,669, of which $567,854
was paid in cash and $754,815 was allocated as the Series I Placement Agent Warrants both of which were recorded to mezzanine equity,
and the fair value of the Series I Warrants of $3,981,034. As of December 31, 2025, it is probable that the Series I Preferred Stock
will be redeemed. In accordance with ASC 480-10-S99-3A, the Company is accreting the discount on the effective interest method and $1,882,957
was recorded as a deemed dividend during the year ended December 31, 2025.
In
connection with the Series I Purchase Agreement, the Company and the investors entered into a Registration Rights Agreement (the Registration
Rights Agreement), pursuant to which the Company is required to file a resale registration statement (the Registration
Statement) with the SEC to register for resale 200% of the shares of common stock issuable upon conversion of the Series I Preferred
Stock and upon exercise of the Series I Warrants promptly following the closing date, but in no event later than 30 calendar days after
the closing date, and to have such Registration Statement declared effective by the Effectiveness Deadline (as defined in the Registration
Rights Agreement). On September 8, 2025, the Company filed the Registration Statement with the SEC and subsequently amended the Registration
Statement on October 10, 2025. On January 9, 2026, the SEC declared the Registration Statement effective.
During
the year ended December 31, 2025, the Company recognized $140,972 of net preferred dividends.
| F-22 | |
**Common
Stock Warrants**
**Series
H-7 Warrants**
In
August 2023, the Company issued certain warrants to purchase common stock (the Series H-7 Warrants) pursuant to the
Series H-7 Purchase Agreement (as defined above). The Series H-7 Warrants are entitled to certain anti-dilution adjustments, if the
Company issues shares of its common stock at a lower price per share than the applicable exercise price. The exercise price of the
Series H-7 Warrants is subject to adjustments for stock dividends, stock splits, reclassifications and the like, and subject to
price-based adjustment in the event of any issuances of common stock, or securities convertible, exercisable or exchangeable for
common stock, at a price below the then-applicable exercise price. As a result of the 2023 Reverse Stock Split, the exercise price
of the Series H-7 Warrants was adjusted from $128.00to $32.00and the number of shares of common stock issuable upon
exercise of the Warrants was adjusted proportionally to an additional525,937shares of common stock.
Pursuant to the
share combination event adjustment provisions in the Series H-7 warrant the Reverse Stock Split adjusted the exercise price from
$32.00
per share to $6.1933
per share and the number of shares of common stock issuable upon the exercise of the Series H-7 Warrants was adjusted proportionally
to an additional 2,922,020
shares of common stock, for an aggregate of 3,623,270
Series H-7 Warrants outstanding.
The
additional Series H-7 Warrants were determined to be subject to liability classification as they are considered to be indexed to the
Companys own stock but contain a provision where the holder of the Series H-7 Warrants have the right to require the Company to
redeem the Series H-7 Warrants from the holder in cash in an amount equal to the Black Scholes Value of the remaining unexercised portion
of the Series H-7 Warrants at that time, in accordance with ASC 815. As such, the Company recorded the Series H-7 Warrants as a liability
at fair value with subsequent changes in fair value recognized in earnings. See Note 10. Fair Value Measurements for inputs related to
the Companys use of the Black-Scholes Model to calculate the value of the Series H-7 Warrants.
**Series
I Warrants**
On
August 6, 2025, the Company issued certain warrants to purchase up to an aggregate of 875,000 shares of the Companys common stock
(the Series I Warrants) pursuant to the Series I Purchase Agreement (as defined below), with an exercise price of $8.00
per share and a date of expiration five years from the date of issuance. The Series I Warrants are entitled to certain anti-dilution
adjustments, if the Company issues shares of its common stock at a lower price per share than the applicable exercise price.
The
Series I Warrants were determined to be subject to liability classification as they are considered to be indexed to the Companys
own stock but contain a provision where the holder of the Series I Warrants have the right to require the Company to redeem the Series
I Warrants from the holder in cash in an amount equal to the Black Scholes Value of the remaining unexercised portion of the Series I
Warrants at that time, in accordance with ASC 815. As such, the Company recorded the Series I Warrants as a liability at fair value with
subsequent changes in fair value recognized in earnings. The Company utilized the Black Scholes Model to calculate the fair value of
these Series I Warrants. The fair value of the Series I Warrants of $3,981,034 was estimated at the date of issuance using the stock
price of $5.92, an exercise price of $8.00, and the following weighted average assumptions: (i) dividend yield 0%; (ii) expected term
of 5 years; (iii) equity volatility of 110%; and (iv) a risk-free interest rate of 4.21%.
In
addition, the Company also issued the Series I Placement Agent Warrants (as defined herein) to purchase up to an aggregate of 140,000
shares of the Companys common stock to the Placement Agents (as defined herein). The Company utilized the Black Scholes Model
to calculate the value of the Series I Placement Agent Warrants issued during the year ended December 31, 2025. The fair value of the
Series I Placement Agent Warrants of $636,966 was estimated at the date of issuance using the stock price of $5.92, an exercise price
of $8.00, and the following weighted average assumptions: (i) dividend yield 0%; (ii) expected term of 5 years; (iii) equity volatility
of 110%; and (iv) a risk-free interest rate of 4.21%.
| F-23 | |
**Series
H-7 and Series I Warrant Amendment**
On
August 26, 2025, the Company entered into an omnibus amendment (the Warrant Amendment) with the Required Holders (as defined
in the Series H-7 Purchase Agreement and the Series I Purchase Agreement) to amend certain terms of the Series I Warrants and Series
H-7 Warrants. The Warrant Amendment makes certain adjustments to the definition of a Fundamental Transaction and related
provisions in each of the Warrants. In addition, the Warrant Amendment amends (i) the definition of the Black Scholes Value
in the Series H-7 Warrants related to the volatility input, which is now calculated utilizing an expected volatility equal to the 30
day volatility obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of
the trading day immediately following the earliest to occur of (1) the public disclosure of the applicable Fundamental Transaction and
(2) the date of a holders request, and (ii) the definition of the Black Scholes Consideration Value in the Series
H-7 Warrants related to the volatility input, which is now calculated utilizing an expected volatility equal to the 30 day volatility
obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the trading day
immediately following the date of issuance of the applicable options, convertible securities or Adjustment Right (as defined in the Series
H-7 Warrants). Further, the Warrant Amendment removes the provision in the Series H-7 Warrants providing for an adjustment in the exercise
price of the Series H-7 Warrants upon (a) the increase or decrease of the purchase or exercise price of any options, (b) the issuance
of additional consideration upon the conversion of any convertible securities or (c) the increase or decrease of the rate of conversion
of any convertible securities.
The
Warrant Amendment resulted in the Series I Warrants and Series H-7 Warrants to be considered equity classified in accordance with ASC
815. The fair value of the Series I Warrants and Series H-7 Warrants on August 26, 2025, of $18,608,000, was reclassified from warrant
liability to additional paid-in capital. The Company remeasured the Series I Warrants and Series H-7 Warrants at fair value as of August
26, 2025, and recognized the change in fair value as a non-cash loss of $17,971,034. The fair value of the Series I Warrants and Series
H-7 Warrants of $18,608,000 was estimated at August 26, 2025, utilizing the Black Scholes Model using the following weighted average
assumptions: dividend yield 0%; remaining term of 4.95 years and 2.96 years, respectively; equity volatility of 105% and 97%, respectively;
and a risk-free interest rate of 3.7% and 3.6%, respectively.
**Altucher
Consulting Warrants**
On
August 4, 2025, the Company entered into a consulting agreement (the Altucher Consulting Agreement) with James Altucher
and Z-List Media, Inc. (the Consultant), pursuant to which, the Consultant agreed to provide certain consulting services
to the Company, including fund raising, crypto portfolio management, investor relations, strategic planning, deal flow analysis, introductions
to further its business goals, advice related to sector growth initiatives and any other consulting or advisory services which the Company
reasonably requests that Consultant provide to the Company. The Altucher Consulting Agreement has a term of two years unless earlier
terminated pursuant to the terms of the Altucher Consulting Agreement or upon mutual written consent of the Company and the Consultant
in accordance with the terms of the Altucher Consulting Agreement.
Pursuant
to the Altucher Consulting Agreement, the Company issued to the Consultant warrants to purchase up to an aggregate of 1,000,000 shares
of common stock, consisting of: (i) a warrant to purchase up to 300,000 shares of common stock at an exercise price of $8.00 per share,
which are immediately exercisable upon issuance (the First Tranche Warrant), (ii) a warrant to purchase up to 200,000 shares
of common stock at an exercise price of $12.00 per share, which will be exercisable six months from the date of issuance (the Second
Tranche Warrant), (iii) a warrant to purchase up to 200,000 shares of common stock at an exercise price of $15.00 per share (the
Third Tranche Warrant), which will be exercisable twelve months from the date of issuance, and (iv) a warrant to purchase
up to 300,000 shares of common stock at exercise price of $17.50 per share (the Fourth Tranche Warrant and together with
the First Tranche Warrant, the Second Tranche Warrant and the Third Tranche Warrant, the Consultant Warrants), which will
be exercisable eighteen months from the date of issuance, in each case, with each Consultant Warrant subject to exercisability, forfeiture
and such other terms as set forth therein.
The
Consultant Warrants were valued using the Black-Scholes option pricing model on the date of issuance using the following assumptions:
(a) fair value of common stock with a range of $8.00 - $17.50 per share, (b) expected volatility of 79.00%, (c) dividend yield of 0%,
(d) risk-free interest rate of 3.80%, and (e) expected life of 2 years. The grant date fair value of the Consultant Warrants was $4,892,000,
of which, $1,680,930 of fair value assigned to the First Tranche Warrant was initially recorded to prepaid expense on the consolidated
balance sheets as of December 31, 2025, and will be expensed as the services are rendered.
| F-24 | |
For
the year ended December 31, 2025, the Company recorded $1,068,825 of stock-based compensation related to the First Tranche Warrants under
general and administrative expenses on the consolidated statement of operations.
A
summary of the Companys warrants to purchase common stock activity is as follows:
SCHEDULE OF WARRANT ACTIVITY
| 
| | 
Shares
Underlying Warrants | | | 
Weighted
Average Exercise Price | | | 
Weighted
Average Remaining Contractual Term (in years) | | |
| 
Outstanding at December 31, 2024 | | 
| 722,761 | | | 
$ | 51.04 | | | 
| 3.44 | | |
| 
Granted | | 
| 4,928,427 | | | 
| 6.66 | | | 
| | | |
| 
Exercised | | 
| (178,200 | ) | | 
| 6.19 | | | 
| | | |
| 
Expired | | 
| (19,112 | ) | | 
$ | 964,48 | | | 
| | | |
| 
Outstanding at December
31, 2025 | | 
| 5,453,876 | | | 
$ | 7.35 | | | 
| 3.00 | | |
**Rights
Dividend and Shareholder Rights Plan**
On
July 31, 2025, the Board declared a dividend of one preferred share purchase right (a Right) for each outstanding share
of Company Stock (as defined in the Rights Agreement (as defined below)). The dividend was distributed on August 11, 2025, to the stockholders
of record at the close of business on that date. Each Right initially entitles the registered holder to purchase from the Company one
one-thousandth of a share of Series A Junior Participating Preferred Stock, par value $0.0001 per share, of the Company (the Series
A Preferred Stock) at a price of $30 per one one-thousandth of a share of Series A Preferred Stock, subject to adjustment.
The
Rights are governed by the Rights Agreement, dated as of July 31, 2025, between the Company and Equiniti Trust Company LLC, as Rights
Agent, and the terms of the Series A Preferred Stock are as set forth in the Certificate of Designations of the Series A Preferred Stock,
filed with the Delaware Secretary of State on August 1, 2025. The Company has reserved one hundred thousand (100,000) shares of Series
A Preferred Stock for potential issuance upon the exercise of the Rights.
The
declaration of the Rights dividend was a non-cash distribution and had no impact on the Companys consolidated financial statements,
as no liability or expense was recorded. The Rights will become exercisable only upon the occurrence of certain events specified in the
Rights Agreement.
**NOTE
8. STOCK-BASED COMPENSATION**
**StableX
Technologies, Inc. 2020 Long Term Incentive Plan**
On
May 28, 2020, the Companys shareholders approved the StableX Technologies, Inc. 2020 Long Term Incentive Plan (the
2020 Plan) for future grants of incentive stock options, nonqualified stock, stock appreciation rights, restricted
stock, restricted stock units, performance and other awards. The Company originally reserved 76,872
shares of its common stock pursuant to the 2020 Plan. Stock options issued under the 2020 Plan have a maximum contractual term of 10
years. On December 30, 2024, the Companys stockholders approved an amendment to the 2020 Plan to increase the reserved shares
by 187,500,
to a total of 264,372
shares. On October 3, 2025, the Companys stockholders approved a further amendment to the 2020 Plan to increase the maximum
number of shares of Common Stock that may be delivered pursuant to awards granted under the Plan to 400,000
shares. The Company has 92
shares available for future issuance remaining under this plan as of December 31, 2025.
| F-25 | |
**AYRO
2017 Long Term Incentive Plan**
The
Company has reserved a total of 3,734 shares of its common stock pursuant to the AYRO, Inc. 2017 Long-Term Incentive Plan. At December
31, 2025, no shares remained available for grant under future awards under the 2017 Long-Term Incentive Plan, and in connection with
the 2020 Plan, the remaining unissued amounts were cancelled.
**DropCar
Amended and Restated 2014 Equity Incentive Plan**
The
Companys equity incentive plan created in 2014 (the 2014 Plan) was amended in 2018 to increase the number of shares
of Company common stock available for issuance. Pursuant to the 2014 Plan, 1,104 shares of common stock were reserved for issuance. The
Company had 422 shares of common stock outstanding and no shares available for grant under the 2014 Plan at December 31, 2025.
****
**Stock
Options**
Option
awards are generally granted with an exercise price equal to the market price of the Companys stock at the date of grant; those
options are determined by the Administrator and specified in the individual award agreements; and generally have a contractual term of
10 years. Awards granted under the 2020 Plan during the year ended December 31, 2025, vested under one of two schedules as specified in
the individual award agreements: either immediately upon grant, or 75% upon grant with the remaining 25% vesting on December 31, 2025.
All options granted during the year ended December 31, 2025, were fully vested as of December 31, 2025.
The
fair value of each option is estimated on the date of grant using the Black-Scholes option valuation model that uses assumptions in the
following tables. Because Black-Scholes option valuation models incorporate ranges of assumptions for inputs, these ranges are disclosed.
Expected volatilities are based on historical volatilities of the Companys stock. The Company uses the simplified method to estimate
the expected term. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve
in effect at the time of grant.
In
applying the Black-Scholes option pricing model to the options issued, the Company used the following assumptions:
SCHEDULE
OF SIGNIFICANT WEIGHTED AVERAGE ASSUMPTION
| 
| | 
December
31, 2025 | | |
| 
Risk free interest rate | | 
| 3.64%
- 3.73 | % | |
| 
Expected term
(years) | | 
| 5.00 | | |
| 
Expected volatility | | 
| 110.48%
- 128.00 | % | |
| 
Expected dividends | | 
| 0.00 | % | |
Below
is a table summarizing the changes in stock options outstanding during the year ended December 31, 2025:
SCHEDULE OF STOCK BASED COMPENSATION, STOCK OPTIONS, ACTIVITY
| 
| | 
Number
of Shares | | | 
Weighted
Average Exercise Price | | | 
Contractual
Life (Years) | | |
| 
Outstanding at December 31, 2024 | | 
| 479 | | | 
$ | 5,280 | | | 
| 3.45 | | |
| 
Grants | | 
| 325,468 | | | 
| 6.33 | | | 
| | | |
| 
Exercised | | 
| | | | 
| | | | 
| | | |
| 
Expired | | 
| (57 | ) | | 
| 20,032 | | | 
| | | |
| 
Outstanding at December
31, 2025 | | 
| 325,890 | | | 
$ | 10.52 | | | 
| 9.8 | | |
| 
Exercisable at December
31, 2025 | | 
| 325,890 | | | 
$ | 10.52 | | | 
| 9.8 | | |
The
weighted average grant date fair value of options granted during the years ended December 31, 2025 was $5.95. There were no stock options
granted during the year ended December 31, 2024. The aggregate intrinsic value of stock options vested and exercisable was $0 and $0
for the years ended December 31, 2025 and 2024, respectively.
The aggregate intrinsic value at December 31, 2025 and 2024, is calculated as the difference between the exercise
price of the underlying options and the closing stock price of $2.63 and $10.93 from the Companys common stock as of December 31,
2025 and 2024, respectively.
The
Company recognized $1,235,419
and $8,158
of stock option expense for the years ended December 31, 2025,
and 2024, respectively. As of December 31, 2025, there was no unrecognized compensation cost related to stock options.
| F-26 | |
Total
stock-based compensation, including restricted stock awards and stock options is included in the consolidated statement of operations as follows:
SCHEDULE OF STOCK BASED COMPENSATION
| 
| | 
2025 | | | 
2024 | | |
| 
| | 
Years
Ended December 31, | | |
| 
| | 
2025 | | | 
2024 | | |
| 
Research and development | | 
$ | | | | 
$ | 3,810 | | |
| 
Sales and marketing | | 
| | | | 
| 453 | | |
| 
General
and administrative | | 
| 1,235,419 | | | 
| 709,486 | | |
| 
Total | | 
$ | 1,235,419 | | | 
$ | 713,749 | | |
**Restricted
Stock**
****
On
December 2, 2024, pursuant to the StableX Technologies, Inc. 2020 Long-Term Incentive Plan, the Company granted 58,646 shares of restricted
stock to non-executive directors. As of December 31, 2025 and 2024, all shares of restricted stock were vested and issued. (See Note
7. Stockholders Equity)
The
total fair value of restricted stock vested for the years ended December 31, 2025 and 2024 was $0 and $731,889, respectively.
The
Company recognized compensation expense related to all restricted stock during the years ended December 31, 2025 and 2024, of $0 and
$705,591, respectively. No compensation expense was recognized during the year ended December 31, 2025, as all restricted stock awards
were fully vested as of December 31, 2024. As of December 31, 2025, there was no unrecognized compensation cost related to restricted
stock awards.
****
**NOTE
9. COMMITMENTS AND CONTINGENCIES**
**Manufacturing
Agreement**
On
August 27, 2024, the Company partnered with Lithion Battery Inc. (Lithion), a manufacturer of certain iron phosphate and
lithium-ion battery cells, modules and battery packs, and entered into a purchase agreement with Lithion (the Lithion Purchase
Agreement), pursuant to which, the Company agreed to purchase batteries from Lithion for an aggregate of $1,211,150 through 2025.
On June 17, 2025, Lithion filed a complaint with the Supreme Court of the State of New York Country of New York, pursuant to which, Lithion
claimed the Company was in breach of contract of the Lithion Purchase Agreement for failure to pay amounts owed under the Lithion Purchase
Agreement in connection with the order of certain batteries. Lithion sought damages equal to $717,120 plus interest. On July 28, 2025,
the Company entered into a Settlement Agreement (as defined herein) with Lithion, pursuant to which the Company paid Lithion $540,000
on July 30, 2025, and upon payment, the Company took possession of the remaining battery cells, modules, and battery packs. Pursuant
to the Settlement Agreement, all causes of action, counterclaims, and claims that were asserted or could have been asserted by the parties
against each other in connection with the Lithion Purchase Agreement were settled in full, with no party having continuing liability
to the other party.
**Litigation**
The
Company is subject to various legal proceedings and claims, either asserted or unasserted, which arise in the ordinary course of business,
that it believes are incidental to the operation of its business. While the outcome of these claims cannot be predicted with certainty,
other than the matters noted above, management does not believe that the outcome of any of these legal matters will have a material adverse
effect on its results of operations, financial positions, or cash flows.
On October 20, 2023, Club Car filed a complaint against
the Company in the Superior Court of Columbia County, Georgia (Civil Action File No.2023ECV0838) (the Club Car Complaint),
alleging that the Company had breached its contractual obligations to Club Car under a master procurement agreement (the MPA)
entered into by and among AYRO Operating Company, Inc., the Companys subsidiary (AYRO Operating), and Club Car on
March 5, 2019 due to alleged defects in the vehicles sold to Club Car and the Companys termination of warranty support following
termination of the MPA. During December 2024, the Company entered into a $1.5million settlement agreement with Club Car, resolving
all claims asserted in or arising from the litigation. As of December 31, 2024, the related accrued warranty reserve balance of $403,778was
no longer required and applied against the $1.5million legal settlement. The warranty reserve was for Club Car product warranty,
and upon the legal settlement, all claims were released against future warranties.
In February of 2024, Inventus Power, Inc. filed a
complaint against the Company in the Circuit Court of the Eighteenth Judicial Circuit, County of DuPage, Illinois, alleging that the Company
failed to pay invoices for certain battery packs and related equipment. In April of 2024, the Company filed counterclaims asserting that
the battery packs in question were defective and not in compliance with contractual specifications. In August of 2024, the parties entered
into a confidential settlement agreement, pursuant to which they agreed to dismiss with prejudice the claims and counterclaims in this
lawsuit. The settlement agreement did not have a material impact on the Companys results of operations or financial condition.
**Executive
Compensation Agreement**
On
August 14, 2025, the Company entered into an executive compensation agreement (the Employment Agreement) with Joshua Silverman,
who served as the Companys Executive Chairman, to become the Companys Chief Executive Officer. The Employment Agreement
has a three-year initial term commencing on August 14, 2025, which term automatically renews each year for successive one-year terms,
unless earlier terminated by either party in accordance with the terms of the Employment Agreement. Pursuant to the Employment Agreement
Mr. Silverman is entitled to receive an annual base salary of three hundred thousand dollars ($300,000) (Base Salary) effective
as of January 1, 2025, payable in accordance with the Companys normal payroll practices. For each fiscal year during the employment
period, Mr. Silverman is eligible to receive an annual bonus upon achievement of target objectives and performance criteria, payable
on or before March 15 of the fiscal year following the fiscal year to which the bonus relates. The Employment Agreement also entitles
Mr. Silverman to receive customary benefits and reimbursement for ordinary business expenses. In addition, the Company agreed to grant
Mr. Silverman long-term incentive awards under the Companys long-term equity incentive plan (the LTIP) on such terms
and conditions as determined by the Board and the Compensation Committee in their sole discretion. For each fiscal year during the employment
period, Mr. Silverman shall receive annual long-term incentive awards under the LTIP of up to 300% of his Base Salary upon achievement
of target objectives and performance criteria established by the Board in their sole discretion, subject to and governed by the terms
and provisions of the LTIP as in effect from time to time and the award agreements evidencing such awards.
| F-27 | |
In
the event Mr. Silvermans employment is terminated by the Company for Cause (as defined in the Employment Agreement) or by Mr.
Silverman without Good Reason (as defined in the Employment Agreement) , Mr. Silverman will be entitled to: (i) any earned but unpaid
Base Salary earned during his employment and applicable to all pay periods prior to the termination date, and (ii) any unpaid expense
reimbursements and vested amounts and benefits in accordance with the terms of any applicable plan, program, corporate governance document,
policy, agreement or arrangement of the Company (collectively, Accrued Compensation).
If
Mr. Silvermans employment is terminated prior to the end of the term by the Company without Cause or by Mr. Silverman for Good
Reason, then, subject to certain conditions set forth in the Employment Agreement (including the execution and non-revocation of a general
release of claims), Mr. Silverman will be entitled to: (i) Accrued Compensation; (ii) severance equal to two times the sum of (A) Mr.
Silvermans Base Salary in effect at the time his employment terminates and (B) the target bonus for the year of termination prorated
based upon the number of days worked for the year of termination; and (iii) accelerated vesting of the unvested portion of any outstanding
equity awards.
If
Mr. Silvermans employment is terminated prior to the end of the term by the Company without Cause or by Mr. Silverman for Good
Reason within two (2) years after a Change in Control (as defined in the Employment Agreement) or within six (6) months prior to a Change
in Control, Mr. Silverman will be entitled to: (i) Accrued Compensation; (ii) severance equal to three times the sum of (A) Mr. Silvermans
Base Salary in effect at the time his employment terminates and (B) the target bonus for the year of termination prorated based upon
the number of days worked for the year of termination; and (iii) accelerated vesting of the unvested portion of any outstanding equity
awards.
**Lease
Agreements**
****
In
2019, the Company entered into a new lease agreement for office and manufacturing space (the 2019 Lease). The 2019 Lease
commencement date was January 16, 2020. Prior to the commencement date of the 2019 Lease, the Company
leased other office and manufacturing space on a short-term basis. The Company determined if an arrangement is a lease at commencement of
the contract and whether a contract is or contains a lease by determining whether it conveys the right to control the use of identified
asset for a period of time. These leases provide the right to substantially all the economic benefits from the use of the identified
asset and the right to direct use of the identified asset, as such, the contract is, or contains, a lease. In connection with the adoption
of ASC 842,*Leases*(ASC 842), the Company has elected to treat the lease and non-lease components as a single component.
Leases
were classified as an operating lease at commencement. An operating lease results in the recognition of a Right-of-Use (ROU)
assets and lease liability on the balance sheet. ROU assets and operating lease liabilities are recognized based on the present value
of lease payments over the lease term as of the commencement date. Because the lease does not provide an explicit or implicit rate of
return, the Company determines an incremental borrowing rate based on the information available at the commencement date in determining
the present value of lease payments on an individual lease basis.
The
incremental borrowing rate for a lease is the rate of interest the Company would have to pay on a collateralized basis to borrow an amount
equal to the lease payments for the asset under similar terms, which is10.41%. Lease expense for the lease is recognized on a straight-line
basis over the lease term.
**
The
Companys leases do not contain any residual value guarantees or material restrictive covenants. Leases with a lease term of 12
months or less are not recorded on the balance sheet and lease expense is recognized on a straight-line basis over the lease term. The
Company currently has no finance leases.
The Companys sole operating lease has a one-time
option to renew the lease term for an additional sixty months. In accordance with ASC 842, the lease term excludes the renewal option
period, as the Company is not reasonably certain to exercise the option.
During the second quarter of 2025, the Company entered
into a sublease arrangement with a third party for the remaining term of the head lease, as the underlying facility is no longer being
utilized due to the pause in the Companys electric vehicle manufacturing operations. The sublease term does not extend beyond the
noncancelable period of the head lease.
As of December 31, 2025, the Company has concluded
that it does not have an economic incentive to exercise the renewal option. Accordingly, the renewal period has not been included in the
measurement of the lease liability or right-of-use asset. The Company will continue to reassess this conclusion if facts and circumstances
change.
During the year ended December 31, 2025, the Company recognized sublease
income of $274,623, which is recorded as a reduction of general and administrative expense within the consolidated statement of operations.
No sublease income was recognized during the year ended December 31, 2024. The Company does not have any sublease arrangements that extend
beyond the remaining term of the head lease, and accordingly, no additional future sublease income has been included beyond the contractual
sublease term.
During
the year ended December 31, 2024, the Company reassessed the carrying value of its right-of-use asset due to a sublease arrangement and
concluded that the carrying amount of the right-of-use asset exceeded its estimated recoverable amount. Consequently, an impairment charge
of $44,175was recognized in the consolidated statement of operations for the year ended December 31, 2024.
During
the years ended December 31, 2025 and 2024, cash paid for amounts included in the measurement of lease liabilities - operating cash flows
from operating lease were $261,223and $254,277, respectively. Total lease expense is allocated to selling, general and administration
expense, and cost of goods sold. The components of lease expense (within different expense groupings) consist of the following:
SCHEDULE
OF LEASE COST
| 
| | 
| | | | 
| | | |
| 
| | 
Years Ended December 31, | | |
| 
| | 
2025 | | | 
2024 | | |
| 
Operating lease expense | | 
$ | 244,785 | | | 
$ | 244,785 | | |
| 
Variable lease expense | | 
| 91,719 | | | 
| - | | |
| 
Short-term lease expense | | 
| 327,305 | | | 
| 190,203 | | |
| 
Total lease cost | | 
$ | 663,809 | | | 
$ | 434,988 | | |
| 
| | 
| | | | 
| | | |
| 
Sublease income | | 
$ | (274,623 | ) | | 
$ | - | | |
Variable lease expense consists primarily of the Companys
proportionate share of common area maintenance, real estate taxes, insurance, utilities, and other operating costs under its real estate
lease, which are recognized as incurred.
Sublease income includes fixed rental payments as
well as reimbursements from the subtenant for common area maintenance, taxes, insurance, and other operating expenses.
Sublease income exceeded operating lease expense for
the year ended December 31, 2025, due to the timing and structure of the sublease arrangement. The Company remains obligated under the
head lease and recognized an impairment of the related ROU asset related to the sublease during the year ended December 31, 2024, based
on expected future cash flows over the remaining lease term.
Balance
sheet information related to leases consists of the following:
SCHEDULE
OF BALANCE SHEET INFORMATION RELATED TO LEASES
| 
| | 
| | | | 
| | | |
| 
| | 
December 31, | | |
| 
| | 
2025 | | | 
2024 | | |
| 
Assets | | 
| | | | 
| | | |
| 
Operating lease right-of-use asset | | 
$ | 227,171 | | | 
$ | 429,819 | | |
| 
Total lease assets | | 
$ | 227,171 | | | 
$ | 429,819 | | |
| 
| | 
| | | | 
| | | |
| 
Liabilities | | 
| | | | 
| | | |
| 
Current liabilities: | | 
| | | | 
| | | |
| 
Lease obligation operating lease | | 
$ | 250,517 | | | 
$ | 219,085 | | |
| 
Noncurrent liabilities: | | 
| | | | 
| | | |
| 
Lease obligation - operating lease, net of current portion | | 
| 33,225 | | | 
| 283,742 | | |
| 
Total lease liability | | 
$ | 283,742 | | | 
$ | 502,827 | | |
As
of December 31, 2025, the weighted-average remaining lease term and discount rate is as follows:
SCHEDULE
OF WEIGHTED AVERAGE REMAINING LEASE TERM AND DISCOUNT RATE
| 
Weighted average remaining lease term (in years) operating lease | | 
| 1.20 | | |
| 
Weighted average discount rate operating lease | | 
| 10.41 | % | |
Future
minimum lease payment under non-cancellable leases as of December 31, 2025, are as follows:
SCHEDULE
OF FUTURE MINIMUM LEASE PAYMENTS
| 
| | 
Operating Leases | | |
| 
2026 | | 
$ | 268,378 | | |
| 
2027 | | 
| 44,929 | | |
| 
Total minimum lease payments | | 
| 313,307 | | |
| 
Less: effects of discounting | | 
| (29,565 | ) | |
| 
Present value of future minimum lease payments | | 
$ | 283,742 | | |
| F-28 | |
**NOTE
10. FAIR VALUE MEASUREMENTS**
Fair
value measurements discussed herein represent managements best estimate of fair value as of and during the year ended
December 31, 2025 and 2024. The fair value of the bifurcated embedded derivative related to the convertible preferred stock was estimated
using a Monte Carlo simulation model, which uses as inputs the fair value of the Companys common stock and estimates for the
equity volatility and traded volume volatility of the Companys common stock, the time to maturity of the convertible
preferred stock, the risk-free interest rate for a period that approximates the time to maturity, dividend rate, a penalty dividend
rate, and the Companys probability of default. The fair value of the warrant liability was estimated using the Black Scholes
Model which uses as inputs the following weighted average assumptions, as noted above: dividend yield, expected term in years,
equity volatility, and risk-free interest rate.
The Company determines the fair value of its financial instruments in accordance with ASC 820, Fair Value
Measurement. The fair value hierarchy, which prioritizes the inputs used in measuring far value, is described in Note 3. Summary
of Significant Accounting Policies.
**Fair
Value on a Recurring Basis**
The
Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each
reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The estimated
fair value of marketable securities and money market accounts represents a Level 1 measurement. The estimated fair value of the warrant
liability and bifurcated embedded derivatives represent Level 3 measurements.
Level 3 financial instruments are valued using significant
unobservable inputs and require the use of judgment and estimates by management.
The following table presents information about the Companys
liabilities that are measured at fair value on a recurring basis as of December 31, 2025 and 2024, and indicates the fair value hierarchy
of the valuation inputs the Company utilized to determine such fair value:
The
following table sets forth a summary of the Companys assets and liabilities that are measured at fair value on a recurring basis:
SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS
| 
| | 
December
31, 2025 | | | 
December
31, 2024 | | |
| 
Fair
Value Level 1 | | 
Cash
Equivalents | | | 
Marketable
Securities | | | 
Cash
Equivalents | | | 
Marketable
Securities | | |
| 
Prime institutional money market fund | | 
$ | | | | 
$ | 450,250 | | | 
$ | 13,891,997 | | | 
$ | 4,089,832 | | |
| 
U.S. Treasury Notes 
under 90 days | | 
| 1,007,324 | | | 
| | | | 
| | | | 
| | | |
| 
U.S.
Treasury Notes over 90 days | | 
| | | | 
| 2,718,112 | | | 
| | | | 
| | | |
| 
Total
debt investments | | 
$ | 1,007,324 | | | 
$ | 3,168,362 | | | 
$ | 13,891,997 | | | 
$ | 4,089,832 | | |
| 
Fair
Value Level 3 | | 
Warrant
Liability | | | 
Derivative
Liability | | | 
Warrant
Liability | | | 
Derivative
Liability | | |
| 
Derivative
financial instruments | | 
$ | | | | 
$ | 19,000 | | | 
$ | 2,362,900 | | | 
$ | 2,661,000 | | |
| 
Total
financial derivatives | | 
$ | | | | 
$ | 19,000 | | | 
$ | 2,362,900 | | | 
$ | 2,661,000 | | |
The
following table sets forth a summary of the change in the fair value of the warrant liability, which is considered a Level 3 investment,
which is measured at fair value on a recurring basis:
SCHEDULE OF CHANGE IN FAIR VALUE WARRANT LIABILITY
| 
Balance on December 31, 2023 | | 
$ | 13,319,800 | | |
| 
Balance on December 31, 2023 | | 
$ | 13,319,800 | | |
| 
Change
in fair value of warrant liability | | 
| (10,956,900 | ) | |
| 
Balance on December 31, 2024 | | 
| 2,362,900 | | |
| 
Add: Fair value of Series
I warrant liability | | 
| 3,981,034 | | |
| 
Reclassification of warrants
to equity upon amendment | | 
| (17,410,379 | ) | |
| 
Change
in fair value of warrant liability | | 
| 11,627,100 | | |
| 
Balance on December 31,
2025 | | 
$ | | | |
During
the year ended December 31, 2025, the Company recorded a loss of $11,627,100, respectively, related to the change in fair value of the
Series H-7 and I Warrant liability which is recorded in other income (expense) on the consolidated statements of operations. During the
year ended December 31, 2024, the Company recorded a gain of $10,956,900 related to the change in fair value of the Series H-7 Warrant
liability which is recorded in other income (expense) on the consolidated statements of operations.
These fair value measurements are classified within
Level 3 of the fair value hierarchy due to the use of significant unobservable inputs.
The fair value of the Series H-7
Warrants and Series I Warrants of $0 and $2,362,900 were estimated at December 31, 2025 and 2024, respectively, utilizing the Black Scholes
Model, with the following inputs:
SCHEDULE OF BLACK SCHOLES MODEL INPUTS AND VALUATION TECHNIQUES
| 
| | 
December
31, | | | 
December
31, | | |
| 
| | 
2025 | | | 
2024 | | |
| 
Stock price | | 
$ | 7.37 | | | 
$ | 10.88 | | |
| 
Exercise price | | 
$ | 6.19 | | | 
$ | 32.00 | | |
| 
Dividend yield | | 
| 0.0 | % | | 
| 0.0 | % | |
| 
Remaining terms | | 
| 3.11 | | | 
| 3.61 | | |
| 
Equity volatility | | 
| 71.0 | % | | 
| 75.0 | % | |
| 
Risk-free interest rate | | 
| 3.7 | % | | 
| 4.3 | % | |
The
following table sets forth a summary of the change in the fair value of the derivative liability, which is considered a Level 3 investment,
that is measured at fair value on a recurring basis:
SCHEDULE OF CHANGE IN FAIR VALUE OF DERIVATIVE LIABILITY
| 
Balance on December 31, 2023 | | 
$ | 9,400,000 | | |
| 
Balance on December 31, 2023 | | 
$ | 9,400,000 | | |
| 
Change
in fair value of derivative liability | | 
| (6,739,000 | ) | |
| 
Balance on December 31, 2024 | | 
| 2,661,000 | | |
| 
Add: Fair value of Series
I derivative liability | | 
| 24,000 | | |
| 
Add: Change in fair value
Series H-7 derivative liability due to amendment | | 
| 188,000 | | |
| 
Change
in fair value of derivative liability | | 
| (2,854,000 | ) | |
| 
Balance on December 31,
2025 | | 
$ | 19,000 | | |
| F-29 | |
During
the years ended December 31, 2025 and 2024, the Company recorded income of approximately $2,654,000 and $6,739,000, respectively, related
to the change in fair value of the derivative liability which is recorded in other income (expense) on the consolidated statements of
operations.
These fair value measurements are also classified
within Level 3 of the fair value hierarchy due to the use of significant unobservable inputs.
The Company estimated the $19,000 and $2,661,000 fair value of the bifurcated embedded derivative at December 31, 2025 and
December 31, 2024, respectively, using a Monte Carlo simulation model, with the following inputs:
SCHEDULE OF MONTE CARLO SIMULATION MODEL INPUTS AND VALUATION TECHNIQUES
| 
| | 
December
31, | | | 
December
31, | | |
| 
| | 
2025 | | | 
2024 | | |
| 
Volatility | | 
| 130.0 | % | | 
| 70.0 | % | |
| 
Time to maturity | | 
| 1.10 | | | 
| 0.58 | | |
| 
Discounted market interest | | 
| 7.5 | % | | 
| 9.1 | % | |
| 
Dividend rate | | 
| 7.0 | % | | 
| 8.0 | % | |
| 
Penalty dividend rate | | 
| 15.0 | % | | 
| 15.0 | % | |
| 
Probability of default | | 
| 9.0 | % | | 
| 15.1 | % | |
The valuation of the Companys
Level 3 financial instruments is inherently subjective, as it requires the use of significant unobservable inputs. Changes in these inputs
could result in materially different fair value measurements. In particular, increases in the Companys stock price, expected volatility,
or expected term, as well as decreases in the discount rate or probability of default, would generally result in a higher fair value of
the derivative and warrant liabilities, while decreases in these inputs would generally result in a lower fair value. The Company evaluates
the sensitivity of its fair value measurements to changes in significant unobservable inputs as part of its valuation process.
**NOTE
11. INVESTMENTS IN MARKETABLE SECURITIES**
The Companys investments consist of (i) U.S. Treasury bills and
notes and (ii)investments in a U.S. government money market fund. These investments are measured at fair value with changes in fair value
recognized in. earnings within Other income (expense), net in the consolidated statements of operations.
The Company classifies investments with original maturities of three months
or less at the date of purchase as cash and cash equivalents and those with original maturities greater than three months as marketable
securities.
Trading debt securities: The Companys U.S.
Treasury bills and notes are classified as trading debt securities and are recorded at fair value. Realized and unrealized gains and losses
are recognized in earnings.
Money market fund: The Company also invests in a prime institutional money market fund, which is a pooled investment
vehicle that invests in a diversified portfolio of short-term, high-quality debt instruments, including U.S. government securities, commercial
paper, certificates of deposit, and repurchase agreements. The investment is recorded at fair value and changes in fair value are recognized
in earnings.
The
following table summarizes the Companys trading securities by major investment type as of December 31, 2025 and
2024:
SCHEDULE
OF INVESTMENTS TRADING SECURITIES
| 
| | 
December
31, | | | 
December
31, | | |
| 
Security
Type: | | 
2025 | | | 
2024 | | |
| 
U.S. Treasury
Bills | | 
$ | 2,718,112 | | | 
$ | 4,089,832 | | |
| 
U.S.
Treasury Notes | | 
| | | | 
| | | |
| 
Total
U.S. Treasury Securities | | 
$ | 2,718,112 | | | 
$ | 4,089,832 | | |
| 
Prime institutional money market fund | | 
| 450,250 | | | 
| | | |
| 
Total
Trading Securities | | 
$ | 3,168,362 | | | 
$ | 4,089,832 | | |
The Company recognized unrealized losses of $91,936 and $98,315 for the years ended December 31, 2025 and 2024, respectively,
and realized gains of $409,818 and $1,322,971 for the years ended December 31, 2025 and 2024, respectively.
| F-30 | |
**NOTE
12. SEGMENT REPORTING**
The
Company currently operates as one
operating segment, which is also the sole reportable segment. The Companys CODM is its Executive Chairman and Principal
Executive Officer, who assess performance and makes all resource allocation decisions based on consolidated net income
(loss).
The CODM does not review discrete financial information
or separate performance metrics for any individual business activity and all decisions are made based on consolidated results. The measure
of segment assets is consolidated total assets as presented on the consolidated balance sheets. The accounting policies of the segment
are the same as those described in Note 3. Summary of Significant Accounting Policies.
During the third quarter of 2025, the Company adopted a digital asset treasury management strategy. These activities
are managed centrally and discrete operating results are not regularly reviewed separately by the CODM; accordingly, they are included
within the single reportable segment.
In
addition to the significant expense categories included within net loss presented on the Companys Consolidated Statements of Operations,
see below for disaggregated amounts that comprise consulting and personnel expenses:
SCHEDULE OF CONSOLIDATED STATEMENTS OF OPERATIONS
| 
| | 
2025 | | | 
2024 | | |
| 
| | 
Years
Ended December 31, | | |
| 
| | 
2025 | | | 
2024 | | |
| 
Consulting expenses | | 
$ | 4,822,857 | | | 
$ | 4,578,735 | | |
| 
Personnel expenses | | 
| 2,394,957 | | | 
| 3,336,242 | | |
| 
Other
expenses* | | 
| 2,281,925 | | | 
| 4,874,832 | | |
| 
Total
operating expenses | | 
$ | 9,499,739 | | | 
$ | 12,789,809 | | |
| 
* | 
Other
expenses materially comprised of rent, property taxes, insurance, depreciation, licenses and business taxes, software subscription
fees, issuance cost, bad debt, dues and subscriptions, travel and entertainment, and marketing. Other expenses includes loss on impairment
of long-lived assets of $1,659,835 for the year ended December 31, 2024. | |
**NOTE
13. RELATED-PARTY TRANSACTIONS**
Gilbert
Villarreal, the president of the Companys subsidiary, Ayro Operating Company, Inc. (AYRO Operating), through GLV
Ventures and Electric Power, entities owned and controlled by Mr. Villarreal, has been providing consulting services to the Company in
connection with the reengineering of the Companys Vanish at a rate of $30,000 per month. In addition to the compensation paid
to Mr. Villarreal as president of AYRO Operating, see below for related-party incurred expenses and liabilities:
**Related-Party
Incurred Expenses**
SCHEDULE OF RELATED-PARTY INCURRED EXPENSES AND LIABILITIES
| 
Related Party | | 
Classification | | 
2025 | | | 
2024 | | |
| 
| | 
| | 
Years
Ended December 31, | | |
| 
Related Party | | 
Classification | | 
2025 | | | 
2024 | | |
| 
Electric Power
Energy | | 
Research and development | | 
$ | 630,544 | | | 
$ | 99,070 | | |
| 
Electric
Power Energy | | 
General
and administrative | | 
| 904,431 | | | 
| 374,972 | | |
| 
Total | | 
| | 
$ | 1,534,975 | | | 
$ | 474,042 | | |
| 
Related party incurred expenses | | 
| | 
$ | 1,534,975 | | | 
$ | 474,042 | | |
**Related-Party
Liabilities**
| 
Related Party | | 
Classification | | 
December
31, 2025 | | | 
December
31, 2024 | | |
| 
Electric
Power Energy | | 
Accrued
expenses and other current liabilities | | 
$ | 5,000 | | | 
$ | 103,717 | | |
| 
Total | | 
| | 
$ | 5,000 | | | 
$ | 103,717 | | |
| 
Related-party
liabilities | | 
| | 
$ | 5,000 | | | 
$ | 103,717 | | |
| F-31 | |
**NOTE
14. INCOME TAXES**
****
****
****
The Company adopted ASU 2023-09
on January 1, 2025, on a prospective basis. Accordingly, the enhanced income tax disclosures required under the new standard are presented
only for the year ended December 31, 2025. Prior period amounts have not been recast and are therefore not comparable.
**Components
of Income Tax Expense (Benefit)**
The
components of income tax expense (benefit) from continuing operations for the years ended December 31, 2025 and 2024, are as follows:
SCHEDULE OF COMPONENTS
OF INCOME TAX EXPENSE (BENEFIT)
| 
| | 
December 31, 2025 | | | 
December 31, 2024 | | |
| 
Current income tax expense (benefit): | | 
| | | | 
| | | |
| 
Federal | | 
$ | | | | 
$ | | | |
| 
State | | 
| | | | 
| | | |
| 
Foreign | | 
| | | | 
| | | |
| 
Total current income taxes | | 
$ | | | | 
| | | |
| 
Deferred income tax expense (benefit): | | 
| | | | 
| | | |
| 
Federal | | 
$ | 2,395,152 | | | 
$ | 3,866,700 | | |
| 
State | | 
| 3,612 | | | 
| 158,207 | | |
| 
Foreign | | 
| | | | 
| | | |
| 
Total deferred income taxes | | 
2,398,764 | | | 
4,024,907 | | |
| 
Change in valuation allowance | | 
| (2,398,764 | ) | | 
| (4,024,907 | ) | |
| 
Income tax expense (benefit) | | 
$ | | | | 
$ | | | |
The
Company recorded no current or deferred income tax expense for the years ended December 31, 2025 and 2024, primarily due to losses and
a full valuation allowance on deferred tax assets.
**Enhanced Disclosures (ASU 2023-09 2025)**
Effective Tax Rate Reconciliation (2025)
****
The
following is a reconciliation of the statutory federal income tax rate applied to pre-tax net loss compared to the income taxes in the
statement of operations for the year ended December 31, 2025.
In
accordance with ASU 2023-09, reconciling items greater than 5% of the statutory tax rate are presented separately. Amounts below this
threshold are aggregated within Other. The 2025 reconciliation below is not presented on a comparable basis with prior
periods due to the adoption of ASU 2023-09.
SCHEDULE OF RECONCILIATION
| 
| | 
Amount | | | 
% of Pretax Income | | |
| 
Income tax benefit at statutory U.S. federal rate (21%) | | 
$ | (4,428,721 | ) | | 
| (21.00 | %) | |
| 
Warrant liability | | 
| 2,441,691 | | | 
| 11.36 | % | |
| 
Derivative liability | | 
| (599,340 | ) | | 
| (2.84 | %) | |
| 
Change in valuation allowance | | 
| 2,398,764 | | | 
| 11.37 | % | |
| 
Other (1) | | 
| 187,606 | | | 
| 0.89 | % | |
| 
Income tax expense (benefit) | | 
$ | | | | 
| 0.00 | % | |
| 
(1) | Includes
equity-based compensation, state taxes, return to provision adjustments, and other individually
immaterial items. | |
Income
Taxes Paid (Disaggregated) 2025
SCHEDULE
OF INCOME TAX PAID
| 
(in dollars) | | 
| Amount | | |
| 
U.S. federal | | 
$ | | | |
| 
U.S. state | | 
| | | |
| 
Foreign | | 
| | | |
| 
Total income taxes paid | | 
$ | | | |
**Legacy
Disclosures (ASC 740 2024)**
The following is a reconciliation of the statutory
federal income tax rate applied to pre-tax net loss compared to the income taxes in the statement of operations as of December 31, 2024.
| 
| | 
December
31, 2024 | | 
|
| 
Income tax benefit
at statutory U.S. federal rate | | 
$ | (368,651 | ) | 
|
| 
Warrant liability | | 
| (2,300,949 | ) | 
|
| 
Derivative liability | | 
| (1,415,190 | ) | 
|
| 
Equity based compensation | | 
| 217,188 | | 
|
| 
Income tax expense/(benefit)
attributable to U.S. states | | 
| (2,372 | ) | 
|
| 
Change in valuation allowance | | 
| 4,024,907 | | 
|
| 
Change in state tax rate | | 
| (64,328 | ) | 
|
| 
Return to provision adjustments | | 
| (91,202 | ) | 
|
| 
Other | | 
| 597 | | 
|
| 
Total
tax expense | | 
$ | 0.00 | | 
|
**Deferred Income Taxes**
Deferred
income taxes reflect the net effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting
purposes and the amounts used for income tax purposes. The following table sets forth deferred income tax assets and liabilities as of
the date shown:
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES
| 
| | 
December
31, 2025 | | | 
December
31, 2024 | | |
| 
Deferred tax assets: | | 
| | | | 
| | | |
| 
Net
operating losses | | 
$ | 26,315,852 | | | 
$ | 24,007,075 | | |
| 
Intangible
assets | | 
| 74,149 | | | 
| 78,264 | | |
| 
Capitalized
research and development expense | | 
| 1,560,586 | | | 
| 2,203,714 | | |
| 
Equity
based compensation | | 
| 266,758 | | | 
| | | |
| 
Lease
liability | | 
| 61,267 | | | 
| 108,573 | | |
| 
Warrants | | 
| 142,765 | | | 
| 22,405 | | |
| 
Digital assets | | 
| 464,455 | | | 
| | | |
| 
Other | | 
| 400,898 | | | 
| 531,543 | | |
| 
Deferred tax assets | | 
| 29,286,730 | | | 
| 26,951,574 | | |
| 
| | 
| | | | 
| | | |
| 
Deferred tax liabilities | | 
| | | | 
| | | |
| 
ROU asset | | 
| (49,052 | ) | | 
| (92,809 | ) | |
| 
Other | | 
| (5,168 | ) | | 
| (25,020 | ) | |
| 
Deferred tax liabilities | | 
| (54,220 | ) | | 
| (117,829 | ) | |
| 
| | 
| | | | 
| | | |
| 
Valuation
allowance | | 
| (29,232,509 | ) | | 
| (26,833,745 | ) | |
| 
Net
deferred tax asset/(liability) | | 
$ | | | | 
$ | | | |
| F-32 | |
In assessing the realization of deferred tax assets,
management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized.
The ultimate realization of deferred tax assets is dependent upon the generation of future rewrite taxable income during the periods
in which the net operating losses and temporary differences become deductible. Management considers the scheduled reversal of deferred
tax liabilities, projected future taxable income, and projections for future taxable income over periods in which the deferred tax assets
are deductible. Management believes it is more likely than not that the Company will not realize the benefits of these deductible differences.
A valuation allowance has been applied to the amount of deferred tax assets management expects will be unrealized.
The Companys policy is to record interest and
penalties associated with unrecognized tax benefits as additional income taxes in the statement of operations. As of January 1, 2025,
the Company hadnounrecognized tax benefits and no charge during 2025, and accordingly, the Company did not recognize any interest
or penalties during 2025 related to unrecognized tax benefits. There is no accrual for uncertain tax positions as of December 31, 2025.
The
Company has federal net operating loss carryforwards of $112,929,929 and $101,941,194 as of December 31, 2025 and 2024, respectively. $995,801 of the
federal net operating loss is subject to a 20 year carry forward, with a portion beginning to expire in 2036. $111,934,128 of the federal net
operating loss has an indefinite carry forward period. The Company has State net operating loss carryforwards totaling $55,089,305 and $56,427,513
at December 31, 2025 and 2024. The Company has various state net operating loss carryforwards. The determination of the state net operating
loss carryforwards is dependent upon apportionment percentages and state laws that can change from year to year and impact the amount
of such carryforwards. If such net operating loss carryforwards are not utilized, they will begin to expire in 2031.
The
following table sets for the tax years subject to examination for the major jurisdictions where the Company conducted business in the
prior years and as of December 31, 2025.
****SCHEDULE OF INCOME TAX EXAMINATION
| 
Federal | 
| 
2021
to 2025 | |
| 
Texas
and Georgia | 
| 
2020
to 2025 | |
****
Federal
and state laws impose substantial restrictions on the utilization of NOL carryforwards in the event of an ownership change for income
tax purposes, as defined in Section 382 of the Internal Revenue Code (IRC). Pursuant to IRC Section 382, annual use of
the Companys NOL carryforwards may be limited in the event a cumulative change in ownership of more than 50% occurs within a three-year
period. The Company has not completed an IRC Section 382 analysis regarding the limitation of NOL carryforwards.
However,
it is possible that past ownership changes will result in the inability to utilize a significant portion of the Companys NOL carryforward
that was generated prior to any change of control. The Companys ability to use its remaining NOL carryforwards may be further
limited if the Company experiences an IRC Section 382 ownership change in connection with future changes in the Companys stock
ownership.
The
Tax Cuts and Jobs Act (TCJA) requires taxpayers to capitalize and amortize research and experimental expenditures under
IRC Section 174 for tax years beginning after December 31, 2021. This rule became effective for the Company during the year ended December
31, 2022 and resulted in the capitalization of research and development costs of $1,394,905 and $1,493,202 during the years ended December 31,
2025 and 2024, respectively. Before the TCJA, businesses have had the option of deducting Section 174 expenses in the year incurred or
capitalizing and amortizing the costs over five years. The Company will amortize these costs for tax purposes over five years if the
research and development was performed in the U.S. and over 15 years if research and development was performed outside the U.S.
****
**NOTE
15. SUBSEQUENT EVENTS**
The
Company has evaluated subsequent events and transactions that occurred after the balance sheet date through the date the financial statements
were issued, which is the date the Company filed its Form 10-K. Based on this evaluation, the Company has determined that there were no subsequent events that require adjustment to or
disclosure in the accompanying consolidated financial statements.
| F-33 | |